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“A boy became a man when he killed his first full-grown buck. From an early 
age his father, uncles and grandfather taught him the ways of hunting. The 
hunter is required to follow traditions that insure good hunting and unselfish 
sharing of the harvest.” 
 
Washoe’s Boy's Rite-of-Passage 
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Summary 
Immunological tolerance, that is, the failure to mount an immune response to 
an otherwise immunogenic molecule, is one of the fundamental questions in 
immunology. The fact that lymphocytes express antigen receptors that are 
generated randomly and have the potential to recognize any conceivable 
antigen, adds another puzzle to the physiology of immunological tolerance. 
The other side of the coin, the general absence of immune responses to self 
antigens, is ensured by a tight regulation and several selection steps during 
T and B cell differentiation. One of these processes is the differentiation of 
regulatory T cells (Treg). While developing in the thymus, T cell clones 
bearing receptors with high affinity/avidity to antigens present at the time of 
differentiation may be eliminated by apoptosis or, alternatively, express 
Foxp3 and become Treg. Treg are key players in the regulation of 
immunological tolerance since humans and mice with complete loss of 
function variants of this gene develop fatal autoimmune conditions early in 
life. Importantly, peripheral CD4+Foxp3- T cells have recently been 
demonstrated to acquire Foxp3 expression upon stimulation in a non-
inflammatory environment. Thus, understanding how Treg develop and 
function may be expected to guide future therapeutic approaches. 
The focus of this thesis is therefore to address rules and factors that affect 
Treg differentiation, in particular cell intrinsic properties related to T cell 
ontogeny. Making use of several transgenic (Tg) mouse strains, we 
addressed: I) the source of Treg specific to peripherally administered antigen 
in an inflammatory setting; II) the susceptibility of T cells at different states of 
maturation to upregulate Foxp3; and III) the function and stability of Treg 
developed from peripheral cells. 
It is established that peripheral antigens, either blood born or transported by 
dendritic cells, can impact on thymic selection leading to deletion or Treg 
differentiation in clones that recognize such antigens. However, it was not 
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known if peripheral antigens can also contribute to these processes in 
inflammatory settings. Using TCR Tg mice that recognize either self or 
exogenous antigens we showed that Treg can develop in the thymus after 
peripheral Ag immunization with a strong adjuvant and demonstrated that 
the thymus was essential to achieve a tolerant state. In the self reactive TCR 
Tg strain, Treg were also found to be essential to prevent the spontaneous 
autoimmune disease that develops in untreated mice. We further 
demonstrated that thymocytes, unlike peripheral T cells, are refractory to IL-
6, a cytokine that inhibits Foxp3 induction in mature cells. 
We then assessed the capacity of immature cells to upregulate Foxp3 
outside the thymus. A small fraction of naïve Foxp3- CD4 T cells upregulates 
Foxp3 when adoptively transferred to lymphopenic recipients. Using this 
experimental system we report that CD4 Foxp3- SP thymocytes differentiate 
to Treg more efficiently than peripheral naive CD4 Foxp3- cells. We then 
showed that this results from an intrinsic property of the cell that does not 
require the presence of the thymus in recipient mice. By varying the number 
of recent thymic emigrants (RTE) in the transferred cells by thymectomizing 
donor mice or by cell sorting, we demonstrated that RTE are the main 
source of Treg differentiated during lymphopenia induced proliferation (LIP). 
Last, by manipulating available TGF or the sensitivity of T cells to TGF, we 
found that immature, but not mature, cells are able to differentiate into Treg 
when TGF availability is limited. 
Finally, we assessed the function and stability of Treg differentiated from 
peripheral cells in vivo, and once again using the lymphopenia induced 
proliferation model, we demonstrated that upregulation of Foxp3 by 
peripheral cells limits LIP. Then, by isolating Foxp3+ developed during LIP 
(iTreg) and performing secondary adoptive transfer together with fresh 
Foxp3- cells, we found that few cells from iTreg origin were recovered. 
Nevertheless, these cells kept Foxp3 expression showing that Treg derived 
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in vivo from peripheral cells are stable. The low recovery of iTreg could be 
due to a requirement of factors secreted by the activated T cells that were 
present when they differentiated in the first transfer. In concordance with this 
hypothesis we found that in vivo derived iTreg upregulate the IFN- receptor 
which matches the dominant Th1 polarization associated with LIP, 
consistent with the recently described notion of Treg plasticity. 
In conclusion, the work in this thesis shows that T cells lose the potential to 
become Treg as they age in a cell intrinsic manner that also applies to 
extrathymic Treg differentiation.  This new piece of information suggests that 
therapeutic interventions aiming at generating tolerance through Treg will 
have a higher chance of success if administered at the earliest age possible. 
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Título 
A Maturação das Células T e a Diferenciação de Células T Reguladoras: Do 
Timo à Periferia 
Resumo 
A Tolerância Imunológica, ou seja, a ausência de uma resposta imunitária a 
moléculas de outro modo imunogénicas, é uma das questões fundamentais 
em imunologia. O facto de os linfócitos expressarem recetores de antigénio 
que são gerados aleatoriamente com o potencial de reconhecerem qualquer 
antigénio concebível acrescenta um quebra-cabeças formidável à fisiologia 
da tolerância imunológica. No entanto, a ausência de resposta imunitária 
contra antigénios do próprio organismo é garantida por uma forte regulação 
e vários passos de seleção no processo de diferenciação dos linfócitos T e 
B. Um destes processos é a diferenciação de células T reguladoras (Treg). 
Ao maturarem no timo, clones de células T que apresentam recetores com 
alta afinidade/avidez para antigénios presentes no momento são induzidas a 
entrar em apoptose ou, a expressarem o fator de transcrição Foxp3 e assim 
diferenciarem-se em Treg. O fato de Humanos e ratinhos com uma 
deficiência completa da proteína Foxp3 desenvolverem, rapidamente após o 
nascimento, condições fatais de origem autoimune, ilustra o carácter 
essencial das Treg. Mais recentemente foi descrito que células já 
exportadas do timo também apresentam capacidade de expressar Foxp3 
quando estimuladas em condições não inflamatórias. Desta forma, é 
esperado que a elucidação da fisiologia das Treg possa guiar aplicações 
terapêuticas futuras. 
O foco desta tese é estudar regras e fatores que afetam a diferenciação das 
Treg, em particular propriedades intrínsecas das células T relacionadas com 
a sua ontogenia. Usando várias estirpes de ratinhos transgénicos (Tg), 
estudámos: I) a origem das Treg diferenciadas contra antigénios periféricos 
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em condições de inflamação; II) a suscetibilidade de células T em diferentes 
estados de maturação para serem induzidas a expressar Foxp3; e III) a 
função e estabilidade das Treg diferenciadas a partir de células isoladas da 
periferia. 
Encontra-se estabelecido que antigénios da periferia, quer em circulação na 
corrente sanguínea ou transportados por células dendríticas, podem 
contribuir para a diversidade antigénica no timo, levando à eliminação ou à 
diferenciação para Treg de clones que os reconhecem. No entanto, não se 
encontrava clarificado se os antigénios periféricos podem participar nos 
mesmos processos durante reações inflamatórias. Através do uso de 
ratinhos que expressam recetores transgénicos reativos quer com 
antigénios endógenos quer exógenos, mostrámos que a diferenciação de 
Treg pode ocorrer no timo após imunização com um adjuvante que gera 
uma forte reação inflamatória. Demonstrámos também que o timo era 
essencial para se atingir um estado de tolerância imunológica. Nas 
experiencias em ratinhos em que o recetor transgénico reconhece um auto-
antigénio demonstrámos que as Treg são essenciais para se obter uma 
proteção da doença autoimune que se desenvolve de forma espontânea 
nesta estirpe. Demonstrámos ainda que os timócitos, ao contrário das 
células periféricas, são refratários ao efeito da IL-6, uma citoquina que inibe 
a expressão de Foxp3 em células maturas. 
De seguida, estudámos a capacidade das células T imaturas de expressar 
Foxp3 fora do timo. Uma pequena fração de células T Foxp3 - isoladas da 
periferia passa a expressar Foxp3 quando as células são transferidas para 
ratinhos linfopénicos. Usando este sistema experimental, observámos que 
os timócitos CD4 SP Foxp3- são mais eficazes a diferenciarem-se em Treg 
do que as células CD4 Foxp3- isoladas da periferia. Demonstrámos ainda 
que esta propriedade é intrínseca das células imaturas e é independente da 
presença do timo nos ratinhos recipientes. Variando a quantidade de células 
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que foram exportadas do timo recentemente (RTE – do inglês Recent 
Thymic Emigrants) na população de células transferidas, quer ao 
timectomizar os dadores ou por isolamento seletivo das células RTE e das 
células já residentes na periferia, demonstrámos que as células RTE são a 
principal fonte de Treg que se diferencia durante a expansão induzida por 
linfopenia. Por último, através da manipulação da quantidade de TGF 
disponível ou a sensitividade das células ao TGF, estabelecemos que as 
células imaturas, ao contrário das imaturas, têm a capacidade de se 
diferenciar em Treg quando os níveis de TGF são limitados. 
Finalmente, testámos a função e estabilidade das Treg diferenciadas in vivo 
a partir de células T isoladas da periferia. Usando novamente o sistema de 
transferência de células para ratinhos linfopénicos, observámos que a 
diferenciação de Treg a partir de células T Foxp3- controla a expansão da 
população global de células T transferidas. Por outro lado, ao isolar as Treg 
diferenciadas a partir de células T periféricas durante a sua expansão em 
recipientes linfopénicos e transferindo-as de novo com uma nova população 
de células Foxp3- isoladas de fresco, observámos que poucas células da 
população que era Foxp3+ eram recuperadas. No entanto, as células 
recuperadas mantiveram a expressão de Foxp3, o que indica representarem 
uma linhagem de Treg estável. O baixo número de Treg recuperado pode 
ser causado por uma necessidade de receber sinais das células T ativadas 
durante a expansão em linfopenia, o que ocorre concomitantemente com 
diferenciação das Treg. De acordo com esta hipótese, verificámos que as 
Treg diferenciadas durante a expansão em linfopenia aumentam o nível do 
recetor para IFN, o que é concordante com a polarização dominante das 
células transferidas para o tipo Th1, e é também consistente com a noção 
recente de plasticidade das Treg. 
Em conclusão, o trabalho apresentado nesta tese demonstra que as células 
T perdem o potencial para se diferenciar em Treg à medida que envelhecem 
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de uma forma intrínseca e que se aplica à diferenciação de Treg fora do 
timo. Este fato sugere que aplicações terapêuticas com o objetivo de 
estabelecer tolerância imunológica através da diferenciação de Treg terão 
uma maior probabilidade de sucesso se forem postas em prática em 
pacientes o mais jovens possível. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
Introduction
Chapter 1 
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This chapter is intended to provide enough background, as it existed at the 
time this doctoral work was initiated, to frame the hypotheses put forward by 
then. This thesis concerns the study of T cells, specifically the differentiation 
and function of a subpopulation of this lymphocyte subset known to provide 
powerful regulation in a broad collection of settings, the Foxp3 expressing 
regulatory T cells (Treg). As such, the results presented in later chapters 
require an introduction on the origin and development of the concept of 
immunological tolerance, T cell differentiation and basic notions on 
regulatory T cell physiology. 
 
1.1 Immunological Tolerance: An historical note 
The development of a theory of Immunity has been attributed to Elie (Ilya) 
Metchnikoff in the end of the 19th century early 20th century (1), however 
Immunology has its foundations in the applications of the first vaccines and 
its examination through the lens of the scientific method performed by 
Edward Jenner in the end of the 18th century (2). The early vaccines in the 
western world were actually only the systematic study, reporting and 
application of a behavior based on centuries of empiric knowledge. There is 
historical evidence supporting that inoculation was already applied 
throughout the globe centuries before the first applications by Jenner. The 
development of the crude forms of immunization are predicted to have been 
put in practice after sporadic observations that individuals that had survived 
an often fatal infectious disease had became protected from contracting it a 
second time (3). In fact, the understanding of vaccines started almost a 
century later after the introduction of vaccination itself (4). With the mounting 
interest in microbiology and the germ theory of disease championed by 
Louis Pasteur (5), the initial explorations into the working of the immune 
system by Metchnikoff (1), Jules Bordet (6), Paul Ehrlich (7) and Robert 
Koch (8, 9), Immunology, as the study of the protection mechanisms 
Chapter 1 
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organisms possess against invading foreign bodies, gained sufficient 
momentum to become a field of research by itself. While the separation of 
immunology from microbiology has in many aspects never taken place, early 
reports and conceptual dwellings of the founding fathers of immunology fell 
upon the possible reactivity against self. Of note, Ehrlich put forward the 
concept of horror autotoxicus, which proposed, without offering an 
explanation, that the organism could not produce pathogenic anti self toxins 
(10). This concept remained an unchallenged dogma despite experimental 
evidence indicating the existence of auto immune diseases and immunology 
concerned the study of protection from pathogens and little attention was 
given to explore the possibility of self reactivity. 
While Metchnikoff exposed his interpretation of natural and acquired 
immunity (1) (which have later been developed to the notions of innate and 
adaptive immunity) he was also in the middle of a scientific riddle that was 
another foundation of immunology. He supported the exclusive cellular 
nature of immunity as opposed to the humoral theory of immunity, of which 
Ehrlich was a fierce supporter. Later, reconciliating experiments showing a 
synergistic effect of blood derived factors with cellular processes to eliminate 
pathogens led to the attribution of the 1908 Nobel Prize in Physiology or 
Medicine to both Metchnikoff and Ehrlich (11, 12). While the cellular theory 
of immunity was based solely in phagocytes the humoral theory was based 
in anti toxins and the components that allow efficient cellular lysis and toxin 
neutralization to take place. 
Retrospectively, the discovery of antibody production could be seen as the 
foundational lead from which modern immunology got its start. The facts that 
an animal could be immunized with an extract of any pathogen and even 
with synthetic molecules (13), and that antibodies would be produced on 
demand, without being detected beforehand, opened a wide array of 
questions. Notably, regarding the identification of the antibodies’ source and 
the mechanisms by which they are formed. With the identification of B cells, 
Chapter 1 
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or at least lymphocytes, as antibody producing cells, the focus turned to the 
questions linked with the ability to mount a response with specificity to any 
given antigen. At this point two competing hypothesis dominated the 
conceptual framework. One was the instructive mechanism, which implied 
that the antigen would itself shape the antibodies with a subsequent auto 
induction to produce more of the same (14). The other, was the elective 
model, in which the pre-existence of a very diverse set of antibodies allows 
that one recognizing the antigen would always be found, and this interaction 
would then stimulate the production of more of the same antibody. The 
cornerstone of this debate can be considered the model developed by Niels 
Jerne and Macfarland Burnet of the clonal selection theory (15, 16), built 
upon the early elective theories (7). In this model it was proposed that the 
antibody producing cells would be the selected unit. A great number of 
antibody producing cells would be generated and upon encounter with the 
antigen the ones producing appropriate antibodies would be selected to 
produce the amounts required to neutralize antigen. The confirmation that 
each cell only produces one antibody (17) and the clarification of the 
mechanism of generation of antibody diversity, by somatic rearrangement of 
B cell receptor genes (18-20), set the field to understand how clones were 
produced and how a functional repertoire is achieved. With the fact that the 
immune system has indeed the ability to generate a virtual infinite set of 
receptors came the question of how is the system set not to attack self, that 
is, immunological self tolerance. 
However, the concept of Immunological tolerance had been already put 
forward, again by Burnet, inspired by the description of Owen and 
colleagues that non-identical calf twins which undergo anastomosis during 
fetal development are immunologically unresponsive to blood from each 
other while mounting an immune response to an unrelated third party blood 
donor (21). Burnet proposed that there would be a time window when the 
organism is developing for the establishment of tolerance to foreign antigens 
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(22). The concepts underlying Burnets theory were then formally 
demonstrated by Peter Medawar and colleagues (23), and both Burnet and 
Medawar shared the 1960 Nobel Prize in Physiology or Medicine for the 
discovery of acquired immunological tolerance.  
Later came developments to the theory for the mechanistic basis of acquired 
tolerance, from a developmental time window (22, 23) and experiments 
addressing recessive and dominant regulation modes have been clarifying 
the processes behind the self/non-self discrimination and anti-self immune 
reactivity regulation and deregulation.  
Joshua Lederberg put forward a theory in line with Burnet’s proposition. 
According to the Lederberg model, cells would first differentiate in a state 
which allowed their disabling in case of self-reactivity (24). While Burnet 
proposed a developmental time window, that is, tolerance could only be 
attained at young age, Lederberg transformed this into a cell age, rather 
than an organism age, interpretation in which recently made cells would 
have this property, which would obviously be more frequent in fetal and 
neonatal life. At this point, the theories concerned the production of 
antibodies and the antibody forming cells. While a role for the thymus to 
establish functional immunity was reported shortly after, the existence of T 
cells and the variable nature of T cell receptors came only some three 
decades later (25-27). Also later came the clarification of the existence of 
MHC recognition and compatibility (28) which added a new piece to the 
puzzle of immunological tolerance. 
With the knowledge about T cells building up, a seminal collection of 
experiments was performed by Le Douarin and colleagues paving the way to 
the demonstration of the existence of regulatory T cells. The ground 
breaking experiments consisted in the transplantation of thymic epithelium 
from quail to chick embryos and showed that only the thymic epithelium 
allowed for lifelong tolerance to a wing transplanted shortly after birth, 
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allowing a quail wing to not be rejected and fully develop (29). The fact that 
the wing transplant was performed during neonatal life, together with earlier 
work showing that neonatal thymectomy led to autoimmune disease (30), led 
to the reformulation of Burnet’s theory to include an essential requirement for 
Thymic T cell selection to achieve a fully functional tolerant T cell 
compartment. Later work applying a similar approach to the mouse model 
organism showed that the thymic epithelium requirement to achieve 
tolerance across MHC incompatible donors was also true in mice (31). It is 
nevertheless worthwhile mentioning that the tolerance put in check in the 
thymic epithelium systems is related to MHC alloreactivity, which may 
involve a specific mode of T cell activation rather than tolerance to a novel 
antigen presented in the MHC in which T cells are selected. 
The strong suggestion of a thymic derived dominant mode of tolerance 
started a race to identify the regulatory cells. This search was based in 
surface sub-phenotyping and cell isolation coupled to functional assays for 
tolerance. This endeavor is extensively reviewed by Shimon Sakaguchi in 
(32) and culminated in the identification of CD25 positive (33), and later 
Foxp3 expressing (34, 35), CD4 T cells as the long sought after Treg subset. 
Even after close to one century of research, immunological tolerance is not 
fully understood. As a good example of our ignorance is the lack of 
understanding for the etiology and of efficient treatment for the majority of 
autoimmune diseases. Likewise, the management of uncontrolled immune 
responses to innocuous agents as allergies is also still rather inefficient. 
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1.2 T cell ontogeny: Thymocytes and Recent Thymic Emigrants 
T cells when stimulated through the TCR in a proinflammatory 
microenvironment differentiate to an effector phenotype that may consist in a 
direct cytotoxic activity (for CD8 T cells) or to become a helper T cell (CD4 T 
cells). As such T cells can be direct effectors in an immune response or 
orchestrate and amplify the response of other cells according to cues 
received from the antigen presenting cells and microenvironment (36-39). 
On the other hand, and as introduced in the section above, T cells are also 
essential actors to attain immunological self tolerance, and the focus of this 
thesis, regulatory T cells, are particularly important in that function. 
When a microorganism invades the host, cells from the innate immune 
system get activated, either by sensing the pathogen directly or by sensing 
alteration in tissue integrity. Such cells, like macrophages, neutrophils, and 
dendritic cells provide an early immune response, which is an initial barrier 
to confine and destroy pathogens. On the other hand, these cell subsets are 
the most common cells to initiate an inflammatory response that leads to the 
participation of the adaptive arm of the immune system (40, 41). Antigen 
presenting cells phagocyte and digest the microorganisms while migrating to 
the LN where they present peptides from the digested material to T cells. T 
cells that recognize processed antigens presented in the context of MHC 
molecules are activated and mobilized to initiate the adaptive phase of the 
immune response. CD4 T cells recognize their cognate antigens presented 
in the context of MHC-II (loads mainly Ags from extracellular origin) and are 
able to interact with B cells that also recognize Ags from the same 
environment and give rise to a humoral immune response. At the same time 
CD4 helper T cells can also potentiate CD8 T cell responses and influence 
the phenotype of other cells of the immune system. On the other hand, CD8 
T cells recognize their cognate Ags when presented in the context of MHC-I 
(mainly loaded with peptides of intracellular origin) and mount a cytotoxic 
immune response (42). 
Chapter 1 
28 
 
Antigen receptors are generated in each clone by re-arranging one of 
several V (D) and J gene segments, with extra nucleotides being added 
and/or deletions taking place in the junction between each segment in the 
recombination events. This mechanism offers the possibility to generate 
TCRs that can recognize any conceivable antigen. However, the rather non-
templated generation of Antigen receptors leads to the generation of non 
functional TCRs and TCRs that recognize self derived Ags. As a 
consequence, T cells have to undergo a stringent selection and maturation 
program to ensure the peripheral, ready to respond, naïve T cells are 
competent to scan MHC molecules in search for foreign antigens while 
presenting minimal anti-self reactivity (43, 44). 
For T cells, this “education” process takes place in the thymus (Fig. 1). The 
immunological role of the Thymus was first reported by Jacques Miller in 
1961 (27), who also later reported the requirement for the presence of both 
thymus and bone marrow derived cells to obtain efficient antibody production 
eventually leading to the identification of B and T lymphocytes (45). Since 
the early progenitors of T cells reside in the bone marrow, T cell progenitors 
have to migrate to the thymus to differentiate into T cells. Common 
Lymphoid Progenitors (Lin- IL-7R+ Thy-1- Sca-1lo c-Kitlo) migrate through 
the blood stream and enter at the Thymus at cortico-medullary junction (46). 
In the first steps of thymocyte maturation, cells go through several stages 
denominated double negative (DN – due to the lack of expression of CD4 
and CD8) which can be subdivided from DN1 to DN4 by the expression of 
CD44 and CD25. The progressive differentiation of Thymocytes to T cells 
takes place while cells migrate from the initial entry point, to the sub capsular 
zone of the thymic cortex, and later to the medulla passing through the 
cortico-medullary junction (46). DN1, or Early T cell progenitors (ETP), are 
characterized by expressing CD44 but not CD25, and retain some potential 
to become dendritic cells, macrophages, Natural killer cells and B cells. 
While differentiation to these lineages is restrained by the thymic 
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Figure 1. Overview of T cell differentiation in the thymus. Haematopoietic 
precursors migrate from the bone marrow through the blood stream and enter the 
thymus in the cortico-medullary junction. After receiving T cell determining signals 
the progenitor undergoes several steps of maturation. First, it upregulates CD44 and 
enters the Double Negative 1 stage (DN1 – CD4
-
CD8
-
), or early T cell precursor 
(ETP), then after receiving further T cell driving signals it progresses to the DN2 
stage, or pro-T cell, where it upregulates CD25 expression becoming CD44
+
CD25
+
. 
Between DN2 and DN3, pre-T, where thymocytes downregulate CD44 becoming 
CD44
-
CD25
+
, RAG1 and RAG2 are expressed and  chain locus of the TCR is 
rearranged. After successful pairing with the pre-T alpha thymocytes progress to the 
DN4 (CD44
-
CD25
-
) and later to the DP stage where RAG1 and RAG2 are re-
expressed and the  chain locus is recombined. At this stage cells that do not 
generate a functional receptor die by neglect due to the lack of the essential survival 
signal provided by a functional TCR and its interaction with MHC. The cells that 
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generate a functional TCR are probed for interaction with MHC-I and MHC-II and 
become committed to the CD8 or CD4 lineage, accordingly to the respective MHC 
with which the TCR forms stable contacts. This is positive selection step and occurs 
through interactions with the cortical thymic epithelial cells (cTECs). After succesfull 
positive selection DP thymocytes cross the cortico-medullary junction to the medulla 
where they interact with DCs and with medullary thymic epithelial cells (mTEC) and 
undergo negative selection. This selection step consists in elimination of clones that 
present TCRs with high affinity/avidity for the presented peptide-MHC complexes. 
Concomitantly, cells that interact with the MHC-II with high affinity/avidity but below 
deletion threshold are diverted to the Treg pool. Adapted from (47). 
 
 
microenvironment, Notch 1 signaling together with transcription factors 
Runx1, Gata-3 and E box proteins enforce a T cell lineage commitment by 
inducing T lineage gene expression (48). After receiving T cell driving 
signals, DN1 cells progress to the DN2 stage, or pro-T cell. This stage is 
characterized by CD25 and CD44 expression and marks the loss of the 
potential to differentiate to other lineages. At the late DN2 and early DN3 
(CD44-CD25+) stages, cells upregulate the enzymes responsible for the 
rearrangement of antigen receptors, the recombination activating genes 1 
and 2 (RAG1 and RAG 2), that, for the case of cells that are directed to the 
 lineage, rearrange the TCR beta chain. The clones with the generated 
gene segments at this stage undergo the  chain selection, which is a test 
for the ability to pair with the pre-T chain and be expressed at the cell 
surface (48, 49). At this point the precursors are at the DN3 stage, or early 
pre-T, and only the clones with a valid TCR progress to the late DN3 and 
then to DN4 (CD25-CD44-), or late pre-T, stages. After a proliferative burst 
cells progress to the Double Positive stage (DP – CD4+CD8+), RAG1 and 
RAG2 are re-expressed and the TCR chain locus recombined (43). At this 
stage, cells are found close to the cortico-medullary junction and it is here, 
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and through the interaction with cortical thymic epithelial cells, that positive 
selection takes place. Clones need to receive survival signals through the 
generated TCR otherwise they undergo programmed cell death, a process 
denominated “death by neglect” (50). After a full TCR molecule is 
expressed at the cell surface, MHC-II or MHC-I valid interaction lead to the 
commitment of the clones to the respective CD4 or CD8 lineage. DP 
thymocytes migrate then through the cortico-medullary junction to the 
medulla where they encounter DCs and medullary thymic epithelial cells 
(46). The interactions with these cell subsets undertake the negative 
selection checkpoint in which clones presenting TCRs with high 
avidity/affinity for the presented antigens are deleted. In the same stage 
clones that present TCRs that interact with peptide-MHC with 
affinities/avidities just below the threshold for deletion are diverted to the 
Treg lineage (51, 52). These last steps are the essential tolerance 
determining mechanisms inside the thymus. Deletion of autoreactive 
thymocytes prevents the majority of self reactive T cell clones from being 
exported to the periphery (recessive tolerance), while the positive selection 
of clones with string interaction with peptide-MHC ascertains peripheral 
recognition of Antigens and dominant tolerance over T cell clones that 
escape deletion. 
The positive and negative selection of generated  and  chains of TCR 
involves the interaction with peptide loaded MHCs. Therefore the efficient 
generation of a functional peripheral pool of T cells by these processes 
depends to a large extent in the diversity and amount of peptides available in 
the thymus. On one hand, efficient positive selection ensures that T cells, 
once in the periphery, will receive low TCR signaling essential for their 
survival. On the other hand, the diversity of antigens is essential for the 
deletion of auto-reactive clones preventing them from reaching the 
periphery. Since Treg are also selected based on the interaction of their 
TCR with peptide-MHC, the diversity of antigen is equally important to 
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generate a Treg pool that can recognize enough peripheral antigens to 
ensure self-tolerance. 
The thymus architecture and cellular composition is known to be correlated 
with the establishment of a functional T cell compartment, and its 
deregulation is usually accompanied by the development of a dysfunctional 
T cell peripheral population (53, 54). However, the antigenic relationship 
between the thymus and the periphery is not fully elucidated. Establishing a 
functional T cell repertoire is tied to the efficient selection of thymocytes and 
the later incorporation of nascent T cells in the peripheral pool. As such, the 
intra and extra thymic T cell maturation are key points to be clarified in order 
to understand how the T cell repertoire develops and to indicate ways it may 
be manipulated with therapeutic goals (55). Antigen diversity in the thymus is 
determined by AIRE driven ectopic expression of peripheral tissue antigens 
in medullary thymic epithelial cells (56), uptake of blood borne antigens (57) 
and by antigen carried by immigrating DC (58, 59). 
Ectopic expression of endogenous antigens is mainly driven by the 
autoimmune regulator (AIRE). AIRE is expressed in medullary thymic 
epithelial cells and is thought to randomly facilitate ectopic gene expression. 
AIRE is essential for immune self-tolerance as it the multi-organ 
manifestations that develop in humans and mice that cannot express a 
functional protein (56). Intriguingly, AIRE is only essential during the first 
days of life which indicates that deletion after the neonatal period has a 
much less preponderant factor than in the initial steps of building a 
peripheral T cell pool (60). The thymus is partially isolated from the 
circulatory system by a thymus-blood barrier (61). However, this barrier, 
while preventing the passage of high molecular weight molecules, is 
permeable to low molecular weight compounds such as free peptides. Last, 
it has been shown that DCs from the skin are able to travel into the thymus 
carrying antigens that can mediate negative selection and induce Treg (62). 
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Despite being known that the antigenic landscape in the thymus has some 
cross talk to the periphery the full characterization of the dynamics and 
constraints of such antigen exchange is still lacking. In particular, we 
address in a later chapter if peripheral antigen could also access the thymus 
in conditions of pro-inflammatory immunization. 
In physiological conditions most T cells come through the intrathymic 
differentiation process able to correctly interact with the host MHC. The 
interaction of selected TCRs allows T cells to scan MHC-peptide complexes 
in search for foreign antigens and, in the absence of foreign antigens, to 
receive low intensity TCR signaling that allows them to survive and be ready 
to mount an efficient response (63, 64). The clones that are on the higher 
end of self reactivity, but have escaped negative selection and induction of 
Foxp3 expression, are controlled by Treg, even if after differentiating to the 
naturally activated/memory pool (65-67). However, when T cells are 
exported from the thymus they are not yet fully mature. Recent thymic 
emigrants (RTE) display specific phenotypic characteristics for which the 
molecular basis is largely unknown (55).  
It is known that TCR signaling threshold is increased in DP thymocytes when 
compared to peripheral T cells. Mainly, the amount of antigen to induce 
deletion of double positive thymocytes is much lower (calculated to be about 
100 fold less) than the amount required to induce an effector T cell 
response. The decrease in the threshold of TCR signaling to elicit a 
response in T cells when compared to deletion ensures a minimally self 
reactive T cell repertoire is established in the periphery (66, 68). However, 
the differences in TCR signaling thresholds in later stages of T cell 
maturation are not fully characterized, particularly after the CD4/CD8 lineage 
commitment. Thymocytes do display a maturation dependent TCR sensitivity 
tuning. The changes in TCR signaling response correlates with differential 
inhibitory co-receptor expression, signaling pathways triggered glycosylation 
of cell surface molecules and specific microRNA expression. These 
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characteristics eventually become indistinguishable from peripheral T cells 
as the cells are exported and incorporate the peripheral pool (69-74).  
However, the study of the steps of maturation that take place outside the 
thymus is still poorly understood, including the molecular basis that rules the 
final maturation of nascent T cells as they incorporate the resident peripheral 
T cell pool (55). While all T cells could be referred to as recent thymic 
emigrants, since it is a question on how long ago the cells differentiated and 
were exported, several studies have indicated a window of around 3 weeks 
were phenotypic characteristics that discriminate RTE from resident T cells  
can still be detected. The recent advances of RTE understanding have been 
manly led by Pamela Fink research group. The fast pace of new findings 
was made possible by the innovative use of a mouse line that expresses a 
green fluorescent protein (GFP) driven by the RAG2 promoter (75) to follow 
RTE. In this mouse line, thymocytes start to express the reporter while in the 
DN stage and achieve high levels of GFP in all DP thymocytes, in 
concordance with the expected RAG expression. In the periphery, more than 
50% CD4 T cells are positive for GFP at 5-6 weeks of age. This percentage 
decreases to background levels by 4 weeks after thymectomy (76). The 
aforementioned results confirm that this mouse model provides an accurate 
tool to identify and isolate RTEs.  This is a big step from the previous 
experimental systems available, such as intrathymic injection or thymus 
graft, which implied heavy manipulation of mice or cells with the inherent 
potential to create artifacts. Using this experimental system it has been 
clearly established that RTE undergo phenotypic changes that occur 
progressively and are concomitantly to the loss of GFP signal. In the 
periphery, it is possible to discriminate 3 populations according to GFP 
expression, a GFPhi (calculated to be T cells exported in the previous week), 
GFPlo (exported between 2-3 weeks) and GFP- (peripheral resident T cells) 
(76). The study of the 3 populations revealed a change in both surface 
phenotype and functional readouts. After thymic export, RTE progressively 
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downregulate CD24, Thy1 and CD3, rapidly loose CD69 expression and 
progressively upregulate Qa-2, CD28, CD45RB and IL7-R. Functionally, 
RTE display an intermediate dependence on IL-2 in in vitro proliferation 
assays, that is, lower dependence than CD4SP thymocytes but higher than 
peripheral resident mature cells. RTE also show a slightly impaired 
upregulation of CD25 upon in vitro activation (76). Later work has shown that 
RTEs are outcompeted by peripheral resident mature cells in lymphoreplete 
recipients, an effect that can be reverted by forced expression of the IL7-
Ror expression of the anti apoptotic protein Bcl-2. However, when in 
lymphopenic hosts RTE are then able to repopulate the peripheral pool as 
well as mature cells, which is concordant with a limiting niche for RTE when 
tested in lymphoreplete recipients (77). Fink group has also reported that  
RTE display a bias to differentiate to a Th2 against Th1 effector T cell 
polarization (78), require contact with lymphoid organs to mature (79), but 
while interaction with MHC shapes the RTE TCR repertoire, it does not 
induce phenotypic maturation. However, the maturation of RTE to a mature 
naïve phenotype seems to be dependant of an yet unidentified dendritic cell 
derived cue (80). 
In the case of Humans, RTE have been mainly studied through the detection 
of the excision circles that are a byproduct of TCR rearrangement (TCR 
rearrangement excision circles – TRECs). Since TRECs do not undergo 
replication with cell divisions, they are diluted as cells proliferate. As a 
consequence, recently exported cells that have undergone fewer cell 
divisions than peripheral resident cells are enriched in TRECs. In any case, 
just after the first cell division one of the daughter cells will not carry the 
TREC which makes this method highly unreliable from the beginning. 
Together with the fact that identification of TRECs does not allow for cell 
isolation, this method offers limited value except for the information of how 
many thymocytes gave rise to the cells for which the TREC content is being 
measured. However, CD31 expression has been more recently identified as 
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a marker that positively discriminates RTE. And, while this marker is 
apparently not identifying all RTEs, the inclusion of PTK7 positive cells has 
recently improved the capacity of researcher to more accurately isolate 
Human RTEs. In general Human RTEs have been reported to display a 
similar phenotype as mouse RTEs. They display poor proliferation and 
produce low amounts of IL-2 and IFN upon in vitro stimulation and their 
survival is highly dependent on IL-7 (81).  
In healthy conditions the peripheral number of T cells is remarkably stable 
(82). The maintenance of peripheral T cell numbers and TCR diversity is a 
maintained by the incorporation of newly formed T cells into the resident 
pool and by proliferation of the resident cells. Replenishment of the 
peripheral T cell pool by proliferation leads to the decrease of T cell diversity, 
due to not all clones proliferating equally and stochastic 
survivability/proliferation. On the other hand, incorporation of newly 
differentiate cells is essential to maintain T cell diversity which is required for 
an efficient immune response to be mounted against pathogens 
encountered for the first time (82).  
Several experimental approaches have shown that T cells have several 
niches which are occupied and competed for, by respective cellular subsets 
(82). By performing thymic grafts under the kidney capsule of euthymic 
recipients it has been demonstrated that the number of cells in the periphery 
of grafted recipients increases accordingly to the expected contribution of 
extra thymic output (83). The increase, while being indexed to the number of 
grafts, reached a plateau illustrated by the number of cells being unaltered 
irrespective of recipients being analyzed 8 or 16 weeks after grafting. After 
thymic removal T cell numbers decayed again to normal levels showing that 
the increase of cell number when the graft was present was exclusively 
derived from the extra production of recent thymic emigrants. Calculations 
regarding the cell numbers obtained were concordant with RTEs being 
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exempted from competing with the mature resident T cells peripheral for 
about 3 weeks.  
In contrast activated/memory T cells have been shown to depend on 
cytokine signaling alone and to not require TCR signaling to survive (82). 
The activated/memory T cell pool less stringent requirements for survival, 
than the requirements for naïve T cells, guarantees the maintenance of 
immunological memory. On the other hand, the timely determined, less 
stringent niche for nascent T cells ensures that the pool of naïve T cells can 
be continuously replenished by recruiting RTEs in that way maintaining TCR 
diversity, guaranteeing an higher chance of an effective primary response in 
the future.  
However, thymic function is sometimes reduced, either due to age 
dependent thymic involution, thymectomy or severe inflammation. When 
thymic output is diminished the lack of replenishment of the naïve T cell pool 
diminishes the competition for the available niches. As naïve T cells 
proliferate in response to increased cytokine availability and a decrease in 
clonal competition for MHC-peptide signaling, they acquire an 
activated/memory phenotype. Initial proliferation by the resident cells masks 
the lack of incorporation of new T cells into the pool. However, the 
proliferative potential of cells will eventually decrease, and the enrichment in 
activated/memory T cells leads to an increase in Treg which results in a 
contracted naïve T cell pool (82). 
Naïve and activated/memory T cell niches are mainly determined by clonal 
competition for peptide-MHC accessibility and/or cytokine signaling (84, 85), 
while the factors conditioning RTE survival and maturation are largely 
unknown. Similarly to the determination of peripheral T cell numbers, the 
thymus also has mechanisms that determine the number of thymocytes at 
any given moment and the amount of T cells exported. The thymic 
architecture is highly dependent on the interaction between thymocytes and 
Chapter 1 
38 
 
stromal cells and IL-7 has a prominent role in intrathymic homeostasis (86, 
87). 
Another classical system related to T cell maturation is the newborn immune 
system. After birth, the T cell pool is exclusively composed of recently 
differentiated T cells and the innate immune system displays lower activation 
levels, taking about 3 weeks in mice to become fully immunocompetent (88, 
89). As introduced in the previous section, the particular response of 
newborns to antigenic challenges is one of the original propositions for the 
establishment of tolerance. In the same line of thought as the concepts 
behind the particular characteristics of RTE, recent reports have identified 
other developmental determined phenotypes of cell intrinsic nature. One 
report has shown that neonatal RTEs are more responsive than adult RTEs 
in respect to Th1/Th2 cytokine secretion and proliferative response to IL-7 
alone (90). On the other hand, it has been shown that the susceptibility of 
thymocytes to upregulate Foxp3 decreases with age (91). This is a finding 
closely related to the concepts addressed in the following chapters of this 
thesis.  
The classical role of the thymus, in producing correctly selected functional T 
cells, and the less commonly studied contribution of RTE export, need to be 
fully clarified so that the thymic activity may one day be harnessed for 
clinical applications. The clarification of the intrathymic antigenic landscape 
and its interconnection with the peripheral sources of antigen has great 
potential to vaccine development, be it to generate protective immunity or to 
establish tolerance.  Still on the thymus role, understanding the particular 
characteristics of nascent T cells is an important missing link to understand 
immune responses at young age. At the same time, it is possible that some 
RTE specific properties may open opportunities for new and more efficient 
therapeutic applications.  
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1.3 Regulatory T cells: Differentiation and Function 
T cells have a central role not only in orchestrating adaptive immune 
responses but also as its regulators. While T cells can differentiate to several 
different phenotypes that direct the immune response they can also adopt 
immunoregulatory transcriptional programs that limit immune responses and 
maintain immune homeostasis. Several T cells with regulatory properties 
exist, such as Tr1 (92) and Th3 (93), and even Th17 when differentiated in 
particular microenvironment (94, 95). However, the T cell subset that has 
been most studied and shown to be essential for immune self tolerance is 
the Foxp3 expressing regulatory T cells. As mentioned above, the work 
presented in this thesis is focused on the study of the later subset, and as 
such, they are the focus of this introductory section. 
The research focus on Treg has mainly been concerned in accurately 
identifying Treg, their differentiation mechanisms and functions. The vast 
amount of knowledge harnessed, mainly with the use of the mouse as a 
model organism, have now taken the field to invest in exploring potential 
clinical applications for Treg. However, Treg differentiation, function and 
physiology in general are still not fully understood. It is likely that key 
features of this T cell subset that may prove invaluable to guarantee the 
safety and efficiency of Treg based therapies, are still to be fully 
characterized. 
As introduced in the first section of this chapter, following early indications of 
a thymus derived component for immune tolerance (29, 30), regulatory T 
cells were identified as Foxp3 expressing CD4 T cells (34, 35). The real 
frenzy in the regulatory T cell field started with the identification of the high 
affinity IL-2 receptor alpha chain (CD25) as a marker for regulatory T cells. 
In the seminal paper by Shimon Sakaguchi et al. (33), peripheral cells of a 
WT mouse, either unfractionated or after CD25 expressing cells being 
depleted, were transferred to nude recipient mice, which lack a thymus and 
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therefore all T cells. When recipients were analyzed 3 months later the 
authors found that depletion of CD25+ cells from the transferred population 
resulted in multiorgan auto-immune attack. This effect could be prevented if 
CD25+ cells were re-introduced into the mixture, clearly showing the 
regulatory properties of this subset. Since this was the smallest subset of T 
cells, 5-15 % of CD4 T cells, identified to date that presented this regulatory 
property, CD25 became the gold standard to identify and isolate regulatory T 
cells. With the possibility to isolate Treg and its conventional counterpart the 
field regained credibility lost due to past misguided directions and started to 
advance at a fast pace. 
CD25 maintained its position as the best marker to identify Treg until 2003 
when two independent groups identified the Foxp3 as the master 
transcription factor for Treg differentiation and function. This finding was 
fueled by the identification of mutations in the Foxp3 gene in the Scurfy 
mouse and in IPEX patients which develop severe multiorgan autoimmune 
disease at early age. Hori et al showed that forced expression of Foxp3 in 
conventional T cells would turn them regulatory while generating phenotypic 
characteristics identical to the ones found in isolated CD25+ Treg (34). 
Simultaneously, Fontenot et al. generated a conditional Foxp3 KO and a 
similar ectopic expression system which resulted in similar findings (35). 
Moreover, CD25 expressing CD4 T cells express high amounts of Foxp3 
while CD25 negative counterpart express very little, confirming the specificity 
of this transcription factor to identify Treg and endow them with regulatory 
properties. With this two works Foxp3 became the new marker to identify 
Treg.  
However, it was known that activated T cells upregulate CD25 expression 
and this was taken as a possible source of confounding factors for the study 
of Treg. Despite the majority of CD25+ cells isolated from naïve mice being 
Foxp3+ (>90-95%), the potential for discrepancies between CD25 and Foxp3 
expression called for new methods that allowed the use of Foxp3 as an 
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identification marker for Treg in standard cellular immunology assays. Since 
Foxp3 is a transcription factor it is found inside the cells and not in its 
surface. As a consequence, its labeling with antibodies requires the cells to 
be permeabilized, which impedes the isolation of live cells. 
The strategy that was put in practice to allow for the isolation of live Foxp3 
expressing cells was the generation of genetically modified mouse lines 
expressing fluorescent proteins together with Foxp3. Two reporter mice were 
developed in parallel. Fontenot et al. developed a GFP-Foxp3 fusion 
reporter while Wan et al. generated an IRES-mRFP reporter, both by 
knocking in the designed constructs into the Foxp3 gene (96, 97). These 
new tools allowed FACS sorting of live Foxp3 expressing cells, as well as 
their negative counterpart, to very high purity. With this new capacity, Treg 
experiments became cleaner and it was possible to clarify the doubts that 
had been casted upon Treg data based on the not so high purity of Foxp3 
populations, isolated through CD25 discrimination. While, the use of genetic 
based reporter systems have failed to refute any claim made from the work 
performed using the CD25 as a marker to isolate Treg, the high purity of cell 
populations fractionated according to Foxp3 expression has allowed the 
execution of experiments for which results using CD25 would have been 
less clear or even un-interpretable. The development of fluorescent based 
Foxp3 expression reporters set the road to the actual state of the art in Treg 
identification and isolation. 
One of the fundamental questions about Treg is their differentiation 
mechanism(s). Soon after the identification of CD25 as a marker to identify 
and isolate Treg (33), it was described that CD25+ cells could be found in the 
thymus within the CD4 SP subset (98). At the same time, the fact that, if 
Treg are subtracted from a peripheral T cell pool that is transferred to 
syngenic T lymphopenic recipients, an uncontrolled response takes place 
(33), strongly undermined the notion that Treg could differentiate from non 
Treg cells after thymic export. Added up with the original observations of a 
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thymic derived tolerance, the paradigm of an exclusive thymic origin for 
Tregs settled in. 
With the experimental confirmation that Treg originated in the thymus from 
developing thymocytes, two models regarding the mechanism by which 
Foxp3 expression is induced dominated the conceptual framework. One 
hypothesis was, or is, that some thymocytes randomly turn on the Treg 
genetic program somewhere between positive and negative selection and 
later undergo TCR based selection to confirm the Treg fate (99). This is the 
so called stochastic model. Alternatively, the instructive model proposes that 
the TCR reactivity is the inducing signal that turns Foxp3 expression on. In 
this case clones receiving TCR signals close to negative selection but below 
the threshold of deletion would be diverted to the Treg lineage (100).  
The collection of data found in the literature indicates that the instructive 
model is likely to be the correct one. First, the identification of Foxp3+ cells in 
monoclonal CD4 derived TCR Tg mice requires the concomitant presence of 
the Ag in the thymus (101-103). In its absence Foxp3 is not expressed nor a 
Treg phenotype observed. If the mice are not in a Rag deficient background 
Treg do appear irrespective of TCR specificity (104). Work with TCR Tg mice 
in a Rag competent setup may have blurred the conclusion for the need of 
the cognate antigen, mainly by giving the impression that Treg may develop 
in its absence. The presence of Treg in these conditions seemed to indicate 
a stochastic/elective model of Treg differentiation. However, it was later 
clarified that Foxp3 is exclusively expressed in clones that rearrange the 
endogenous alpha chain that pairs with the beta chain from the transgenic 
TCR, therefore not recognizing the same antigen as the full TCR Tg receptor 
but rather other antigen present in the thymus (105). Furthermore, the fact 
that anti-nonself TCR Tg T cells, Rag competent but Foxp3 deficient, 
eventually develop multiorgan autoimmune disease that parallels the one 
observed in scurfy mice, whereas the Rag deficient do not, has reinforced 
the notion that the Treg differentiated in Rag competent TCR Tg systems are 
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indeed recognizing a self antigen (106, 107). This collection of data 
strengthened the notion of the antigen being required in the thymus for Treg 
differentiate and supported the view of a mostly anti-self Treg repertoire. 
Nevertheless, a more concrete confirmation came only more recently with 
the use of Treg derived TCR Tg mouse lines (108-110). To evaluate the 
Treg differentiation dynamics several groups set to develop TCR Tg mice in 
which the TCR had been extracted from a Treg. Given that the early body of 
work on this issue clearly indicated that Treg are mainly self reactive, 
selected in the thymus and with high affinity/avidity to antigens present 
there, it was predicted that Treg would readily be identified in the thymus of 
such TCR Tg mice. Two main outcomes were expected, either Treg would 
develop at very high frequencies, as it is often observed in TCR Tg mice that 
also express the cognate Ag in the thymus through a second Tg, or they 
would be limited to frequencies similar to what Is observed in WT mice. 
However, for the utmost surprise, monoclonal TCR Tg lines displayed very 
little Treg in the thymus and peripheral lymphoid organs (108-110). To test 
for possible effects of the TCR Tg authors performed BM chimeras with WT 
mice and intrathymic transfer of thymocytes to WT recipients. In these 
conditions, Treg promptly developed. Moreover, through titrated 
combinations of WT and TCR Tg progenitors it was observed that the 
frequency of Foxp3+ cells within the TCR Tg cells was inversely correlated 
with the frequency of TCR Tg cells within the total population. Basically, the 
less TCR Tg cells in the total thymocytes pool, the higher the frequency of 
Foxp3+ cells differentiated, reaching up to almost 100%. Actually, each 
group developed several TCR Tg lines and found differences in the kinetics 
of Foxp3+ enrichment showing that TCR specificity imposes a quantitative 
limit on each clone’s representation in the Treg pool. This limit is likely to be 
a product of the strength of TCR affinity and the amount of available antigen, 
but a contribution of other factors to determining this niche has not been 
excluded. Despite these modern approaches, there were older reports 
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already indicating a limited niche for Treg differentiation for a particular TCR 
(111). In this work it was described that increasing the amount of intrathymic 
cognate antigen for a particular TCR Tg led to an increase of Foxp3+ cells 
but just to a certain extent, and that after hitting a plateau of a maximum 
number, there was only an increase in frequency as a result of increased 
deletion. In summary, these findings established that there are limited niches 
for Treg differentiation. 
The reports mentioned above regarding the requirement of Ag to obtain Treg 
clearly indicate that Treg are anti-self. Another classical experimental system 
contributing to this notion was the anti MBP TCR Tg mice. When in a RAG 
deficient background T cells direct an immune response against the central 
nervous system and the mice develop EAE (112). However, when in a Rag 
competent background disease does develop (105). The later work showed 
that Rag expression allowed the rearrangement of the endogenous TCR 
alpha chain that in some instances could pair with the transgenic TCR beta 
chain and lead to new specificities that included Treg.  More importantly this 
work was also among the first to demonstrate that Treg can regulate T cells 
known beforehand to be specific for a self Ag, and that its absence can lead 
to TCR targeted autoimmunity (105). 
In summary, the fact that Treg differentiate in the thymus upon interaction 
with cognate antigen sealed the long sought after demonstration for 
dominant tolerance orchestrated by self recognition in T cell differentiation 
and function (100). At the same time, data like the one produced in the study 
of Treg derived TCR Tg also demonstrated that TCR specificities that can 
incorporate the Treg pool, even if doing so close to 100% in a given 
condition, also have a chance to escape both, the incorporation of the Treg 
pool and elimination by deletion. This apparently depends on the functional 
clonal size of its specificity and the competition for a limited niche for Treg 
differentiation. Treg guarantees immunological tolerance by the recognition 
of self antigen to control immune responses, and therefore does so by 
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assertion, in contrast, deletion is a mechanism that achieves tolerance by 
ignorance, a required but insufficient mechanism. 
A later turnaround to the established concept of exclusively thymus derived 
Treg origin was the demonstration by Wanjun Chen and colleagues that 
CD25- T cells isolated from the peripheral lymphoid organs of adult mice 
could be induced to upregulate CD25 and gain regulatory activity through 
the action of TCR stimulation in the presence of TGF (113). The potential of 
Tconv cells to upregulate Foxp3 after thymic export represented a serious 
shake of the pillars of thymic Treg fundamentalists. This mechanism opened 
the potential to differentiate Treg to exogenous antigens with the inherent 
potential risk of tolerance induction against pathogens or even full immune 
paralysis. Irrespective of such theoretical worries the field rapidly progressed 
to demonstrate several protocols by which it was possible to induce the 
differentiation of Treg in the periphery. 
The differentiation of Treg from CD45RBhi CD25- CD4 T cells isolated from 
the periphery of naïve WT mice was rapidly shown to also take place in vivo 
upon adoptive transfer to lymphopenic hosts and involving upregulation of 
Foxp3 expression (114). The conversion of polyclonal WT naïve T cells to 
Treg was later also shown to take place in lymphoreplete recipients (115). 
Apostolou and von Boehmer reported that slow delivery of low amounts of 
antigen, through the use of an implanted osmotic pump, also lead to Treg 
and tolerance (116). This was shown to be accompanied by the induction of 
a regulatory T cell phenotype in TCR Tg recipients, euthymic or 
thymectomized, as well as in adoptively transferred monoclonal TCR 
transgenic T cells recognizing the infused antigen. Tolerance was also 
achieved in implanted WT Balb/c mice. Treg generated through Ag delivered 
by the pump were capable of controlling in vitro proliferation, in vivo recall 
responses to the infused antigen, and diabetes progression in a system of 
insulin driven Ag Tg plus TCR Tg T cell transfer. Moreover, this work showed 
that increasing the amount of antigen delivered led to an inhibition of Treg 
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differentiation, which indicates that the Ag as to be presented in a sub 
immunogenic condition and that TCR signaling for peripheral Treg induction 
is likely to follow its own rules when in comparison to the high stimulation 
required for thymic Treg differentiation. Cobbold et al. demonstrated that 
anti-CD4 blockade together with antigen stimulation could lead to Treg 
induction. The authors also showed that tolerance to skin grafts achieved 
through anti-CD4 administration was dependent on TGF and led to long 
lasting Foxp3 expressing CD4 Treg that accumulated in the grafted tissue 
(117). The induction of CD4 T cell mediated dominant tolerance through 
manipulation of co-stimulation was later extended to antibodies against other 
molecules, such as CD154 (118), CD45RB  (119) and others (120). Mucida 
et al. showed that oral delivery of Ag led to the differentiation of Treg in a 
TCR-BCR double Tg mouse line, which are devoid of Treg if left 
unmanipulated (121). Developed Treg suppressed asthmatic reactions, as 
measured by cell number in bronchoalveolarlavage and immunoglobulin 
levels in sera, as well as the differentiation of effector/memory T cells upon 
i.p. immunization. In this setting tolerance induction and Foxp3 expression 
were shown to be dependent on TGF but independent of IL-10. Kretschmer 
et al. reported that Ag targeting to DCs leads to Treg differentiation (122). In 
their system, adoptive transfer of monoclonal TCR Tg T cells reactive to 
hemagglutinin A (HA) to lymphoreplete recipients together with HA coupled 
to anti-DEC antibody administration led to de novo generation of Foxp3 
regulatory T cells. Treg generation was more efficient when low dose 
antigen was administered and no DC maturation signal was delivered. Once 
again Treg induction was demonstrated to be TGF dependent. Surprisingly, 
if TCR Tg T cells could not express IL-2 there was an enrichment of Foxp3 
expressing cells in comparison to the IL2 competent counterpart. This 
collection of methods represents the main mechanisms described so far for 
the induction of regulatory T cells from T cells harvested from secondary 
lymphoid organs, that is, from cells that after thymic selection and maturation 
were not part of the Treg pool. 
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Notably, experimental evidence that peripheral cells could be recruited to the 
Treg pool had been produced earlier (123). In particular, a study by 
Modigliani and colleagues indicated that RTE are licensed to be “educated” 
into the Treg pool by pre-existing Treg. This evidence was nevertheless of 
indirect nature as this conclusion was inferred from observing that the timing 
of T cell reconstitution was inversely correlated with the capacity to induce T 
cell based regulation on newly formed cells, without Treg being directly 
addressed. Based on this finding and other reports indicating that T cells 
could be tolerized in the periphery, it was proposed that Treg differentiation 
in the periphery could be a particular case of the Lederberg model in which 
recently made T cells would have a maturation determined window of 
opportunity to be influenced to become Treg by other Treg (100).  
The fact that Treg can differentiate from both the thymus and periphery 
provides a reconciliatory explanation for initial studies where Treg TCR 
repertoire was shown to display some degree of overlap with Tconv 
repertoire, and even TCRs that could equally well recognize exogenous 
antigens (124, 125). It is nowadays clear that the peripheral Treg may 
contain Treg that recognize non self antigens and the Tconv pool may 
recognize self. These antagonistic reactivities are maintained at equilibrium 
where pathological autoimmunity is a rather rare event and immune 
responsiveness against invading pathogens the norm. 
Regardless of the many experimental systems already described that lead to 
Foxp3 expression in peripheral T cells it is not possible to accurately 
determine the contribution of peripherally differentiated Treg to the pool of 
Treg found at steady state in healthy unmanipulated hosts. Two main angles 
have been taken in Treg research addressing this shortcoming. First the 
study of the rules determining both thymic and peripheral Treg induction, 
and second, the comparison of Treg found at steady state in naïve mice with 
Treg differentiated from peripheral Tconv cells. Studying Treg differentiated 
by different methods or harvested from different organs, searching for ways 
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to discriminate extrathymic from intrathymic Treg has mainly brought about a 
notion of Treg heterogeneity. Furthermore, the several studies indicating 
differences between Treg of thymic and peripheral origin have been shown 
to be true only for particular settings and to not apply to iTreg induced by 
some of the methods. Helios expression was one of such markers, 
expression of which was proposed as a potential marker to identify Treg 
originating in the thymus. However, Treg differentiated from naïve T cells 
only lack Helios expression when obtained through the classical in vitro 
protocol while they do upregulate Helios if differentiated in vivo (126, 127). 
Apart from this false positive, other markers have only been found to be 
partially enriched in one or the other subset. Thus the unequivocal 
identification of Treg origin in naïve mice is still not possible. In general, 
iTreg present the prototypical Treg surface phenotype, expressing high 
levels of CD25, CTLA4 and GITR (113, 114). Other molecules such as 
Helios, KLRG and Nrp-1 are up or down regulated in different conditions and 
while sometimes discriminating iTreg from nTreg its expression level does 
not offer a valid prediction for iTreg differentiated in all conditions. 
On the other hand it is becoming clear that Treg have the potential to further 
adopt specific phenotypes according to its origin or conditioning. The 
potential heterogeneity of Treg was well captured in a work by Feuerer et al. 
where Treg from the thymus or periphery of WT naïve mice were compared 
to Treg differentiated from naïve T cells in vitro and in vivo through several 
protocols. This report identified a core Treg transcriptional profile and 
several additional genes upregulated or downregulated in Treg from several 
of the conditions studied (128). 
 
Studies addressing the mechanisms ruling Treg differentiation have 
identified T cell activation, IL-2 and TGF as the main factors that lead to 
Foxp3 expression and the ensuing regulatory activity in T cells. The 
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molecular details of the requirement for these signals and the pathways that 
are activated or inhibited leading to Foxp3 expression have been extensively 
characterized. 
There are several proofs that indicate TCR signaling is essential for Treg 
differentiation. First, the requirement for Antigen presence in TCR Tg mouse 
lines for the differentiation of Tregs, as already mentioned above, offers the 
most striking evidence (101-103). More recently, Moran et al. using a 
reporter for Nur77, which expression levels follow the intensity of TCR 
signaling, have shown that Treg display signs of having suffered higher TCR 
stimulation than positively select Tconv cells, as had been postulated and 
indicated by TCR Tg systems (129), again reinforcing the requirement for Ag 
recognition with high affinity/avidity. On the other hand, B7/CD28 co-
stimulation has also been reported has being essential for the differentiation 
of Treg (130, 131). Thus, T cell activation through the TCR together with co-
stimulatory signals is essential for the induction of Foxp3 expression. 
TCR and CD28 induce several downstream pathways that have been shown 
essential for Treg differentiation, the most notable being the NF-B pathway. 
Regarding Treg differentiation, T cell activation delivers essential signals 
through PKC-CARMA1, Bcl-10 and Malt-1 which eventually lead to c-Rel 
activation and its translocation to the nucleus (132-136). CARMA-1, Bcl-10 
and Malt-1 are denominated the CBL complex and have been shown to be 
involved in the expression of Foxp3. In a study to elucidate the role of this 
complex, Molinero et al. found that CARMA1 is absolutely required for the 
expression of Foxp3 (132). Using a CARMA1 KO mouse line they showed 
that the inability to signal through the CBL complex led to a cell intrinsic 
defect in Treg generation. This defect was not rescued by the expression of 
a STAT5 constitutively active transgene, showing that the defect was not 
linked to the lack of IL-2 signaling which is also caused by the defect in the 
CBL complex. 
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C-Rel is a member of the NF-kB family that is involved in the response to T 
cell activation. Ruan et al. and Long et al. reported that c-Rel deficient mice 
have dramatically reduced Treg, both in the thymus and the periphery (137, 
138). It was also reported that the Treg deficiency in c-Rel KO mice is a cell 
intrinsic defect and that it can also be detected in TGF mediated Foxp3 
induction in naïve T cells in vitro. Long et al. focused in demonstrating that 
artificially increasing NF-kB activity rescued the Treg deficiency in other 
mutant mouse lines in pathways involved in NF-kB activation, showing that 
NF-kB activity through c-Rel was indeed the essential signal driving Foxp3 
expression. On the other hand, Ruan et al. extensively characterized the 
thymic and in vitro Treg differentiation impairment in c-Rel deficient mice, 
which occurs in a cell intrinsic manner. In this last report the authors also 
demonstrated the assembly of a “c-Rel enhaceossome” composed of c-Rel, 
p65, NFAT, Smad and CREB in the Foxp3 promoter and enhancer regions. 
Visekruna et al. revealed that c-Rel was also relevant in Treg differentiation 
through the regulation of IL-2 production, a cell extrinsic effect having impact 
on the induction of Foxp3 in naïve T cells (139). Last Deenick et al. 
confirmed that c-Rel and not NF-kB1 (p50) was the main NF-kB effector 
molecule leading to Foxp3 expression (140). These studies established that 
c-Rel translocation is an essential, non redundant, mechanism leading to 
Foxp3 expression. 
T cell activation for the induction of Foxp3 expression requires not only TCR 
signaling but also co-stimulation. T cells need to receive signals through 
CD28 to activate the NFAT-AP-1 pathway. It has been shown that NFAT 
cooperates with Smad3 to induce Foxp3 induction in peripheral T cells (141). 
These factors bind to a conserved nucleotide sequence in an enhancer 
close to Foxp3 and promote epigenetic changes that allow Foxp3 
expression. 
As an apparent exception, it has been reported that 
CD4+CD25+GITR+Foxp3- peripheral T cells and thymocytes become Foxp3+ 
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under the sole action of cytokines (142-144). However, it was shown that the 
cells had to get the activation signal to get this Treg permissive phenotype 
which then allows the action of cytokines, mainly IL-2, to induce Foxp3 
expression. This proposed mechanism implies a two step model for Treg 
induction, in which cells are first activated and later a cytokine signal 
directing them to the Treg lineage (145). 
The other essential factor for Treg induction, as for any other T cell 
polarization mechanism, is the milieu surrounding the T cells receiving the 
TCR activation signals introduced above. The main cytokines that lead to 
Foxp3 expression are TGF and IL-2, with retinoic acid enhancing the 
process. The essential role of TGF in immune homeostasis was clearly 
demonstrated by several transgenic mouse models tampering with the ability 
of cells to sense TGF signals (146). Regarding Treg differentiation, the fact 
that TGFsignaling deficient mouse models still display Treg in the thymus 
led to the notion that TGFwas not required for thymic Treg differentiation 
(147). However, later work demonstrated that IL-2 was amplifying a very 
small proportion of Treg that differentiated when TGF signaling was 
abolished (148). For extrathymic Treg, it is clear that TGFis absolutely 
required. Molecularly the main mediators of TGF signaling are SMAD2 and 
SMAD3, which have some degree of redundancy so that Treg differentiation 
is only prevented by the absence of both (149). This and other works have 
shown that TGF is a central molecule allowing the expression of Foxp3. 
The other essential factor is IL-2. IL-2 and IL-2R deficient mice suffer from 
T cell mediated autoimmune disease, but, both mouse models display 
thymic Treg (150). However, the concomitant abolishment of IL-2R and the 
common gamma chain cytokine receptor leads to a dramatic reduction of 
Treg (143, 150), indicating a redundant role of other cytokines signaling 
through the common gamma chain. In a study following the requirement for 
common gamma chain receptor dependent signaling it was found that IL-
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2R and IL-7R double KO mice present a nearly complete absence of 
thymic Foxp3+ cells demonstrating that IL-7 is the major redundant factor 
leading to Foxp3 expression in the absence of IL-2 signaling (151). The 
requirement of common gamma chain cytokines is translated through the 
requirement of STAT5 signaling, of which, regarding Treg differentiation, IL-2 
seems to be the more potent inducer (143). In contrast to thymic Treg 
differentiation, in vitro induction of Foxp3 by the action of T cell activation 
and TGF is strictly dependent on IL-2 and other common gamma chain 
binding cytokines, such as IL-7 and IL-15 cannot rescue IL-2 signaling 
deficiency (152). The fact that IL-7 and IL-15 cannot compensate for the lack 
of IL-2 is not clear but indicates that a pathway other than STAT5 
phosphorilation is triggered by IL-2.  
On the opposite side, the cellular milieu can also convey inhibitory signals 
that prevent Foxp3 induction in the presence of TGF and IL-2. The 
cytokines with stronger inhibitory effect known to date are IL-6 and IL-4. 
When T cells are activated in the presence of IL-6 and TGF the cells do not 
upregulate Foxp3 expression and are instead polarized to an IL-17 secreting 
(153). IL-6 induces STAT3 and reinforces expression of IL-21 and IL-23R, 
which, in the presence of TGF, lead to RORt expression and the 
establishment of a Th17 phenotype (154). In turn, IL-4 together with TGF 
lead to an IL-9 secreting helper T cell pathway, again preventing Foxp3 
expression (155, 156). This pathway has been recently described and is yet 
ill characterized. Inhibition of Treg differentiation from naïve T cells can also 
be caused by activated/memory T cells which readily secrete pro-
inflammatory cytokines upon activation. In this scenario, retinoic acid has 
been reported to relieve naïve T cells from this inhibitory effect. Retinoic acid 
and TGF enrichment in the gastrointestinal tract seem to be accountable for 
the increased Treg differentiation that has been reported to be associated 
with that anatomical location as well as being another factor in the TGF 
determined Treg-Th17 crossroad (157-159).  
Chapter 1 
53 
 
Apart from the essential T cell stimulation and favorable cytokine milieu 
required for Treg differentiation there have been other pathways not 
traditionally related with T cell polarization that have been implicated. In 
particular pathways originally linked with responses to different metabolic 
states such as the FoxO1 and mTOR. In summary, Treg differentiation is 
determined by the right intensity of T cell activation and the 
microenvironment in which the cells are laying. 
Other important aspect of Treg physiology is the maintenance of the 
suppressor phenotype and the potential sub-phenotypes required for Treg 
activity in different scenarios. T cell polarization as a terminal differentiation 
process has been recently disputed and several pieces of evidence have led 
to a concept of phenotypic plasticity, a novel concept in the T cell field. For 
helper T cells, this plasticity has been found between Th17 - Th1 and Th2 - 
Th9 phenotypes. In the case of Treg, plasticity has been addressed through 
the possibility of Treg to lose Foxp3 expression and through the 
establishment of diverse gene expression programs specific for the 
conditions in which Treg differentiate or are later embedded. 
Early work by Tung et al. had shown that T cell based self tolerance is only 
maintained if the antigens remain present (160). This was demonstrated by 
testing tolerance of female mice to ovaries after having been or not 
ovariectomized. The experiments performed in this work revealed that 3-7 
days after the organ is removed the immune system looses the capacity to 
tolerate the same organ from a naïve donor once it is re-implanted. While 
the fate of the cells responsible for tolerance in this system was not 
addressed, it was clearly demonstrated the need for the presence of the 
antigen for the maintenance of tolerance. In light of the actual knowledge 
about antigen specific immune tolerance, Treg are prime candidates to 
mediate this phenomenon, which implies Treg require continuous TCR 
signaling to be maintained or to maintain their regulatory phenotype. 
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More recently it has been shown that Treg can lose Foxp3 expression, while 
surviving and becoming T cells with pathogenic potential (161-163). Given 
the enrichment in self reactivities of high affinity/avidity in the Treg pool, the 
evaluation of the potential harm resulting in autoimmune targeting from the 
exchange of the regulatory activity for an effector one is rather 
straightforward. Besides the requirement for TCR signaling, these works 
have established IL-2 and TGF signaling as another requirement for Treg to 
maintain Foxp3 expression and its regulatory activity.  
Using a Foxp3 driven lineage tracer Zhou et al. reported that in a naïve 
mouse a small population of cells that have ever expressed Foxp3 
downregulate its expression (163). Similarly in this work and in the report by 
Duarte et al. it was also established that Treg loose Foxp3 expression when 
transferred to lymphopenic recipients (161, 163). The later report described 
that the Treg population transferred tends to be divided in half of Treg and 
Tconv after 4 weeks in this system. The loss of Foxp3 expression may be 
avoided if Tconv cells are co-transferred or if exogenous IL-2 is provided. 
These results are in accordance to earlier works showing that the amount of 
Treg is indexed to the amount of naïve T cells, likely through the IL-2 
secreted by the non regulatory T cells (82). In parallel Komatsu et al. 
showed that loss of Foxp3 expression could also be prevented by sustained 
TGF signaling (162). Curiously, the main signals that lead to the 
maintenance of the Foxp3 expression in Treg are also the crucial ones 
required for its induction. 
The other facet of Treg plasticity, that is, the adoption of different 
phenotypes according to the milieu they are inserted in, was mainly explored 
using genetically modified mouse models where Treg were made deficient in 
several transcription factors known to be relevant for Tconv cell phenotypes. 
These include T-bet, IRF4, and Stat3 (164-166). What these works have 
established is that Treg need to turn on a transcriptional program dependent 
on the same transcription factors that control Tconv polarization. 
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Accordingly, mice in which Treg are deficient in T-bet develop uncontrolled 
Th1 responses (164), if deficient in IRF-4 a Th2 response (165) and if Treg 
are deficient in Stat3 a Th17 response (166). While this is a very recent 
concept, the evidence produced so far clearly supports the notion that Treg 
heterogeneity extends beyond the initial differentiation pathways leading to 
Foxp3 expression. 
Treg encompass 5-10% of peripheral T cells but provide a powerful and 
diverse collection of regulatory activities. The strongest demonstrations of 
the essential role of Treg are the autoimmune conditions that develop in both 
mice and humans harboring non-functional Foxp3 alleles (167-169). While 
original works about T cell based tolerance addressed mainly reactivity 
against non self antigens, when Treg were first identified they were readily 
shown to be essential for immunological self-tolerance (33). Nevertheless, 
older models of tolerance were readily revisited applying new tools that 
allowed the demonstration of a central role for Treg in many different 
scenarios. 
In the scope of regulating anti-self responses, Treg were shown to maintain 
self reactive T cell clones in check preventing systemic autoimmunity, but 
also to be involved in controlling responses targeted at specific organs, such 
as the pancreas in mouse models of Type I Diabetes (130). However, Treg 
are also able to regulate T cell responses to non self antigens. In 
physiological conditions and in the absence of external manipulations, they 
are responsible to control the immune activity against commensal 
microorganisms or innocuous environmental antigens at mucosal interfaces, 
such as the intestine and lungs (170-172). On the other hand, manipulations 
leading to Treg differentiation can lead to tolerance against allogeneic grafts 
or prevention of allergic reactions (33, 117). 
Treg are also able to regulate responses in scenarios where the target is 
composed of both self and non-self antigens. Good examples of this 
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condition are the control of responses against the fetus in pregnancy (where 
maternal and paternal antigens are both present) and responses against 
neo-self antigens expressed by tumors (where new antigens may be present 
but are embedded in a collection of self antigens shared with healthy 
tissues) (173, 174). 
Another important role of Treg is the setting of T cell homeostatic states, 
such as controlling the extent of immune responses and immune pathology 
caused by exacerbated immune responses (175), or simply control the size 
of the peripheral pool of activated/memory CD4 T cells (65). More important 
for the work presented in the later chapters is the known ability of Treg to 
control the expansion of naïve T cells in lymphopenic recipients. Transfer of 
naïve T cells into T and B cell deficient recipients leads to inflammatory 
bowel disease which can be prevented by co-transfer of Treg (176). 
The study of Treg regulation in the several contexts presented above has 
demonstrated that Treg exert their regulatory activity through cell contact 
dependent and independent mechanisms. The cell contact dependent 
mechanisms entail the engagement of surface molecules, such as CTLA-4, 
ICOS (177) and CD103, as well as manipulation of soluble factors, of which 
TGF, IL-10 and IL-2 are the best studied. CTLA-4 delivers inhibitory signals 
by engaging CD80/CD86 on APCs while at the same time outcompeting 
CD28, which conveys the opposite effect. Mice with Treg specific deletion of 
CTLA-4 develop a lymphoproliferative multiorgan autoimmune disorder 
without displaying major abnormalities in thymic Treg differentiation (178). 
This last finding demonstrates that CTLA-4 is essential for Treg activity but 
not for Treg differentiation. Notably, CTLA-4 expression is itself upregulated 
by Foxp3. It is worth mentioning that Foxp3 is not only required for Treg 
differentiation but its sustained expression is essential for Treg activity (179). 
On the other hand, ICOS (177) and CD103 (180) endow Treg with particular 
adhesion properties that allow proper cellular interactions and migration, 
which are essential for regulation to take place. Treg can also directly kill 
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target cells through the action of granzyme B or perforin thus preventing 
those cells from participating in immune responses (181, 182). 
The humoral side of Treg regulation has been best characterized in terms of 
Treg production of TGF and IL-10, as well as the consumption of IL-2. The 
first two are hallmark cytokines that dampen immune reactions or direct 
them to reactions that have lower intrinsic host damage potential (183). On 
the other hand, IL-2 is involved in T cell proliferation and activation and its 
consumption by Treg limits the amplitude of T cell reactions (184). Other 
mechanisms of Treg based suppression have also been reported, such as 
the induction of IDO expression in APCs leading to the degradation of 
tryptophan and the generation of an immunosuppressive milieu (185) and 
their participation in the of the CD39-CD73 extracellular enzymatic reaction 
that leads to the immunosuppressive mediator adenosine (186). 
Of the above mediators of Treg activity, CTLA-4, TGF and IL-2 can be 
considered core mechanisms, given that mice with deficiencies in each 
pathway lead to pathological conditions that parallel the ones observed in 
Foxp3 deficient mice (124, 146, 178, 187). In spite of the diverse set of 
mechanisms already found to be used by Treg, it is likely that more 
pathways are yet to be unraveled, especially given the diverse set of 
immune activities that Treg have been reported to regulate. 
The intense interest that Treg have earned comes from the indispensable 
role they play in immune tolerance and in the regulatory activity exerted in 
many different immune processes. Together with the shortcomings that still 
exist in the clinic to deal with most autoimmune diseases as well as allergic 
and asthmatic pathologies, Treg are expected to provide the solutions of the 
future in this area. 
At the same time the mystery of immune tolerance is still alive and the 
mechanisms behind the way a healthy immune system is able to recognize 
and eliminate invading pathogens while sparing the host from this attack is 
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not fully understood. For this question to be answered and therapeutic 
applications to be developed it is required that the understanding of Treg 
differentiation and physiology to be further characterized. In this work we 
addressed intrathymic generation of Treg in the scope of the origin of 
antigen, extrathymic Treg in relation to the susceptibility of conventional T 
cells to become regulatory and the function and phenotype of this Treg 
generated outside the thymus. We believe these findings bring important 
notions that are relevant for both challenges mentioned above, the 
understanding of immune tolerance in health and for gathering knowledge 
that may help design safe and efficient therapies. 
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Abstract 
Thymocytes differentiate into CD4+ Foxp3+ regulatory T cells (Treg) upon 
interaction between their TCR and peptide-MHC-II complexes locally 
expressed in the thymus. Conversion of naïve CD4+ T cells into Treg can 
additionally take place in the periphery under non-inflammatory conditions of 
Ag encounter. Here, making use of TCR transgenic models naturally devoid 
of Foxp3+ cells, we report de novo generation of Treg upon a single footpad 
injection of Ag mixed with a classic proinflammatory adjuvant. Abrupt Treg 
differentiation upon immunization occurred intrathymically and was essential 
for robust tolerance induction in a mouse model of spontaneous 
encephalomyelitis. This phenomenon could be attributed to a specific feature 
of thymocytes that, in contrast to mature peripheral CD4+ T cells, were 
insensitive to the inhibitory effects of IL-6 on the induction of Foxp3 
expression. Our findings uncover a pathway for Treg generation with major 
implications for immunity and tolerance induction. 
  
Chapter 2 
85 
 
Introduction  
Thymocytes expressing TCRs specific for self-Ags presented in the thymus 
die through the process of negative selection (1) or differentiate into Foxp3+ 
regulatory T cells (Treg) (2). Auto-reactive thymocytes escaping these 
selection events are exported to peripheral organs and tissues, where Treg 
control their activation and pathogenic potential (2). In addition to thymic 
production of ‘natural’ Treg, peripheral CD4+ T cells can differentiate into 
‘adaptive’ (or induced) Foxp3+ cells in a TGF-β-dependent manner upon Ag 
encounter in absence of inflammation in vivo (3, 4). For example, peripheral 
Treg conversion has been observed following administration of free Ag by 
osmotic pumps (5), by the oral route (6) or by specifically targeting the Ag to 
dendritic cells (DC) in absence of adjuvants (7). Proinflammatory and/or 
effector Th cell cytokines, such as IL-6, IFN-γ or IL-4 inhibit peripheral Treg 
conversion and promote instead the differentiation into IL-17, IFN-γ or IL-4 
producing effector Th cells (8-10). 
Negative selection and Treg differentiation in the thymus are believed to be 
restricted to T cells interacting with Ags expressed locally, including many 
tissue-specific proteins ectopically expressed by medullary thymic epithelial 
cells (11, 12). However, recent studies indicate that abundant blood-borne 
Ags and peripheral Ag-loaded DC commonly reach the thymus (13, 14) and 
participate not only to negative selection but also to differentiation of Foxp3+ 
cells (15). Yet, it is not known whether intrathymic differentiation of Treg 
occurs following peripheral administration of Ag mixed with standard 
adjuvants and whether this process is affected by ongoing inflammation. 
Clarifying these issues is essential to determine the full dynamic and 
outcome of immune responses to self and non-self peripheral Ags. 
Here, using monoclonal TCR transgenic (Tg) mice naturally devoid of 
Foxp3+ cells, we show that Ags mixed with CFA and administered by a 
single footpad injection can reach the thymus and locally promote the 
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differentiation of Ag-specific thymocytes into Foxp3+ cells, despite the 
inflammatory conditions. This event could be attributed to a specific feature 
of thymocytes that, in contrast to peripheral mature CD4+ T cells, lack 
surface IL-6-receptor expression and are thus refractory to the inhibitory 
effects of IL-6 on the differentiation of Foxp3+ cells. Our findings reveal a 
previously unrecognized mechanism by which the thymus may establish 
dominant tolerance to self and non-self Ags during the course of an immune 
response. 
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Results and Discussion 
Immunization promotes tolerance induction through differentiation of Treg 
Anti-myelin basic protein (MBP) TCR-specific transgenic RAG-deficient mice 
(T/R-) or homozygote for the Tg-TCR (TgTg) spontaneously develop severe 
progressive experimental autoimmune encephalomyelitis (EAE) by 2 months 
of age and succumb in their third month of life (17). As these mice are 
naturally devoid of Foxp3+ cells, they offer an ideal system to test protocols 
that may induce the de novo generation of Treg. Administration of the 
nominal Ag together with IFA has been shown to prevent EAE occurrence in 
T/R- mice, presumably through the induction of T cell anergy (18). We first 
tested whether immunization protocols known to induce various degrees of 
inflammation would differentially affect disease onset and progression in T/R- 
mice. A single footpad injection of 100 μg of the agonist N-terminal Ac1-17 
MBP peptide (pMBP) mixed with IFA or CFA protected T/R- for at least 3 
months, while administration of CFA alone did not alter the course of the 
disease (Fig. 2.1A). Protection from EAE associated with the emergence of 
Foxp3+ cells, readily detectable in PBL as early as 6 days post-injection and 
undetectable in control animals (Fig. 2.1B,C). Foxp3+ cells reached ~14% of 
CD4+ T cells by 6 weeks post-immunization and remained at ≥ 4% for an 
additional 6-7 weeks. Full EAE protection lasted 3 months, after which 
immunized mice developed a chronic and mild disease that coincided with a 
significant decline in peripheral Foxp3+ cell frequency. Renewed injection of 
CFA-pMBP 3 months after the first immunization prolonged protection to 
more than 7 months of age. As CFA is a more potent adjuvant than IFA, it 
was selected to further analyze the function and origin of Foxp3+ cells 
generated upon proinflammatory immunization. 
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Figure 2.1. CFA-peptide immunization promotes tolerance mediated by de 
novo generated Foxp3
+
 Treg. A, For each protocol, treatment of mice was initiated 
at one month of age and mice were scored for EAE at least twice per week, until 
three months of age. Data represent pooled results of 2 to 8 independent 
experiments. n refers to number of mice. B,C, 1-month-old T/R
-
 mice were 
immunized with CFA-PBS, CFA-pMBP (B) or with IFA-pMBP (C). Percentage of 
Foxp3
+
 cells in a CD4
+
 cell gate in PBL (mean ± s.d, n=3 per group, circles) and 
cumulative EAE incidence (squares) along time. D, 1-month-old TgTg IL-6
+/-
 or IL-6
-/-
 
mice were immunized with CFA-pMBP into the footpad and their draining LN 
analyzed 4 or 14 days later. Representative histogram for Foxp3 and percentage of 
Foxp3
+
cells measured in a CD4
+
 cell gate. n=2-6 in each group. Data are 
representative of two independent experiments. 
 
 
Foxp3+ cells emerging upon CFA-pMBP immunization were phenotypically 
and functionally bona fide Treg. About 60% of them expressed CD25, and 
most CD25+ cells were Foxp3+, GITR+ and CD103+. They efficiently 
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suppressed the proliferation of conventional CD4+ CD25- cells in vitro and 
displayed regulatory activity in vivo, as shown by adoptive transfer 
experiments (Supplemental Fig. S2.1). Finally, immunization did not prevent 
nor delayed severe EAE in TgTg bearing a Foxp3 null mutation (Foxp3scurfy) 
(Fig. 2.1A) formally demonstrating that dominant tolerance through de novo 
induction of Foxp3+ Treg, and not T cell anergy (18), is the mechanism of 
disease prevention following immunization of T/R- mice. 
 
Concomitant differentiation of effector T helper cells and Treg upon 
proinflammatory immunization 
The above observations needed to be reconciled with the notion that CFA is 
an adjuvant used to induce EAE in WT mice. Our immunization regimen 
promoted T cell expansion, activation and differentiation into IFN-γ and IL-
17-producing cells (Supplemental Fig. S2.2), all readily detectable by day 4 
post-injection and concomitant with Foxp3+ cell emergence. Protocols for 
efficient induction of EAE in WT animals commonly rely on the 
coadministration of pertussis toxin (PTX) and the immunogen. Consistently, 
administration of PTX abrogated the protective effect of CFA-pMBP (Fig. 
2.1A), amplified cellular expansion, increased the number of IFN-γ-
producing cells and reduced both Foxp3+ cell frequency and number 
(Supplemental Fig. S2.2). We conclude that while CFA-pMBP promotes 
Th1-, Th17- and Treg-differentiation, PTX inhibits the induction, migration 
and/or expansion of Foxp3+ cells, a role reminiscent of its effect on Treg 
survival and function (19). 
As expected, CFA administration also provoked rapid and vigorous 
production of innate cytokines including IL-6 (not shown). Intriguingly, this 
cytokine has been shown to play a key role in preventing peripheral Treg 
conversion, notably upon CFA administration (8). Consistent with this notion, 
immunized IL-6-/- TgTg mice, displayed a 3 to 5 fold increased frequency of 
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peripheral Foxp3+ cells when compared to control IL-6+/- TgTg mice similarly 
treated (Fig. 2.1D). As unimmunized IL-6-/- and IL-6+/- TgTg mice were 
devoid of Foxp3+ cells, we conclude, as previously shown (8), that 
inflammation driven by IL-6 interfered with Treg conversion. Collectively, our 
results suggest that a subset of T cells in IL-6-competent mice is insensitive 
to the inhibitory effect of IL-6 and consequently can convert to Treg despite 
ongoing inflammation. 
 
Peripheral immunization induces intrathymic differentiation of Ag-specific 
Treg 
We next examined whether Foxp3+ cell differentiation in immunized T/R- 
mice occurred in the thymus. Remarkably, kinetic analysis in T/R- mice 
immunized with a single footpad injection of CFA-pMBP revealed that 
Foxp3+ cells represented ~12% of CD4+ single-positive T (CD4SP) cells in 
the thymus by day 3 post-immunization (Fig. 2.2A-C). Noteworthy, Foxp3+ 
cells were not detectable in LNs before day 4 excluding the possibility that 
thymic Foxp3+ cells represented circulating peripherally differentiated Treg 
(Fig. 2.2A). Despite an increasing frequency of thymic Treg during 7 days 
post-immunization, the total number of Foxp3+ thymocytes was highest at 
day 3 and gradually decreased following the reduction in total CD4SP. In 
contrast, peripheral Foxp3+ cell frequency increased at least until day 14 
post-immunization (Fig. 2.2B,C). Intrathymic differentiation of Treg following 
footpad immunization was Ag-specific and not a singularity of anti-MBP Tg 
mice, or of small synthetic self-peptides, as similar results were obtained 
upon CFA-peptide or CFA-protein, but not CFA-PBS, administration to anti-
OVA DO11.10 RAG1-/- TCR-Tg mice (Supplemental Fig. S2.3 and S2.4). 
Together, these results demonstrate that not only blood-borne (15), but also 
peripheral Ags administered subcutaneously in a stable
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Figure 2.2. Peripheral proinflammatory immunization leads to abrupt Ag-
specific Treg differentiation in the thymus. A-C, 1-month-old T/R
-
 mice were 
immunized with CFA-pMBP into the footpad and thymus and LN were analyzed at 
different time points. A, Representative dot-plot for Foxp3 versus CD25 inside a 
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CD4
+
 CD8
-
 gate from the thymus (upper panel) or from LN (lower panel). B, Number 
of total thymocytes (left) and CD4SP thymocytes (right). C, Percentage of Foxp3
+
 
cells among CD4SP thymocytes or CD4
+
 LN cells (left) and number of Foxp3
+
 
CD4SP thymocytes or Foxp3
+
 CD4
+
 LN cells (right). B and C are pooled kinetic 
analysis from five experiments with 2 to 12 mice in each time point. D, Lethally 
irradiated C57BL/10.PL-Thy1.1 mice were reconstituted with a 9:1 mixture of BM 
cells from Thy1.2
+
 T/R
-
 mice and Thy1.1
+
 WT mice. Chimeric mice were untreated 
(n=3) or immunized into the footpad with CFA-pMBP (n=3) 2 months after 
reconstitution and analyzed 4 days later. Number of CD4SP thymocytes (left) and 
percentage of Foxp3
+
 cells among CD4SP cells (right). Data are representative of 
three independent experiments, Student’s t test. E,F, One group of 1-month-old 
euthymic T/R
-
 mice was left untreated (triangles, n=12) while both TXT (open circles, 
n=7) and sham-TXT (closed circles, n=5) were immunized with CFA-pMBP 3 days 
post-surgery. E, Percentage of Foxp3
+
 cells in a CD4
+
 cell gate from PBL over time, 
Student’s t test. F, Percentage of survival over time (p<0.01: untreated versus TXT 
CFA-pMBP, and p<0.01: TXT CFA-pMBP versus Sham CFA-pMBP; logrank test).
 
 
water-in-oil emulsion, can enter the thymus and be presented locally to 
promote both deletion and Treg differentiation. 
We next ascertained that Ag-specific Treg differentiate in the thymus 
following immunization of mice bearing a polyclonal repertoire of 
lymphocytes. BM from T/R- (Thy1.2+) and WT (Thy1.1+) mice were co-
injected into lethally irradiated WT (Thy1.1+) animals. These mixed BM 
chimeras were immunized with CFA-pMBP at 2 months post-reconstitution 
when they contained 5-10% of Tg CD4SP cells. Analysis of their thymi 4 
days post-immunization revealed both negative selection and Treg 
differentiation of Ag-specific CD4SP thymocytes, as indicated by a 100-fold 
reduction in number and the emergence of ~7% Foxp3+ cells among Thy1.2+ 
cells. Importantly, among the WT polyclonal Thy1.1+ cells, neither thymocyte 
number nor Foxp3+ cell frequency were affected by immunization (Fig. 
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2.2D). These results demonstrate that intrathymic Treg differentiation upon 
peripheral proinflammatory immunization is restricted to Ag-specific T cells 
and can occur in the context of a normal polyclonal repertoire of 
lymphocytes. 
To directly evaluate the contribution of the thymus to tolerance induction and 
to the accumulation of peripheral Treg upon immunization, healthy 4-week-
old T/R- mice were thymectomized (TXT) and immunized with CFA-pMBP 3 
days later. Strikingly, Foxp3+ cells were undetectable in peripheral blood of 
TXT mice for the first 2 weeks post-immunization. In addition, Treg 
frequency was significantly lower in TXT than in euthymic mice at any time 
point of the 10-week-long kinetic (Fig. 2.2E). These results are in agreement 
with our kinetic analysis above, indicating that early and efficient 
differentiation of Treg is restricted to the thymus. Nevertheless, immunization 
delayed disease progression in TXT mice, possibly as a result of peripheral 
generation of functional Foxp3+ cells. However, while all TXT T/R- mice 
succumbed to EAE by 30 weeks after immunization, at this same time, 
euthymic animals were alive and only 40% of them showed signs of mild 
disease (score  2) (Fig. 2.2F). Together, our data demonstrate that the 
thymus, most likely due to intrathymic Treg differentiation, is essential for 
induction of potent and long lasting tolerance. 
 
Immature CD4+ single-positive thymocytes are refractory to IL-6-mediated 
inhibition of Foxp3 induction 
Taken together the above results indicated that intrathymic Treg 
differentiation, in contrast to peripheral, is insensitive to the inhibitory effects 
of inflammation. We next tested whether these differences could be 
attributed to intrinsic features of developing T cells by performing in vitro 
Treg differentiation assays. As expected, addition of IL-6 to T/R- peripheral 
CD4+ T cells inhibited by ~70% the generation of Foxp3+ cells induced by 
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TGF-β (Fig. 2.3A). However, this inhibition was significantly lower (~40%) for 
CD4SP thymocytes. Similar results were obtained when testing WT CD4+ 
CD8- Foxp3- cells isolated from Foxp3GFP knock-in mice (Fig. 2.3B,C). 
Strikingly, purified HSAhigh Foxp3- CD4SP thymocytes, purged of 
recirculating and more mature cells (e.g. (16)), were totally refractory to the 
inhibitory effect of IL-6. The sensitivity of each cell subset to IL-6 directly 
correlated with the level of both surface IL-6Rα expression (Fig. 2.3D) and 
proximal IL-6R signalling, determined by intracellular phosphorylated-Stat3 
detection upon IL-6 exposure (Fig. 2.3E). Together, these results indicate 
that newly formed T cells are insensitive to IL-6 mediated inhibition of Foxp3 
induction due to their very limited responsiveness to this cytokine. These 
findings are in agreement with the notion that maturation stage is one key 
factor controlling the predispostion of T cells towards Treg differentiation (20) 
and provides a molecular basis to our observation that de novo generation of 
Treg takes place in the thymus rather than in the periphery upon 
proinflammatory immunization. 
In conclusion, we show that a single footpad injection of Ags mixed with a 
highly inflammatory adjuvant promotes the de novo generation of protective 
Ag-specific Treg. This unexpected finding is explained with the 
demonstration that vigorous Treg differentiation happened intrathymically 
early post-immunization. The latter phenomenon occurred despite the 
elevated levels of inflammatory mediators in circulation, notably IL-6, due to, 
most likely, the specific resistance of newly formed T cells to the inhibitory 
effects of IL-6 on Treg differentiation. 
An essential role of the thymus in ensuring induced peripheral tolerance has 
been occasionally reported, and mostly attributed to a property of recent 
thymic emigrants (e.g. (21)). In view of our findings, it is tempting to 
speculate that immature T cells exported to the periphery may be the 
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Figure 2.3. Immature CD4SP thymocytes are refractory to IL-6-mediated 
inhibition of Foxp3 induction. A, CD4
+
 CD8
-
 thymocytes or CD4
+
 LN cells were 
isolated from T/R
-
 mice and cultured with plate-bound anti-CD3, anti-CD28, TGF-β ± 
IL-6. Percentage of Foxp3
+
 cells with TGF-β + IL-6 relative to control with only TGF-
β. B,C, CD4
+
 GFP
-
 LN cells and either total CD4
+
 CD8
-
 GFP
-
 or HSA
high
 thymocytes 
were isolated from Foxp3
GFP
 mice and cultured as in A plus IL-2. B, Representative 
histogram of GFP-expression in CD4
+
 T cells. C, Percentage of GFP
+
 cells with 
TGF-β + IL-6 relative to control with only TGF-β. Data are representative of three 
independent experiments. D, Representative histograms of surface IL-6Rα 
expression in gated CD4
+
 GFP
-
 cells from Foxp3
GFP
 mice. Left, CD4
+
 LN cells (thick-
solid histogram) compared to CD4SP thymocytes (grey-filled histogram). Right, 
immature HSA
high
 (grey-filled histogram) compared to mature HSA
low
 (thick-solid 
histogram) CD4SP thymocytes. In both cases, CD4
+
 CD8
+
 thymocytes serve as 
negative control (dashed histogram). E, Representative histograms of intracellular 
phospho-Stat3 staining in untreated or IL-6-stimulated CD4
+
 GFP
- 
cells purified from 
Foxp3
GFP
 mice. Untreated and IL-6-stimulated LN cells (thin-solid and thick-solid 
histograms, respectively) are compared to untreated and IL-6-stimulated immature 
HSA
high
 CD4SP thymocytes (light-grey and dark-grey filled histograms, respectively).
 
Chapter 2 
96 
 
preferential precursors of peripherally differentiated Treg. A recent study 
reported increased Treg frequency in the thymus of non-Tg mice upon 
induction of EAE by immunization, a phenomenon associated with elevated 
intrathymic IL-7 expression (22). These thymic Treg allowed disease 
remission suggesting that they were immunogen specific. Together, this 
work and ours, indicate that intrathymic Treg differentiation upon peripheral 
immunization is a robust event, due to both microenvironment modifications 
and, as we demonstrate here, thymocyte-intrinsic properties. 
Tolerance induction to peripheral Ags that gain access to the thymus may be 
essential not only to purge the repertoire of self-reactive T cells specific to 
Ags that are not expressed by thymic APCs (13) but also to broaden the 
repertoire of Foxp3+ Treg assuring robust dominant tolerance to peripheral 
tissues. In addition, our evidence that intrathymic differentiation of Treg can 
take place under strong and systemic inflammatory conditions uncover a 
potential mechanism for the emergence of pathogen-specific Treg during 
infections, provided pathogen-derived Ags gain access to the thymus. 
Noteworthy, microbe-specific Treg have been shown to be essential for 
protection against a secondary challenge to the microbe (23). Thus, specific 
Treg differentiation upon Ag access to the thymus may play an essential role 
not only in the establishment of self-tolerance but also for immunity to 
reinfection. Finally, our observations have major implications for the design 
of vaccines for prevention or treatment of infectious diseases, cancer or 
autoimmunity. 
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Material and methods 
Mice. 
C57BL/10.PL, C57BL/10.PL-Thy1.1, C57BL/10.PL RAG1-/--MBP-TCR 
transgenic (referred to as T/R-), C57BL/6, and Foxp3GFP reporter knock-in 
mice were bred at the Instituto Gulbenkian de Ciência Animal Facility. 
Foxp3scurfy, IL-6-/-, IL-6+/-, a WT homozygote anti-MBP TCR Tg C57BL/10.PL 
mice were bred at the Skirball Institute Central Animal Facility, New York 
University Medical Center. Mouse experimental protocols were approved by 
the Institutional Ethical Committee and the Portuguese Veterinary General 
Division. Foxp3GFP knock-in mice (16) were kindly provided by A. Rudensky 
(U. Washington, Seattle, WA, USA). 
 
Immunizations, EAE scoring and chimera generation 
For immunizations, mice received 100 µl (50 µl in each foot pad) of peptide 
or protein emulsified in CFA (Difco readymade CFA). When indicated 
pertussis toxin (List Biological Laboratories) was administrated i.v. in two 
doses of 200 ng at a 1-day-interval. EAE was monitored at previously 
described (17). For adoptive transfer, purified cells suspended in 100 µl of 
PBS were injected into the retro-orbital plexus. For mixed bone marrow (BM) 
chimeras, recipient mice were lethally irradiated (900 rads) and reconstituted 
the following day with T-cell-depleted BM cells. 
 
Cell purification and analysis 
Cell suspensions from spleen, blood, thymus or LN (popliteal, inguinal, 
axilary, mesenteric and brachial) were incubated with a saturating amount of 
Fc-block (anti-CD16/CD32) before staining. Nuclear Foxp3 was detected 
following manufacturer (ebioscience) instructions. For intracellular cytokine 
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staining, cells were stimulated for 4h with PMA (50 ng/ml, Sigma) and 
ionomycin (500 ng/ml, Calbiochem). Brefeldin A (10 µg/ml, Sigma) was 
added for the last 2 h of stimulation. Data were acquired on a FACS Calibur 
or Aria (BD) and analyzed inside a lymphocyte gate with CellQuest (BD) and 
Flowjo (Tri Star Inc.) softwares. Cell purification was performed using Aria or 
MoFlo high speed cell sorters (Cytomation Inc.). 
 
Cell culture 
Foxp3-induction assays: cells were plated at 2.5x104 cell/well in flat-bottom 
96-well plates with 3 g/ml plate-bound anti-CD3 mAb, 1 g/ml soluble anti-
CD28 mAb (e-bioscience), ~10 U/ml IL-2 (X63-IL-2 supernatant), 0.2 ng/ml 
TGF-β1 and 20 ng/ml IL-6 (R&D). Cultures were set in triplicates in a final 
volume of 200 µl for 72h. Stat3-phosphorylation assays: cells were 
stimulated for 15 min with 100 ng/ml IL-6 and stained with anti-phospho 
Stat3-AlexaFluor 647 Ab (4/P-Stat3, BD) following manufacturer instructions. 
 
Statistical analysis 
Statistical significance was determined using the two-tailed Student’s t test 
and the logrank test. P<0.05 was considered significant (*, P<0.05; **, 
P<0.01; ***, P<0.001). 
  
Chapter 2 
99 
 
Acknowledgements 
This work was supported by the Fundação para a Ciência e Tecnologia, 
Portugal and the Programa Operacional Ciência e Inovação with the co-
participation of the Fundo Comunitario Europeu (FEDER) and the EU-FP7–
NAIMIT consortium. We thank R. M. Santos for antibody preparation, A. 
Perez and R. Gardner for operating the cell sorter and M. Rebelo for mouse 
colony management. We are most grateful to A. Coutinho and T. L. Carvalho 
for constructive discussions during the development of this work and to C. 
Reis e Sousa for critical reading of the manuscript. 
 
  
Chapter 2 
100 
 
References 
1. Palmer, E. 2003. Negative selection--clearing out the bad apples 
from the T-cell repertoire. Nat Rev Immunol 3:383-391. 
2. Sakaguchi, S., M. Ono, R. Setoguchi, H. Yagi, S. Hori, Z. Fehervari, 
J. Shimizu, T. Takahashi, and T. Nomura. 2006. Foxp3+ CD25+ 
CD4+ natural regulatory T cells in dominant self-tolerance and 
autoimmune disease. Immunol Rev 212:8-27. 
3. Kretschmer, K., I. Apostolou, E. Jaeckel, K. Khazaie, and H. von 
Boehmer. 2006. Making regulatory T cells with defined antigen 
specificity: role in autoimmunity and cancer. Immunol Rev 212:163-
169. 
4. Lohr, J., B. Knoechel, and A. K. Abbas. 2006. Regulatory T cells in 
the periphery. Immunol Rev 212:149-162. 
5. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of 
suppressor commitment in naive T cells. J Exp Med 199:1401-1408. 
6. Mucida, D., N. Kutchukhidze, A. Erazo, M. Russo, J. J. Lafaille, and 
M. A. Curotto de Lafaille. 2005. Oral tolerance in the absence of 
naturally occurring Tregs. J Clin Invest 115:1923-1933. 
7. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M. C. 
Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding 
regulatory T cell populations by foreign antigen. Nat Immunol 6:1219-
1227. 
8. Korn, T., M. Mitsdoerffer, A. L. Croxford, A. Awasthi, V. A. Dardalhon, 
G. Galileos, P. Vollmar, G. L. Stritesky, M. H. Kaplan, A. Waisman, V. 
K. Kuchroo, and M. Oukka. 2008. IL-6 controls Th17 immunity in vivo 
by inhibiting the conversion of conventional T cells into Foxp3+ 
regulatory T cells. Proc Natl Acad Sci U S A 105:18460-18465. 
Chapter 2 
101 
 
9. Wei, J., O. Duramad, O. A. Perng, S. L. Reiner, Y. J. Liu, and F. X. 
Qin. 2007. Antagonistic nature of T helper 1/2 developmental 
programs in opposing peripheral induction of Foxp3+ regulatory T 
cells. Proc Natl Acad Sci U S A 104:18169-18174. 
10. Caretto, D., S. D. Katzman, A. V. Villarino, E. Gallo, and A. K. Abbas. 
2010. Cutting edge: the Th1 response inhibits the generation of 
peripheral regulatory T cells. J Immunol 184:30-34. 
11. Derbinski, J., A. Schulte, B. Kyewski, and L. Klein. 2001. 
Promiscuous gene expression in medullary thymic epithelial cells 
mirrors the peripheral self. Nat Immunol 2:1032-1039. 
12. Aschenbrenner, K., L. M. D'Cruz, E. H. Vollmann, M. Hinterberger, J. 
Emmerich, L. K. Swee, A. Rolink, and L. Klein. 2007. Selection of 
Foxp3+ regulatory T cells specific for self antigen expressed and 
presented by Aire+ medullary thymic epithelial cells. Nat Immunol 
8:351-358. 
13. Bonasio, R., M. L. Scimone, P. Schaerli, N. Grabie, A. H. Lichtman, 
and U. H. von Andrian. 2006. Clonal deletion of thymocytes by 
circulating dendritic cells homing to the thymus. Nat Immunol 7:1092-
1100. 
14. Li, J., J. Park, D. Foss, and I. Goldschneider. 2009. Thymus-homing 
peripheral dendritic cells constitute two of the three major subsets of 
dendritic cells in the steady-state thymus. J Exp Med 206:607-622. 
15. Atibalentja, D. F., C. A. Byersdorfer, and E. R. Unanue. 2009. 
Thymus-blood protein interactions are highly effective in negative 
selection and regulatory T cell induction. J Immunol 183:7909-7918. 
16. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. 
Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage 
Chapter 2 
102 
 
specification by the forkhead transcription factor foxp3. Immunity 
22:329-341. 
17. Lafaille, J. J., K. Nagashima, M. Katsuki, and S. Tonegawa. 1994. 
High incidence of spontaneous autoimmune encephalomyelitis in 
immunodeficient anti-myelin basic protein T cell receptor transgenic 
mice. Cell 78:399-408. 
18. Marusic, S., and S. Tonegawa. 1997. Tolerance induction and 
autoimmune encephalomyelitis amelioration after administration of 
myelin basic protein-derived peptide. J Exp Med 186:507-515. 
19. Chen, X., R. T. Winkler-Pickett, N. H. Carbonetti, J. R. Ortaldo, J. J. 
Oppenheim, and O. M. Howard. 2006. Pertussis toxin as an adjuvant 
suppresses the number and function of CD4+CD25+ T regulatory 
cells. Eur J Immunol 36:671-680. 
20. Wirnsberger, G., F. Mair, and L. Klein. 2009. Regulatory T cell 
differentiation of thymocytes does not require a dedicated antigen-
presenting cell but is under T cell-intrinsic developmental control. 
Proc Natl Acad Sci U S A 106:10278-10283. 
21. Song, F., Z. Guan, I. E. Gienapp, T. Shawler, J. Benson, and C. C. 
Whitacre. 2006. The thymus plays a role in oral tolerance in 
experimental autoimmune encephalomyelitis. J Immunol 177:1500-
1509. 
22. Chen, X., L. Fang, S. Song, T. B. Guo, A. Liu, and J. Z. Zhang. 2009. 
Thymic regulation of autoimmune disease by accelerated 
differentiation of Foxp3+ regulatory T cells through IL-7 signaling 
pathway. J Immunol 183:6135-6144. 
Chapter 2 
103 
 
23. Belkaid, Y., C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. 
Sacks. 2002. CD4+CD25+ regulatory T cells control Leishmania 
major persistence and immunity. Nature 420:502-507. 
  
Chapter 2 
104 
 
 
  
Chapter 2 
105 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix to Chapter 2 – Supplementary Figures   
Chapter 2 
106 
 
 
Supplemental Figure S2.1. Foxp3
+
 cells emerging upon CFA-pMBP 
immunization resemble bona fide Treg. Upper panel: 1-month-old T/R
-
 mice were 
immunized with CFA-pMBP. LN cells were analyzed 14 days after immunization. 
Representative dot- plot for Foxp3 versus CD25 within CD4
+
 cells and histograms 
for GITR and CD103 within CD4
+
 CD25
+
 cells (solid line) or CD4
+
 CD25
-
 cells 
(dotted line). Middle panel: CD4
+
 CD25
+
 cells from CFA-pMBP-treated T/R
-
 mice 14 
days post-immunization (open squares) or from naïve WT mice (filled circles) were 
plated at different ratios with CD4
+
 CD25
-
 cells from WT mice at 2.5x10
4
 cell/well in 
U-bottom 96-well plates for 72 h together with 10
5
 irradiated (30 Gy) splenocytes as 
APC and 1 μg/ml anti-CD3 mAb (clone 145.2C11; home-made). Cultures were set in 
triplicates in a final volume of 200 l. Proliferation was monitored by addition of [
3
H] 
thymidine for the last 6 h of culture. Lower panels: RAG1
-/-
 mice received 2.5x10
5
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CD4
+
 cells isolated from either 1-month-old T/R
-
  mice (naive, n=7), or from CFA-
pMBP-immunized T/R
-
  mice 60 days after immunization (CFA-pMBP, n=3) or 
2.5x10
5
  CD4
+
  cells of each  population  (Co-T,  n=5).  EAE score of each mouse 40 
days after transfer (p<0.05: naïve versus CFA-pMBP, and p<0.01: naïve versus Co-
T; Pearson’s Chi- square exact test). Right, Percentage of survival over time 
(p<0.05: naïve versus CFA- pMBP, and p<0.01: naïve versus Co-T; logrank test). 
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Supplemental Figure S2.2. Simultaneous differentiation of Treg and effector T 
helper cells upon proinflammatory immunization. 1-month-old T/R
-
 mice were 
immunized with CFA-pMBP (white bars) or CFA-pMBP and PTX (black bars, PTX 
on day 0 and 2) and their draining LN analyzed at different time points after 
immunization. A, Representative dot-plot for CD25 versus Foxp3 and IL-17 versus 
IFN-y within CD4
+
 T cells. B, Number of total CD4
+
 T cells and percentage and 
number of Foxp3
+
 cells, IFN-y- and IL-17-producing cells measured in a CD4
+
 gate. 
The dotted line corresponds to untreated mice. Data are representative of three 
independent experiments with n=3 per group. 
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Supplemental Figure S2.3. No noticeable difference between untreated and 
CFA-PBS injected mice. 1-month-old T/R
-
 mice were either untreated or 
immunized with CFA-PBS or CFA-pMBP into the footpad and thymus and LN were 
analyzed 4 days later. A, Representative dot-plots for CD4 versus CD8 inside a live 
lymphocyte gate, for CD4 versus Foxp3 inside a CD4
+
 CD8
-
 gate from the thymus or 
from draining LN and for IL-17 versus IFN-y from draining LN. B, Number of total 
thymocytes, Foxp3
+
 thymocytes or Foxp3
+
 LN cells. 
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Supplemental Figure S2.4. Intrathymic Foxp3
+
 cell differentiation in DO11.10 
RAG1
-/-
 mice upon CFA-OVA peptide or whole OVA protein immunization. 6-
week-old DO11.10 RAG1
-/-
 were either untreated or injected with CFA mixed with 
PBS or 100 g of OVA peptide or 10 mg of OVA protein into the footpad and 
analyzed 4 days later. Percentage (upper panel) and number (lower panel) of 
Foxp3
+
 cells among CD4
+ 
CD8
-
 thymocytes or LN cells, n=2-6 in each group. 
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Abstract 
Most Foxp3+ CD4 regulatory T cells (Treg) precursors are newly formed 
thymocytes that acquire Foxp3 expression in the thymus. However, 
differentiation of Treg can also occur in the periphery. What limits this 
second layer of Treg production in physiological conditions remains to be 
understood. In this work, we tested the hypothesis that, similarly to thymic 
Treg, the precursors of peripheral Treg are immature T cells. We evidence 
that CD4+CD8-Foxp3- thymocytes and recent thymic emigrants (RTE), 
contrarily to peripheral naïve mature cells, efficiently differentiate into Treg 
upon transfer into lymphopenic mice. By varying donor and recipient mice as 
well as conducting ex vivo assays, we document that the preferential 
conversion of newly formed T cells does not require intrathymic pre-
activation, is cell-intrinsic and correlates with low and high sensitivity to 
natural inhibitors and inducers of Foxp3 expression, such as IL-6 and TGF-, 
respectively. Finally, ex vivo analysis of human thymocytes and peripheral 
blood T cells revealed that human RTE and newly developed T cells share 
an increased potential to acquire a FOXP3bright CD25high Treg phenotype. Our 
findings indicating that RTE are the preferential precursors of Treg 
differentiated in the periphery should guide the design of Treg based 
therapies. 
Chapter 3 
116 
 
Introduction 
Foxp3 expressing CD4 T cells (Treg) are antigen specific suppressors cells 
that prevent autoimmunity and allergy, dampen protective responses and 
restrict associated immunopathologies (1). While never directly 
demonstrated, it is predicted that tight regulation of Treg production and 
expansion is required to prevent immune paralysis. Treg were first shown to 
differentiate in the thymus from newly developed thymocytes upon TCR 
engagement by antigen expressed and/or presented locally (2). Such a 
developmental time and space defined by the thymus, would suffice to 
explain Treg restricted domain of competence once reaching the periphery. 
Hence, the thymic Treg (tTreg) reactive repertoire is necessarily restricted to 
self-antigens, including peripheral tissue and organ specific gene products 
expressed promiscuously by thymic epithelial cells (3), and to peripheral 
antigens accessing the thymus (4, 5). It is now well documented that Treg 
can differentiate in the periphery (pTreg), in both therapeutic and physiologic 
settings. Antigen specific pTreg were reported upon subcutaneous 
administration of peptides (6) or exposure to intestinal antigens either from 
food (7) or microbiota (8). Peripheral de novo differentiation of Treg was also 
documented during pregnancy (9), and upon lymphopenia (8). Hence, pTreg 
differentiation may complement tTreg self-reactive repertoire by including 
reactivities against those self-antigens not expressed in the thymus but it 
also recruits clones reactive to fully foreign antigens. What limits extrathymic 
Treg differentiation in physiological conditions, such that protective immune 
responses are effective, remains to be elucidated. In turn, this knowledge 
would help to improve the development of therapies that aim at enhancing or 
inhibiting de novo Treg differentiation, as in autoimmune diseases and 
transplantation or cancer, respectively.  
In the last few years, several studies have aimed at establishing the 
differences between tTreg and pTreg, phenotypically and functionally as well 
as concerning the signals required for their differentiation. When taken 
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together, these works do not provide a consensual picture. Hence, 
expression of various membrane and nuclear molecules tentatively 
subdivided tTreg and pTreg in some, but not other experimental settings (8, 
10, 11). Epigenetic marks, notably CpG methylation at the Foxp3 regulatory 
sequences were shown to dissociate tTreg from in vitro induced Treg but not 
from pTreg (12). Controversies also arose as whether TGF- is required for 
Foxp3 induction solely in peripheral cells, notably through engagement of 
the Smad3 motif in the CNS1 regulatory sequence 5’ of the coding region 
(13-16). Overall, tTreg and pTreg share many features, among which a 
similar two-step process for their differentiation, from TCR to IL-2 signaling 
(17-19). As these signals are abundant in the periphery, physiological 
limitation of pTreg production should rely on other features. 
In this work we hypothesized that the precursors of pTreg are limiting and 
that similarly to tTreg, their progenitors are recently developed T cells. 
Adoptive transfer experiments in lymphopenic mice indicated that 
thymocytes as well as recent thymic emigrants (RTE) readily acquire a Treg 
phenotype in the periphery. In contrast, very few peripheral mature resident 
naïve cells, purged of RTE by either thymectomy or cell sorting, converted to 
Foxp3+ Treg in this assay. T cell maturation stage also conditioned in vitro 
induced Foxp3 expression, both in mice and humans. The decreased 
susceptibility of mature cells to acquire a Treg phenotype was further 
correlated with their increased sensitivity to inhibitors, such as IL-6, and 
decreased sensitivity to facilitators such as TGF-. Together our results 
show that T cell maturation stage conditions de novo Foxp3 expression and 
that RTE are the preferential precursors of Treg differentiated in the 
periphery. These findings provide a rationale for limited pTreg in physiology 
and raise specific concerns for the success of pTreg based therapies.  
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Results 
Newly developed CD4 T cells are enriched in precursors of regulatory T cells 
To directly test whether maturation stage conditions CD4 T cell susceptibility 
to acquire Foxp3 expression in vivo, we first compared newly formed single 
positive (SP) CD4 thymocytes with peripheral CD4 cells isolated from lymph 
nodes (LN) in assays of lymphopenia induced Treg differentiation (8). The 
two cell subsets were isolated from Foxp3-GFP reporter mice (20), purified 
as GFP- and separately injected i.v. into T cell deficient animals (TCRβ-/-). As 
donor and recipient mice were raised in strict SPF conditions, adoptive 
transfer did not result in noticeable pathology for at least 8 weeks (not 
shown). Cellular analysis was performed at 4 weeks post-transfer and donor 
cells were identified as CD4+ TCRβ+ (Fig. 3.1). As described earlier (8), a 
small but readily detectable fraction of LN cells acquired Foxp3 expression, 
representing a maximum of 2.5 % of the recovered cells. Strikingly, this 
frequency was 4 to 10 fold increased in recipients of thymocytes, in all 
lymphoid organs analyzed, including those draining the intestine (Fig. 3.1A, 
B). Skin-draining LN, such as brachial, inguinal and axillary, analyzed either 
pooled or separately (not shown) appeared as a preferential site for Foxp3+ 
cell differentiation and/or accumulation. Importantly, thymocytes expanded 
less than LN cells in these organs but equally well in other sites (Fig. 3.1C), 
and yet invariably gave rise to more Foxp3+ cells (see Fig. S3.1 for a pool of 
6 independent experiments). We next tested the conversion efficiency of 
thymocytes and LN cells upon adoptive transfer into WT mice rendered 
mildly lymphopenic the day before injection (Fig. S3.1). In this setting, 
resident host lymphocytes limited the expansion of the donor cells that 
represented 7% of total CD4 lymphocytes in spleen and LN at the time of 
analysis. Yet, donor thymocytes showed increased conversion into Treg 
when compared to donor mature cells, a difference noticeable already in 
blood at one week post-transfer. We conclude that thymocytes are 
remarkably more susceptible than peripheral cells to convert into a Treg 
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Figure 3.1. Thymocytes are enriched in precursors of Treg that differentiate in 
the periphery upon lymphopenia. TCR
-/-
 mice received i.v. 3x10
5
 CD4
+
CD8
-
Foxp3
-
 cells purified from either thymi or pooled lymph nodes isolated from Foxp3-
GFP reporter mice and analyzed 4 weeks later by FACS. A) Representative analysis 
of Foxp3 expression in gated CD4
+
TCR
+ 
lymphocytes from the indicated organs in 
mice recipient of either LN cells or thymocytes (THY). B, C) frequency of Foxp3
+
 
cells within CD4
+
TCR
+
 lymphocytes (B) and number of CD4
+
TCR
+
 cells (C) 
recovered in a single experiment, representative of seven independent repeats. 
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Each dot represents one mouse. White and black circles, correspond to LN and Thy 
as donor cells, respectively. Sp: spleen, biaLN: pooled branchial, inguinal and 
axillary LN, mLN: pooled mesenteric LN, PP: pooled payer patches, LIL: large 
intestine lamina propria and intraepithelial lymphocytes. Note the different scales in 
left and right panels. * p<0.05; **p<0.01; ***p<0.001, Mann-Whitney test. LIL data in 
panel (B) p value of 0.0059, t test. 
 
 
phenotype and that this feature is not associated with the extent of T cell 
proliferation. We next ascertained that our results did not owe to trivial cell 
sorting artifacts, by conducting voluntary contamination experiments (Fig. 
S3.1). Thymocyte and LN preparations (Thy1.2 Foxp3-GFP-) were each 
mixed at 99:1 with Thy1.1 Foxp3-GFP+ cells purified from the corresponding 
organs before adoptive transfer. Analysis of the recipient mice 4 weeks post-
transfer revealed that the majority of the recovered Foxp3+ cells derived from 
the originally Foxp3- cell subset, whether thymocytes or LN cells. As 
expected, thymocytes gave rise to higher frequencies of Treg than LN cells 
in these experiments as well as in the single transfers above. Together, 
these results establish that thymocytes are specifically prone to undergo true 
de novo differentiation into a Foxp3+ phenotype once reaching the periphery. 
 
Peripheral Treg derived from thymocytes and LN cells are functionally and 
phenotypically indistinguishable  
Several surface markers have been proposed to discriminate Treg that were 
generated in the thymus or induced in the periphery. We tested whether 
Foxp3+ cells originated from thymocytes or LN cells in the experiments 
above share similar phenotypes. Thymic and peripheral cells from 
unmanipulated WT mice served as references. An additional control 
consisted of in vivo expanded Treg, obtained from TCRβ-/- mice that had 
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received 4 weeks earlier a mixture of Thy1.2 Foxp3+ and Thy1.1 Foxp3- cells 
isolated from LN of unmanipulated WT mice. Pair-wise analysis of the 
surface markers CD103 and KLRG1 or GITR and CD25 revealed no 
differences between Foxp3+ cells that differentiated from LN cells or 
thymocytes upon lymphopenia (Fig. S3.2). Both shared a phenotype 
resembling the previously described iTreg, i.e. enriched in CD103+KLRG1+ 
(10) and GITR+CD25+ (11), clearly distinguishable from thymic and 
peripheral Treg at steady state, but strikingly similar to in vivo expanded 
Treg. Analysis of Helios and Nrp1 expression also did not discriminate LN or 
thymocyte derived Treg in our adoptive transfers (Fig. 3.2A,B). However, 
both cell subsets displayed a phenotype similar to that of thymic Treg, 
namely Helios+ with a clear Nrp1- subpopulation (11), that was only residual 
in Treg found in the periphery, whether or not expanded in vivo. Finally, a 
classical proliferation assay confirmed that both thymocyte and LN derived 
Foxp3+ cells are suppressors (Fig. 3.2C). Together, these analyses indicate 
that Foxp3+ cells developed from thymocyte or LN cells in lymphopenic hosts 
are remarkably similar to bona fide Treg.  
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Figure 3.2. Thymocytes and LN cells converted into Treg upon lymphopenia 
are functionally and phenotypically indistinguishable. A, B) Phenotypic analysis 
of Foxp3
+
 cells from the spleens of animals treated as in Fig. 3.1A for Helios and 
Nrp1. Representative FACS staining (A) and distribution of each subset (B) gated on 
Foxp3
+
 CD4
+
 TCR
+
 cells. Three populations of Natural Treg served as control:  
Foxp3
+
 thymic and peripheral from unmanipulated mice (nTreg steady state, upper 
part), Thy1.2 Foxp3
+
 peripheral cells from TCR
-/-
 recipient mice that received 4 
weeks earlier a mixture of Thy1.1 Foxp3
-
 and Thy1.2 Foxp3
+
 LN cells at a 9:1 ratio 
(nTreg post-transfer, bottom left). THY, thymocytes; LN, lymph nodes; nTreg, natural 
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Treg; pTreg, Treg differentiated in the periphery. C) Standard suppression assay 
performed with naïve Foxp3
-
 cells as responders (R) and CD4
+
Foxp3
+
 Treg. Treg 
were either natural Treg sorted from pooled LN of Foxp3-gfp animals (nTreg) or in 
vivo differentiated Treg sorted from recipient of either thymocytes (THY) or LN 
transfers as in Figure 3.1A. 
 
 
 
Thymocytes enhanced susceptibility to differentiate into Treg is a cell 
intrinsic property 
We next tested whether the differential capacity of thymocyte and peripheral 
cells to acquire Foxp3 expression was controlled by environmental factors. 
The cell surface marker analysis above left open the possibility that de novo 
differentiation of Treg in lymphopenic hosts relied on donor cell recirculation 
to the thymus and that thymocytes would be more competent at this 
migration. We challenged this scenario by repeating the adoptive transfer 
experiments using athymic mice as recipients (Fig. 3.3A). Transfer of 
thymocytes or LN cells into nude-Foxn1-/- animals reproduced the results 
obtained in TCRβ-/- recipients, excluding a contribution of the thymus. 
Secretion of pro-inflammatory cytokines by activated T cells has been 
proposed to limit naïve T cell conversion into Treg in other systems (21). It 
was conceivable that LN preparations, enriched in naturally activated cells 
when compared to thymocytes, would produce more of these inhibitory 
factors upon lymphopenia induced proliferation (LIP). We first tested whether 
purging LN preparations from naturally activated cells would enhance their 
capacity to acquire Foxp3 expression. However, adoptive transfers of 
peripheral CD4+ Foxp3- cells either unfractionated or enriched in naïve cells 
(CD45RBhi) resulted in a similar low frequencies of Foxp3+ cells (Fig. 3.3B). 
It was still possible that naïve peripheral cells produce more inhibitory factors
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Figure 3.3. Enhanced susceptibility of thymocytes to differentiate into Treg in 
vivo is a cell intrinsic property. Donor cell preparation, adoptive transfer and 
analysis were performed as in Fig.1 with the following alterations: A) Recipients 
were athymic nude-Foxn1
-/- 
mice. B) Donor cells were CD4
+
Foxp3
-
 from LN either 
total (GFP
-
) or purged of activated cells by selecting CD45RB
high
 cells (see Fig. 
S3.3). C) LN and Thymocytes CD4
+
CD8
- 
Foxp3
-
 donor cells were isolated from 
Thy1.1 and Thy1.2 Foxp3GFP mice, respectively, and co-injected at a 1:1 ratio (left) 
into TCR
-/-
 animals. Analyses were performed by gating the recovered cells on 
Thy1.1
+
 (LN) or Thy1.2
+
 (THY). D) Donor cells were CD4
+
Foxp3
-
 from LN or 
thymocytes either total (GFP
-
) or purged of potential pre-committed CD25
+
 cells 
(GFP
-
25
-
), as illustrated in Fig. S3.3. E) Donor thymocytes and LN cells were 
isolated from OTII Foxp3
GFP
 Rag2
-/-
 animals. TCR
-/-
 recipient mice received 0.1 mg 
ovalbumin or PBS i.v. the day before and 5 days after adoptive transfer. Analysis 
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was performed at day 8. Shown is one out of at least 2 experiments for each 
condition. 
 
 
than thymocytes upon LIP. We tested this hypothesis by performing co-
transfers of thymocytes and LN cells at a 1:1 ratio, each prepared from 
Thy1.1 and Thy1.2 congenic donors, respectively (Fig. 3.3C). In these 
experiments, as in single transfer assays, recovered cells displayed a 5 to 
10 fold higher frequency of Foxp3+ cells when originating from thymocytes vs 
LN preparations, despite similar expansion. These results exclude specific 
modifications of environmental factors upon LIP as an explanation for 
thymocytes and peripheral cells’ differential conversion to Treg.  
As the thymus is the site of natural Treg differentiation, it was plausible that 
our thymocyte preparations were enriched in pre-committed Foxp3- Treg and 
these could explain an apparent cell population property. Expression of 
CD25 by Foxp3- cells has been proposed to indicate an early step along the 
Treg differentiation pathway resulting from TCR triggering, both in the 
thymus and in the periphery (17-19). However, depleting or not CD25+ cells 
from thymocyte and LN cell preparations before adoptive transfer did not 
modify the frequency of recovered Treg from either donor population (Fig. 
3.3D). To further exclude antigen triggered pre-committed Treg in our 
thymocyte preparations we performed adoptive transfer of monoclonal TCR 
transgenic cells specific for the foreign antigen ovalbumin (OVA), never 
exposed to their nominal antigen. Recipients TCRβ-/- mice were injected i.v. 
with either PBS or endotoxin free OVA protein the day before and 5 days 
after cell infusion. Strikingly, antigen-dependent induction of Foxp3 
expression was efficient in mice that received thymocytes but barely 
detectable in animal recipients of LN cells (Fig. 3.3E). These results 
indicated that neither intrathymic pre-selection nor specific repertoire 
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features suffice to explain the increased susceptibility of thymocytes to 
differentiate into Treg. From this set of experiments, we conclude that cell 
intrinsic properties account for the differential susceptibility of thymocytes 
and LN cells to acquire Foxp3 expression. 
 
Recent thymic emigrants are the precursors of Treg differentiated upon 
lymphopenia 
We show above that thymocytes are specifically prone to undergo true de 
novo differentiation into Treg once exposed to the periphery. We next tested 
whether naturally exported thymocytes share similar features (Fig. 3.4). 
CD4+SP cells naturally exit the thymus before full maturation, and complete 
their differentiation in the periphery (22). Consistent with their intermediate 
maturation stage, recent thymic emigrants (RTE) can be identified through 
their intermediate level of expression for CD24, CD45RB or Qa-2 (22) when 
compared to thymocytes and peripheral mature cells (Fig. S3.4). Upon 
adoptive transfer in lymphopenic hosts, Foxp3- RTE purified from LN as Qa-
2lo gave rise to Foxp3+ cells in similar frequency and number as thymocytes 
(Fig. 3.4A). In the same assay, peripheral mature cells purified as Qa-2hi, 
therefore purged of RTE, showed a very poor capacity to differentiate into 
Treg, as indicated by less than 1% Foxp3+ cells in the recovered CD4 T 
lymphocytes.  
To confirm that most Treg progenitors in the periphery are encompassed in 
the RTE cell subset, we tested LN cells prepared from mice naturally purged 
of RTE following thymectomy. Donor mice were thymectomized (TxT) or, as 
a control, submitted to the surgery procedure except for thymus removal 
(Sham) and left to rest for at least 2 months. At this time point preexisting 
RTE in TxT mice had incorporated the mature T cell pool as indicated by the 
absence of Qa2lo cells in the peripheral organs (Fig. 3.4B). CD4+Foxp3- LN
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Figure 3.4. Recent thymic emigrants are the main precursors of peripherally 
differentiated Treg. Donor cell preparations, adoptive transfers and analysis were 
performed as in Fig. 3.1 with the following alterations: A) Donor LN cells were either 
purged or enriched for Qa-2
lo
 RTE (upper panels) before adoptive transfer (lower 
panels). B) Donor mice were thymectomized (TxT) or sham operated (Sham) 2-3 
months before total LN CD4
+
Foxp3
-
 cells were purified (upper panels) and 
transferred to TCR
-/-
 recipient mice (lower panels). 
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cells isolated from either TxT of Sham mice proliferated equally well upon 
adoptive transfer in TCRβ-/- mice (Fig. S3.4). In contrast, de novo 
differentiated Foxp3+ cells were not or barely detectable in mice recipient of 
TxT donor cells, while as expected, cells from sham donors converted into 
Treg at low but readily detectable levels. Taken together, these results 
confirm that maturation stage defines T cell susceptibility to acquire Foxp3 
expression and in turn, indicate that RTE are the main precursors of Treg 
differentiated in the periphery upon lymphopenia. 
 
Peripheral T cell maturation associates with altered sensitivity to signals 
modulating Treg differentiation in vitro 
Our results above revealing that mature peripheral cells poorly differentiate 
into Treg in vivo contrasted with the efficient production of iTreg from 
peripheral naïve T cells in vitro. However, several natural compounds likely 
to be produced in recipient mice inhibit iTreg induction in vitro. In addition, 
iTreg conversion in vitro requires TGF-β and TCR signaling, likely of 
comparatively reduced strength in vivo. In turn, this reasoning raised the 
possibility that immature and mature T cells display differential sensitivity to 
these inducing and inhibiting signals. Strikingly, LN cell, but not thymocyte, 
conversion was reduced when antigen presenting cells (APC), either BM-
derived DC, T cell depleted splenocytes or CD11c+ purified splenic DCs 
were activated (Fig. 3.5A-D and not shown). This inhibitory effect was 
mediated by IL-6, as it was lost in cultures seeded with IL-6-/- splenic APCs 
(Fig. 3.5D). We further tested and confirmed that Qa-2lo RTE, similarly to 
newly formed thymocytes (5), are resistant to IL-6 in an APC free system 
where IL-6 could be titrated (Fig. 3.5E and S3.5). However, preferential 
inhibition of mature vs. immature cells by IL-6 did not explain fully the lower 
capacity of peripheral T cell to convert into Treg upon lymphopenia. Thus, 
thymocytes performed better than LN cells at acquiring Foxp3 expression
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Figure 3.5. Enhanced sensitivity of mature T cells to modulators of Foxp3 
induction. CD8
-
CD4
+
Foxp3
-
 thymocytes and LN cells were purified as in Fig. 3.1 
and set in cultures containing anti-CD3 Ab at 0.1 µg/ml for 3 days supplemented 
with varying APCs and compounds. A, B) APCs were BM derived DC either 
immature (A) or activated (B), media was supplemented with IL-2 and either 
neutralizing anti-TGF- Ab or TGF-. C) As previous, except that media did not 
contain IL-2 and TGF-was fixed at 0.2 ng/ml. D) APCs were T cell depleted 
splenocytes (spAPC) from either WT of IL6
-/-
 mice, activated or not overnight with 
Lipid A, media contained IL-2. E) LN cells were fractionated as mature resident cells 
(Qa-2
hi
) and RTE (Qa2
lo
), APCs were naive spAPC and media contained IL-2 as 
well as the indicated cytokines. Shown is normalized frequency of Foxp3
+
 cells 
obtained in cultures supplemented with TGF- and IL-6 or IL-4 relative to control 
cultures supplemented with TGF- alone that were given a value of 100. F) Adoptive 
transfers were performed and analyzed as in Fig. 3.1 except that recipient mice 
were TCR
-/-
 IL-6
-/-
 double mutants. G) APCs were naïve spAPC, media contained 
IL-2, 0.2 ng/ml TGF- and the indicated concentration of retinoic acid (RA).  
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upon adoptive transfer into TCRβ-/-IL-6-/- double mutant mice, despite an 
overall increased frequency of conversion, for both cell types, when 
compared to IL-6 sufficient recipients (Fig. 3.5F and S3.5). Among other 
cytokines that could affect Foxp3 induction, only IL-4 and to a lower extent 
TNF- showed a noticeable inhibitory effect that affected mature more than 
immature T cells, possibly explained by lower level of surface receptor 
expression (Fig. 3.5E and S3.5), as shown previously for IL-6 (5). Retinoic 
acid is another factor that has been shown to modulate Treg differentiation, 
both in vitro and in vivo (21, 23, 24). However, while its addition to the 
cultures readily enhanced iTreg differentiation from peripheral T cells it had 
no effect on thymocytes (Fig. 3.5G). We conclude that several natural 
factors known to inhibit or enhance Treg differentiation specifically affect 
mature T cells.  
We next assessed the sensitivity of each T cell subset to bona fide inducers 
of Treg, namely TCR triggering and TGF-. We first monitored the response 
of anti-HY TCR transgenic cells to a large range titration of their nominal 
peptide presented by naïve APC (Fig. 3.6A). As suggested earlier (25, 26) 
the lower the TCR triggering, the larger the frequency of cells acquiring 
Foxp3 expression. More importantly, the slope of the dose response 
obtained with thymocyte cultures was much steeper than that of peripheral 
cells, indicating differential sensitivity to TCR triggering for Foxp3 induction. 
Next, fixing the peptide concentration and varying the concentration of TGF-
 indicated a higher sensitivity of immature cells to this cytokine (Fig. 3.6B). 
Similar differential sensitivity to TGF- was obtained when testing polyclonal 
cells stimulated with anti-CD3 (Fig. 3.6C). However, Ab-mediated 
neutralization of TGF- abrogated Foxp3 induction in all subsets (Fig. 
3.6A,B), confirming the dependency on TGF- for iTreg induction. Yet, 
without exogenous TGF-, conversion was frequently detectable, notably for 
thymocytes, likely the result of variable concentration of active TGF- in the
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Figure 3.6. Enhanced sensitivity of immature T cells to TGF- dependent 
induction of Foxp3 expression in vitro. A, B) CD4
+
 thymocytes and LN cells 
isolated from female Rag
-/-
 Foxp3-GFP anti-HY TCR tg mice were set in cultures 
containing spAPCs, IL2, 0.2 ng/ml TGF-in A) and the indicated concentration of 
nominal peptide. C) Polyclonal CD8
-
CD4
+
Foxp3
-
 cells were stimulated as in (B) 
except anti-CD3 Ab was used instead of peptide. D) LN cells were fractionated as 
mature resident cells (Qa-2
hi
) and RTE (Qa2
lo
) and cultured in presence of spAPC, 
0.1 µg/ml anti-CD3 Ab, IL-2 and the indicated concentration (µg/ml) of neutralizing 
anti-TGF Ab. Results are expressed as % of response in absence of neutralizing 
Ab. E, F) CD8
-
CD4
+
Foxp3
-
 cells were purified from Foxp3-GFP, TGF-RIIdn Tg 
double mutant mice and either cultured (E), as in C or adoptively transferred into 
TCR
-/-
 mice (F), as in Fig. 3.1. 
 
 
serum supplement (not shown). Titration of neutralizing antibodies in such 
cultures revealed that thymocytes and RTE require less TGF- than mature 
T cells to convert into a Foxp3+ phenotype (Fig. 3.6D). As a confirmatory 
experiment we tested cells prepared from donor mice expressing a dominant 
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negative form of the TGF- receptor (dnTGF-RII) that are partially impaired 
in TGF-signaling (27). Compared to the respective WT cells, mature 
mutant cells lost 90% of their capacity to convert into Treg as compared to 
only 40% for mutant thymocytes (Fig. 3.6E). Finally and in line with the 
results above, both LN and thymocytes isolated from mutant mice showed 
dramatically decreased capacity to convert into Treg when tested in vivo. 
This reduction resulted in rare to undetectable (max 0.3% of recovered cells) 
Foxp3+ cells in recipient of LN cells and corresponded to a 7 to 10 fold 
decrease in recipients of thymocytes (Fig. 3.6F and S3.6). From this set of 
experiments, we conclude that T cell maturation associates with several 
features impairing their susceptibility to acquire Foxp3 expression, among 
which an increased sensitivity to inhibitory cytokines and a lower sensitivity 
to inducing signals such as TCR triggering and TGF-. 
 
Human RTE are more susceptible than mature cells to differentiate into Treg 
We next tested whether our findings indicating that peripheral maturation 
limits T cells susceptibility to differentiate into Treg can be extended to 
humans. Human naïve CD4+CD25-CD127hi lymphocytes are devoid of 
Foxp3 expressing cells and can acquire Foxp3 expression in vitro upon 
stimulation with anti-CD3 in presence of TGF-. Among these, FOXP3bright 
CD25high are bona fide Treg (28). Human RTE are enriched in the CD31+ cell 
subset that represents 50 to 80% of the naïve CD4+CD25-CD127hi cells in 
peripheral blood of healthy donors (Fig. 3.7A), a variation previously 
associated with age and thymic involution (29). We tested CD31+ and CD31- 
naïve cells isolated blood donor and CD4SPCD25-CD127hi thymocytes 
isolated from patients undergoing heart surgery for their capacity to acquire 
a Treg phenotype in vitro. Upon culture in presence of plate-bound anti-CD3, 
IL-2 and TGF-, cells in both subsets readily converted to a FOXP3bright
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Figure 3.7. Preferential differentiation of human thymocytes and RTE into Treg 
ex vivo. Human thymocytes and peripheral blood mononuclear cells sorted as 
(CD8
-
) CD4
+
CD25
+
CD127
hi
 and for the latter, according to CD31 expression. Cells 
were cultured for 5 days in media containing IL-2 alone (IL-2) or supplemented with 
plate bound anti-CD3 mAb, soluble anti-CD28 mAb and TGF- (TCR+TGF). A) 
Representative Flow cytometric analyses of CD31 expression within naïve 
CD4
+
CD25
+
CD127
hi
 peripheral blood mononuclear cells before and after sorting. B) 
Representative dot plots show the frequency of FOXP3
bright
CD25
high
 cells within live 
lymphocytes after culture. C) Results of 8 independent blood donors, each pair 
CD31
-
/CD31
+
 represents one donor (paired t-test). Thymocytes were from another 
cohort (n=14). D) Correlation between the frequency of CD31
+
 cells among naïve 
CD4
+
CD25
+
CD127
hi
 cells in each blood sample before sorting and the respective 
fold increase in the frequency of FOXP3
bright
 cells when comparing the induction 
efficiency of the CD31
+
 versus CD31
-
 cell subsets. Spearman coefficient test, r and 
P were 0.5238 and 0.0983, respectively. 
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CD25high Treg phenotype (Fig. 3.7B). A pair-wise comparison revealed that 7 
out of 8 donors analyzed showed more efficient conversion when CD31+ 
instead of CD31- cells were tested for either frequency (Fig. 3.7C) or number 
of FOXP3brightCD25high cells, as well as level of FOXP3 expression, as 
defined by the mean fluorescence intensity (not shown). As the CD31+ cell 
subset is heterogeneous, enriched in RTE but also encompassing more 
mature cells (30), it is expected that low frequency of CD31+ cells would also 
associate with low number of RTE inside the CD31+ cell subset. In 
agreement with this reasoning, the unique donor who showed lower iTreg 
induction in CD31+ vs CD31- cell cultures presented with the lowest 
percentage of CD31+ in total naïve cells, pre-sorting. Symmetrically, the 
donor who showed a 4 fold increased Treg induction in CD31+ vs CD31- cell 
cultures presented with a high percentage of CD31+ cells pre-sorting (Fig. 
3.7D). Finally, analysis of thymocytes in comparison to peripheral blood cells 
further supported the notion that, in human as in mice, peripheral maturation 
progressively affects T cell susceptibility to differentiate into Treg.  
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Discussion 
There has been increasing hope that inducing de novo differentiation of Treg 
would offer a therapeutic solution for autoimmunity and allergy. On the other 
hand, preventing de novo Treg development is needed to improve tumor 
therapies and vaccine efficacy. Our findings that extrathymic maturation of 
CD4 T cells limits their capacity to differentiate into Treg in mice and in 
humans bears several consequences on our understanding of immune 
regulation and on the development of novel therapeutic approaches. 
Earlier works supported directly or indirectly the notion that RTE 
preferentially promote dominant tolerance to peripheral antigens (31, 32). In 
contrast, the more recent literature on Foxp3+ pTreg assumes that any naïve 
cell can be a precursor of pTreg, provided they express the proper TCR 
specificity and are presented antigen in the right context. This notion likely 
derives from in vitro assays, in which most naïve peripheral cells can acquire 
Foxp3 expression. Intriguingly, the fraction of cells successfully induced to 
expressed Foxp3 in vivo in various assays, including in monoclonal TCR 
transgenic mice infused with the nominal peptide (6), is minute. To our 
knowledge this paradox has not been explored before and can be explained 
by our findings indicating that RTE, a limited cell subset in the periphery, are 
the preferential precursors of pTreg.  
To test the hypothesis that limited number of Treg precursors relates to T 
cell maturation stage, we chose the lymphopenia induced Foxp3 expression 
assay. This experimental setting presents the advantage of testing 
polyclonal cells developed in a WT host for their spontaneous differentiation 
into Treg. It also mimics the severe peripheral lymphopenia that takes place 
in various patho-physiological situations, such as upon infection or in clinical 
settings, for instance upon high dose corticosteroid administration. 
Moreover, the physiological relevance of iTreg generated during LIP has 
been previously demonstrated in a model of colitis (8). In addition, induction 
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of Treg upon LIP is readily detectable which allows for reliable quantitative 
measurements. It is worth noticing that the frequency of Treg we obtained 
upon adoptive transfer of peripheral cells into TCR-/- mice was above the 
average values reported in similar LIP assays for which RAG-/- recipient mice 
have been used (10). We confirmed that fully alymphoid mice poorly sustain 
pTreg differentiation (Lino in preparation) and nevertheless also favor 
conversion of immature rather than fully mature peripheral cells (not shown). 
We further confirmed that T cell maturation limits their susceptibility to 
acquire Foxp3 expression in vivo by testing antigen-specific T cells triggered 
by their nominal peptide in vivo. Given that unmanipulated OTII Rag-/- mice 
are devoid of Treg, this set of experiments confirmed that we were 
monitoring true de novo Treg differentiation, as was already indicated by our 
voluntary contamination experiments. This approach also confirmed that our 
results did not owe to an enrichment of T cells pre-committed by TCR 
triggering in thymus, as also indicated by the experiments purging activated 
lymphocytes from polyclonal donor cells. Incidentally, these latter 
experiments provided the experimental design to exclude that our findings 
would owe to the fusion Foxp3-GFP allele, recently shown to be an 
occasional hypomorph and potentially unstable (33, 34). Exclusion of Foxp3+ 
cells from WT lymphocytes by selecting CD45RBhigh CD25- LN cells and 
CD25- thymocytes before adoptive transfer fully reproduced the differential 
phenotype (Fig. S3.7). 
Our findings indicating that cell maturation progressively restricts T 
lymphocytes susceptibility to acquire a Treg phenotype are consistent with 
other studies concerned with thymic Treg differentiation. Hence, thymocytes 
from newborns were more readily differentiated into Treg than from adults 
(35). Moreover, thymic APC were shown to be more potent at sustaining 
thymocyte rather than peripheral naïve cell conversion to iTreg (36). While 
these studies did not provide a molecular mechanism to these differences, 
our present work indicates that differential sensitivity to factors promoting 
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and inhibiting Treg differentiation explains the impaired ability of peripheral 
mature T cells to acquire a Treg phenotype. This finding completes our 
previous report indicating that recently differentiated thymocytes but not 
mature T cells, whether in the periphery or recirculating to the thymus, are 
refractory to IL-6 mediated inhibition of Foxp3 induction (5). Here, by testing 
RTE, we confirm that maturation stage defines CD4 cell sensitivity to IL-6. 
Yet, despite a clear inhibitory effect of IL-6 on LIP induced Treg, other 
factors beyond IL-6 determine the reduced susceptibility of mature cells to 
convert into Foxp3+ cells. We further evidence a decreased sensitivity of 
immature cells to TGF-. The role of this cytokine for the generation of 
thymic natural Treg has been debated and more recently, its requirement for 
de novo generated pTreg was also disputed (13-16). Our in vivo analysis of 
cells expressing a dominant negative form of the TGF-receptor ascertained 
that engagement of this pathway promotes Treg differentiation during 
lymphopenia. Importantly, our finding that T cell maturation associates with 
increased sensitivity to both inhibitors (IL-6 or IL-4) and promoters/facilitators 
(TGF- and RA) of Foxp3 induction, are also compatible with the notion that 
mucosa efficiently support the differentiation of Treg. In this 
microenvironment TGF- and RA are abundant and inflammation maintained 
at check, such that Treg could also be recruited from resident mature 
peripheral cells. The novel concept brought about by our analysis is that 
systemic peripheral conversion, i.e. in situation of limited RA and TGF- 
and/or in inflammatory context, is restricted to RTE. 
Finally, our work reveals a third way by which the adult thymus contributes to 
peripheral tolerance. As first evidenced in the 1990s, selection of natural 
Treg takes place in the thymus upon TCR triggering by self-antigens, 
including those tissue specific genes expressed by TEC (2). Moreover, 
recirculation of peripheral antigens to the thymus also shapes Treg 
repertoire (5). Lastly, as we show here, recently differentiated T cells have a 
limited developmental time-window, before full maturation in the periphery, 
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to readily acquire Foxp3, placing RTE as the preferential precursors of 
pTreg. All together, because the thymus involutes with age, infections and 
upon various drugs administration, these properties call for specific attention 
to thymic activities when developing therapies to enhance or prevent 
immune tolerance.  
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Material and Methods 
Mice  
All mice were on a C57BL/6 background bred and raised in a strict SPF 
facility upon rederivation by embryo transfer when necessary. The Foxp3-
GFP reporter mice (20) were bred to homozygocity with mice congenic for 
Thy1.1 (originally Jackson, USA), with animals transgenic for CD4-dnTGF-
RII (27), with marilyn anti-HY TCR Tg Rag-/- mice (37) and with established 
OT-II Rag2-/- mice (originally OTII from Jackson and Rag2-/- from CDTA, 
France). TCR-/- animals were crossed with IL6-/- mice (both originally from 
Jackson, USA) to generate IL6-/-TCR-/- mice. Nude-Foxn1-/- mice were 
originally from Taconic, UK. All animals were used between 6 and 12 weeks 
of age, unless otherwise indicated. When indicated mice receive i.v. injection 
of 3x105 purified cells, and/or 100 g/mouse of endotoxin free ovalbumin 
protein (endograde ovalbumin - hyglos). Thymectomies were performed by 
aspiration in 5-6 week old mice under ketamine/xillazine anesthesia. Sham 
operated mice underwent the full procedure but aspiration omitted. Mouse 
experiments were approved by the Institutional ethical committee and the 
Portuguese state entity DGV. 
 
Human samples 
Thymic specimens were obtained from routine thymectomy performed 
during pediatric corrective cardiac surgery at the Hospital de Santa Cruz, 
Carnaxide, Portugal, after parent’s written informed consent. Buffy coats 
were provided by Instituto Português de Sangue, Lisboa, Portugal. Human 
studies were approved by the Ethical Board of the Faculty of Medicine of 
Lisbon. 
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Antibodies  
Mouse antibodies for FACS analysis and cell sorting were anti-HSA/CD24-
Cy5 (M1/69), IL4-R/CD124-PE (mIL4R-M1), CD4-PE/PB/APC (RM4-5), 
CD45RB-PE (16A), CD44-biotin/PB (IM7), Thy1.2-biotin (53-2.1), Thy1.1-PE 
(Ox7), Qa-2-biotin (1.1.2), IL6-R/CD126-PE, all from Beckton Dikinson; 
IFN-RI/CD119-PE (2E2), Integrin alpha-IE/CD103-biotin (2-E7), KLRG-1-
APC (2F1), GITR-biotin (DTA-1), Foxp3-FITC/PE/APC (FJK-16s) all from 
ebiosciences; anti-CD3-APC (500 A2-77), IL2-R/CD25-PE (7D4), CD8-
PE/A647 (YTS169.4), produced in house and Helios-PE (22F6, Biolegend), 
Neuropilin-1-APC (polyclonal, R&D). Biotinylated Abs were revealed with 
streptavidin-A488/PE, A647, PB or APC-Cy7 (BD). For cell culture, anti-
CD3 (141.2C11), neutralizing TGF (1D11) and anti-Thy1.2 (30H12) were 
produced and purified on Protein G column in-house and anti-CD28 (37.51) 
was purchased from ebiosciences. Human antibodies were: CD3 (UCHT1 or 
OKT3), CD4 (RPA-T4), CD8α (RPA-T8), CD31 (WM59) and FOXP3 
(PCH101) from ebiosciences, CD25 (2A3) from BD and CD127 (40131) from 
R&D. 
 
Cell preparation 
Mouse LN cells and thymocytes to be injected or maintained in culture were 
prepared from pooled thymi or pooled lymph nodes (inguinal, axillary, 
brachial, cervical, popliteal, mesenteric, para-aortic and pancreatic). 
Analyses were performed on single organs/single mice. Cell suspensions 
were maintained in 1xPBS/2% FCS at 4oC for purification, or 1xPBS/2% 
FCS/0.05% NaN3 for analysis. Cell sorting was performed on a FACSaria or 
MoFlo FACS sorter. For analysis samples collected on BD FACScalibur or 
Cyan ADP analyzers. Staining was preceded by incubation with anti-Fc 
receptor blocking antibody and followed with propidium iodide staining. 
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Human thymocytes were separated on a Ficoll-Paque PLUS (GE 
Healthcare) density gradient while human PBMC were enriched in CD4+ T 
cells using RosetteSep (StemCell Technologies), before cell sorting.  
 
Cell culture 
Mouse cells were cultured in complete RPMI supplemented with 10 mM 
Hepes, 1 mM Sodium Pyruvate, 50 M -mercaptoethanol (all from Gibco); 
10 % FCS and 1% Penicillin/Streptomycin (Invitrogen) and 0.1% gentamicin 
(Sigma). For APC free cultures, flat bottom 96 well plates were coated with 2 
g/ml anti-CD3 antibody (2C11, in house) in PBS for at least 3 hours and 
media was supplemented with 1 g/ml soluble anti-CD28 antibody (in 
house). APCs were either red blood cell lysed splenocytes depleted of Thy1 
positive cells (by anti-Thy1 Ab and complement) and irradiated (3500 rad), 
or else BM derived DC from GMCSF supplemented cultures. When 
indicated, APCs were activated with 1 g/ml Lipid A overnight. In APC 
containing cultures, media was supplemented with anti-CD3 (2 g/ml), TGF-
 (0.02 ng/ml peprotech), IL-2 (1/250 dilution of X63 cell line culture 
supernatant) and/or IL-4, IFN-, IL-12 or IL-6 (R&D), IL-17 (peprotech), 
TNF (R&D), retinoic acid (Sigma) at 100 ng/ml. 3H-thymidine added in the 
last 6 hours of culture to measure proliferation. Human cells were stimulated 
for 5 days with plate bound anti-CD3 mAb (2 and 1 g/ml, respectively, clone 
OKT3 from Ebiosciences), soluble anti-CD28 mAb (1 g/ml, clone CD28.2 
from Ebiosciences) in medium supplemented with IL-2 (50 U/ml, (NIH)/AIDS 
Research and Reference Program, [IL-2] from Hoffman-La Roche) and TGF-
 (5 ng/ml, peprotech).  
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Data analysis 
FACS data were analyzed with FlowJo (Tree Star, Inc.). All numerical data 
were processed in Excell (Microsoft Corp.) and plotted in Graphpad Prism 
(Graphpad Software, Inc.). Statistical significance between sample pairs was 
determined using a non parametric Man-Whitney test (* p<0.05; ** p<0.01; 
*** p<0.001), unless otherwise indicated.  
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Supplemental Figure S3.1. True Treg differentiation from peripheral Tconv 
cells. A) Consistent preferential differentiation of thymocytes to a Foxp3
+
 
phenotype. Pool of 6 independent experiments conducted as in Figure 3.1. 
Frequency and numbers of Foxp3 and CD4 cells recovered. B) As in Figure 3.1, 
except that the recipients were Thy1.1 congenic C57BL/6 1 mice that had received 
400 rad full body irradiation the day before. Shown is analysis 4 weeks later gated 
on donor Thy1.2
+
 CD4
+
 TCR
+
 live cells. biaLN – pooled brachial, inguinal and 
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axillary LNs; SPL – spleen; mLN – mesenteric LNs; PP – Peyer’s patches; LIL – 
large intestine lymphocytes). * p<0.05; **p<0.01; ***p<0.001, Mann-Whitney test. C) 
TCR
-/-
 recipients received a 90:1 mixture of CD4
+
CD8
-
Foxp3
-
 (Thy1.2) and Foxp3
+
 
(Thy1.1) T cells, both prepared from either thymi or pooled lymph nodes of Foxp3-
gfp reporter mice either Thy1.2 of Thy1.1 congenic, respectively (upper panel). 
Bottom panel shows analysis of recipient mice 4 weeks post adoptive transfer after 
gating on CD4
+
TCR
+ 
splenocytes. 
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Supplemental Figure S3.2. Pair-wise phenotypic analysis of Foxp3
- 
or Foxp3
+
 
cells from the spleens of animals treated as in Fig. 3.1A. Shown are 
representative FACS analysis of recovered Foxp3
-
 and Foxp3
+
 cells from 
thymocytes or LN transfers (two last right columns). Other Foxp3
-
 and Foxp3
+
 cell 
populations served as references: From animals kept at steady state, Thymic 
Foxp3
+
 cells and Foxp3
-
 conventional CD8
-
CD4
+
 thymocytes as well as peripheral 
Foxp3
+
 and Foxp3
- 
from LN (first two left columns); from TCR
-/-
 recipient mice that 
received 4 weeks earlier a mixture of Thy1.1 Foxp3
-
 and Thy1.2 Foxp3
+
 LN cells at a 
9:1 ratio (central column). 
 
Chapter 3 
153 
 
 
 
Supplemental Figure S3.3 Representative sorting samples for experiments 
presented in Fig. 3.3. 
A) Purification of CD4
+
Foxp3
-
CD45RB
high
 LN cells used in experiments presented in 
Fig. 3.3B. B) Purification of CD8
-
CD4
+
Foxp3
-
CD25
-
 LN cells and thymocytes used in 
experiments presented in Fig. 3.3D. 
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Supplemental Figure S3.4 RTE phenotypic analysis and Foxp3+ cell number of 
experiments shown in Fig. 3.4. A) Expression level of surface CD24/HSA on 
CD4
+
CD8
-
Foxp3
- 
cells from LN cells and thymocytes (left) and on gated Qa-2
hi
 and 
Qa-2
lo
 LN cells from 2 months old mice. B) Numbers of CD4
+
TCR
+
Foxp3
+
cells 
recovered upon adoptive transfer of peripheral resident mature cells (LN Qa2
hi
), 
RTE (LN Qa2
lo
) and thymocytes as in Fig. 3.4A. C) Idem for adoptive transfer of total 
CD4
+
Foxp3
- 
LN cells purified from thymectomized (TxT) or sham operated donor 
mice as in Fig 3.4B.  
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Supplemental Figure S3.5. Complementary data to experiments presented in 
Fig. 3.5. A, B) Number of CD4
+
TCR
+
 cells recovered in TCR
-/-
 IL-6
-/-
 double 
mutants as in Figure 3.5F (A) and comparison with similar adoptive transfer into IL-6 
competent recipient mice (B) where the later are given a value of 1. C) Detailed 
analysis of LN cells and thymocytes sensitivity to candidate inhibitors of Foxp3 
induction D) surface expression of IL6-R and IL4-R by the three cell types 
analyzed in this work. 
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Supplemental Figure S3.6. Number of CD4 cells recovered and an alternative 
representation of data presented in Fig. 3.6. 
Number of CD4
+
TCR
+
 cells recovered in TCR
-/-
 mice recipient of TGFRIIdn 
transgenic cells as in Figure 3.6F (A) and comparison with similar adoptive transfer 
from WT Foxp3-GFP donors (B) where the later are given a value of 100. 
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Supplemental Figure S3.7. Preferential differentiation of Thymocytes vs. LN 
cells into Treg is not a singularity of the Foxp3-GFP allele. A) CD8
-
CD4
+
CD25
- 
thymocytes and CD8
-
CD4
+
CD25
-
CD45RB
high
 LN cells were sorted from WT Thy1.1 
and Thy1.2 mice, respectively and co-transferred into TCR
-/-
 mice. Recipient 
animals were analyzed as in Fig. 3.3C. B) CD8
-
CD4
+
CD25
- 
thymocytes purified from 
either WT Thy1.1 or Foxp3-GFP Thy1.2 mice were co-transferred into TCR
-/-
 
animals and analyzed as in A. 
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Chapter 4 preliminary notes 
The author of the thesis designed and planed the experiments together with 
the supervisor Dr. Jocelyne Demengeot. The author also participated in all 
the experiments presented with the participation of the remaining authors 
mentioned in the beginning of the chapter in special cases. The author also 
prepared the figures. The analyses and interpretation of the results were 
mainly performed by the author and the supervisor Dr. Jocelyne Demengeot.  
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Abstract 
Foxp3 expressing regulatory T cells constitute a subset of CD4 T cells 
present in humans and mice that has potent regulatory activities. While 
initially thought to originate exclusively in the thymus it is nowadays 
accepted that Treg can develop from Foxp3- T cells isolated from the 
periphery. By performing adoptive transfer of Foxp3- T cells to lymphopenic 
recipients, in which some cells upregulate Foxp3 during the ensuing 
expansion, we explored the potential of Tregs differentiated from peripheral 
cells to regulate the global T cell population transferred. To this aim we 
designed a new protocol to obtain Foxp3 deficient T cells in a naïve state 
and applied a loss of function approach. Transfer of Foxp3 competent or 
deficient naïve T cells revealed that the ability of naïve T cells to upregulate 
Foxp3 allows the control of the expansion of the global T cell population 
transferred. However, it does not have an impact on T cell activation nor 
helper cell differentiation that takes place during lymphopenia induced 
proliferation. By performing secondary adoptive transfers of the Treg 
developed from peripheral cells together with fresh Foxp3- T cells we found 
that these Treg while displaying a low suppressive activity, likely due to low 
cell numbers present, are a stable lineage in respect to maintaining Foxp3 
expression. We also document that iTreg differentiated during lymphopenia 
upregulate IFN receptor which indicates the differentiation of a parallel 
phenotype to the dominant Th1 polarization associated with the 
experimental system used. Understanding the regulatory potential and 
stability of Treg differentiated from peripheral cells is of utmost importance to 
support the investment in future therapeutic applications aiming at 
performing adoptive transfer of Treg differentiated from cells of peripheral 
origin. 
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Introduction 
Foxp3 expressing regulatory T cells (Treg) are in control of pathological 
immune self reactivity and limit the immune response during infection (1-5). 
Treg may be generated in the thymus from developing thymocytes (nTreg) 
or in the periphery after T cells have been exported from the thymus (iTreg) 
(5-8). Differentiation at both stages follows similar rules with the less mature 
T cells being more prone to give rise to Treg due to lower sensitivity to pro-
inflammatory cytokines, that inhibit Foxp3 expression in more mature T cells, 
and being able to differentiate to Treg in lower TGF availability that 
diminishes as T cells age (Chapter 2 – manuscript in preparation). While the 
role of Treg found in the periphery of a naïve mouse, which will likely include 
both thymic and peripheral derived Treg, has been extensively described 
and mechanistically characterized, the contribution of Treg generated from 
each T cell compartment has just started to be explored. However, the 
technological advances have not yet completely fulfilled the requirements for 
a definite determination of the relative contribution of thymic and peripheral 
origin to the peripheral Treg pool. Initial reports have made use of in vitro 
derived Treg to illustrate the functionality of iTreg (6), but recently more 
elaborated approaches have been applied and in vivo derived iTreg have 
been implicated mainly in the control of mucosal associated antigen specific 
CD4 reactions. For instance, iTreg seem to be able to control certain 
aspects of asthma, IBD and successful pregnancy (9-13). 
On the other hand, the stability of Foxp3 expression and the phenotypic 
plasticity of Treg are other crucial features to be understood about Treg if full 
therapeutic and/or diagnostic value is to be extracted from this T cell 
subpopulation. Work based in in vitro derived iTreg showed that iTreg are 
more prone to lose Foxp3 expression than Treg isolated from the periphery 
of naïve mice. This phenomenon has been mainly ascribed to lower 
demethylation of the Foxp3 promoter region in iTreg when compared to Treg 
from the periphery of naive mice (14). However, when investigators 
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evaluated the methylation status of iTreg derived in vivo upon adoptive 
transfer, and therefore thymic independent, of TCR Tg T cells with the 
following administration of the cognate Ag, the Foxp3 promoter of the Treg 
that differentiated was fully demethylated as it happens in Treg isolated from 
naïve mice (15). This report indicates that in vitro differentiation of Treg does 
not fully mimic in vivo Treg differentiation, at least in the experimental 
conditions tested so far. Therefore, the stability of in vivo derived iTreg 
differentiated in different conditions remains an open question. 
In a similar phenotypic concern about Treg recent reports have showed that 
Treg depend on genetic programs elicited in the responding population to 
control the respective response. Of example is the need for Tbet, IRF4 and 
Stat3 expression in Foxp3+ cells to be able to control the respective Th1, 
Th2 and Th17 polarized responses (16-18). These studies have opened the 
concept of phenotypic plasticity beyond maintenance or loss of Foxp3 
expression to a full genetic program that directs Treg activity to the 
environment which they are exposed to (19). Based on the observations of 
iTreg differentiation upon lymphopenia induced proliferation (LIP) of Tconv 
we decided to test if Treg differentiated after adoptive transfer to 
lymphodeficient recipients would bear the classical Treg function of 
controlling T cell proliferation. For this aim, we set up a loss of function 
strategy and developed a new protocol where T cells that cannot become 
Treg develop in a non inflammatory environment and can be harvested in a 
naïve state. This is an important detail since mice that are deficient for 
Foxp3 develop a multi organ auto immune lymphoproliferative disease and 
are therefore comprised almost exclusively of activated T cells (20). Using 
naïve peripheral T cells as donor population and assessing the T cell 
number 4 weeks after transfer to TCR deficient recipients we found that the 
population of T cells that were not able to express a functional Foxp3 
expanded more than the Foxp3 sufficient T cell population. Co-transfer of 
naïve cells from Foxp3 sufficient and deficient background confirmed that 
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iTreg that differentiate during the transfer are able to control the expansion 
of the global population of T cells transferred. After confirming functionally 
and phenotypically that iTreg display a classical Treg phenotype, we decided 
to test iTreg control of proliferation after a secondary transfer to provide a 
final proof of its functionality in vivo. To our surprise, iTreg transferred with a 
fresh naive T cell population were not maintained for 4 weeks in the 
secondary transfer, while if mice recipients of a single transfer were 
observed 8 weeks after, iTreg were still detectable, indicating that the cells 
had the potential to be maintained for the entire 8 week period. An 
evaluation of iTreg surface levels of receptors for cytokines linked with 
different Th polarization indicates that iTreg cells developed in this condition 
are likely to depend in IFN signaling and their disappearance in co-transfer 
with fresh conventional T cells suggests iTreg generated through the 
protocol presented here are only maintained in this inflammatory condition. 
This work provides further support to strategies based on the adoptive 
transfer of iTreg cells but at the same time raises questions to the design of 
its differentiation according to the type of response that is to be regulated. 
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Results 
Generating Foxp3 deficient T cells in a naïve state 
The identification and study of regulatory T cell physiology and function has 
profited from the discovery and later use of the mutation affecting the scurfy 
mouse (Sf), found to be a Foxp3 null mutant. These mice suffer from an 
autoimmune lymphoproliferative syndrome that develops early in life and 
leads to death of the majority of mice by 4-6 weeks of life (20). The 
phenotype observed in mice that have a full Foxp3 deficiency (hemizygous 
males or homozygous females, since the Foxp3 gene is located in the X 
chromosome) was one of the original pieces of evidence that led to the 
identification of the Foxp3 transcription factor as a master regulator for the 
Treg genetic program and perfectly illustrates the essential nature of Treg’s 
regulatory capacity (21). However, to be used in a loss of function approach 
in the study of iTreg, the direct use of Sf cells is a potential source of 
confounder effects, given that the vast majority of CD4 cells found in Sf mice 
are activated and embedded in a complex cytokine milieu. It has been 
reported that WT recipients of Sf BM donors are healthy, even if the 
recipients are subjected to lethal irradiation regimens before transfer. The 
lack of disease transfer to WT recipients has been ascribed to radio resistant 
Treg that are not eliminated through radiation (22). This report is a good 
example of Treg dominant mode of tolerance which allows the use of cells 
carrying a WT Foxp3 allele to keep Foxp3 deficient T cells under control. 
In this work we made use of this knowledge and designed a bone marrow 
(BM) transfer system to obtain naïve Foxp3 deficient T cells. The protocol 
used is depicted in Figure 4.1A and consists of transferring C57BL/6J 
(Thy1.2) Sf BM to congenic C57BL/6J Thy1.1 recipients (hereafter referred 
to as Thy1.1) that had received a 900 rad total body irradiation regimen the 
day before. We also transferred 107 total splenocytes from Thy1.1 donors a 
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Figure 4.1. Foxp3 deficient Naive T cells can be prepared by transferring 
Scurfy bone marrow to WT recipients. (A) Bone marrow transplantation protocol 
to obtain Foxp3 deficient T cells and the respective WT controls. Briefly, bone 
marrow was extracted from femurs and tibias of Scurfy or WT (Thy1.2) donors and 
5x10
6
 cells, after T cell depletion and red blood cell lysis, were transferred i.v. to WT 
(Thy1.1 congenic) recipients that had received 900 rad total body irradiation the day 
before. Recipients of bone marrow received a transfer of 10
7
 WT (Thy1.1) total 
splenocytes 7 days after to minimize the activation and expansion of the first cells to 
differentiate from the transplanted bone marrow. The peripheral T cell pool of 
recipient mice was allowed to reconstitute for at least 8 weeks before mice being 
used as donors of Scurfy or WT naïve T cells. (B) Mice receiving Scurfy bone 
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marrow following the protocol described in A were analyzed by flow cytometry for 
the expression of the activation markers, CD45RB, CD44 and CD62L and were 
found to display a naïve phenotype. Shown are representative histograms of 
CD4
+
Thy1.2
+
 cells from at least 5 mice recipients of Scurfy bone marrow (grey 
shaded) and fresh WT cells (solid line). (C-E) CD4
+
CD25
-
CD45RB
hi
Thy1.2
+
Thy1.1
-
 
cells from LNs of mice prepared as in A were FACS sorted and: cultured in vitro for 
3 days in the presence of plate bound CD3, soluble CD28, IL-2 and anti-
TGF(C); co-cultured in the presence of Treg at a ratio of 2:1 and T cell depleted 
irradiated splenocytes and CD3 (D); or co-transferred in the presence of 
CD4
+
Foxp3-GFP
+
 Treg.  Shown are the c. p. m. derived from tritiated thymidine 
incorporation during the last 6 hours of culture (C and D) and the number of cells 
recovered 4 weeks after transfer (E).  
 
 
week after the BM transfer, to minimize lymphopenia induced proliferation of 
the first nascent T cells and therefore guarantee a naïve and undisturbed 
peripheral cell pool of Foxp3 deficient T cells. The peripheral pool of 
lymphocytes in BM recipients was then allowed to reconstitute for at least 8 
weeks before mice being used as T cell donors or analyzed. Haribhai et al 
have recently used a similar approach to achieve the same goal. Their 
protocol was based on transferring splenocytes to newborn Sf mice (10, 11). 
However, we prefer, and recommend, the use of a BM transplant protocol 
since it allows for the maximization of the usually limiting Foxp3 deficient 
mice, given that a single donor can contribute with bone marrow to at least 5 
recipients. In parallel, WT (Thy1.2) BM was also transplanted to similar 
Thy1.1 recipients to be a source of control, Foxp3 sufficient, T cell donors in 
subsequent experiments. 
BM chimeras prepared according to our protocol survived for several months 
without showing signs of disease (data not shown). We first analyzed the 
peripheral T cells of Thy1.1 mice reconstituted with Sf BM and found that 
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CD4+ Th1.2+ T cells presented similar levels of CD45RB, CD44 and CD62L 
as fresh naïve T cells isolated from WT non manipulated donors (Fig. 4.1B). 
We also found Sf naïve T cells to be functionally equivalent to WT naïve T 
cells in in vitro proliferation assays (Fig. 4.1C). Likewise, naïve Sf T cells 
were equally suppressed by fresh peripheral Treg from naïve WT mice, both 
in vitro and in vivo (Fig. 4.1D and E). These data confirm that Sf cells 
maintain a naïve state in our system, are as functional as WT naïve cells 
generated through the same protocol and, as such, are a valid sample for 
Foxp3 loss of function approaches in naïve T cells when used in comparison 
to WT naïve T cells generated through the same protocol, for which the main 
differences to be observed are due to the expression, or the lack of, a 
functional Foxp3 protein. 
 
Loss of function of Treg differentiated from peripheral cells in vivo during 
Lymphopenia Induced Proliferation – control of T cell activation 
Treg can be induced to differentiate in vivo from peripheral cells by different 
protocols, such as slow low dose antigen delivery, antigen delivery together 
with T cell activation modulating antibodies, like CD4, oral delivery of 
antigen or direct Ag delivery to Dendritic cells (23-26). However, these are 
approaches which best fit the use of TCR Tg systems and pose difficulties 
when applied to polyclonal T cell populations, mainly due to the low 
frequency of clones existing at steady state to any given antigen. On the 
other hand, one can transfer WT polyclonal Foxp3- CD4 T cells (Tconv) to 
lymphopenic recipients and a proportion of these cells upregulates Foxp3 
expression while expanding (27). While this system is more demanding to 
test for Treg function, it allows the use of polyclonal WT cells avoiding 
potential TCR Tg derived artifacts. This system allowed us to assess the 
differentiation and role of in vivo derived iTreg. 
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To test iTreg function we performed transfers of Scurfy or WT naïve T cells 
to TCR KO mice analyzing lymphoid organs 4 weeks after transfer as 
depicted in Figure 4.2A. Naïve T cells were isolated by FACS sorting CD4+ 
Thy1.2+ Thy1.1- CD25- CD45RBhi cells. This sorting strategy displayed a 
typical contamination of Foxp3+ cells below 1% when sorting WT cells (Fig. 
4.2B). While offering an efficient Treg depletion when sorting WT cells, this 
protocol also allowed us to sort the equivalent naïve T cells from Sf origin 
and, according to the report by Gavin et al (28), exclude cells that were 
supposed to be Foxp3+ in the Foxp3 deficient background. 
 
Figure 4.2. Protocol to differentiate iTreg in vivo during lymphopenia induced 
proliferation. (A) Mice prepared as in Fig. 4.1A were used as donors of CD4
+
CD25
-
CD45RB
hi
CD25
-
 T cells which were transferred i.v. to TCR deficient recipients. 
Mice were then analyzed 4 weeks after transfer. (B) Gating strategy used to sort 
naïve T cells. Number inside the last plot represent the frequency of Foxp3
- 
cells 
inside CD4
+
CD45RB
hi
CD25
- 
lymphocytes (n=5) in an analysis of WT mice. 
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Adoptive transfer of naïve T cells to lymphopenic recipients has been widely 
used as an experimental model of colitis and the protective effect of Treg co-
transfer in this system a landmark in setting the role of Treg in regulating T 
cell activity (29). While it was expected that the majority of naïve T cells gets 
activated in this protocol we decided to assess if the ability of the naïve T 
cell population transferred to express Foxp3 would have an impact in the 
extent of such activation. We followed T cell activation by analyzing CD44 
upregulation and CD62L downregulation in cells recovered from recipients of 
Sf or WT naïve T cells’ transfer. Analysis of these markers showed a similar 
activation of naïve T cells irrespective of their Foxp3 genotype (Fig. 4.3A, B 
and C). 
As another read-out of T cell activation, and to test if the ability of naïve T 
cells to upregulate Foxp3 had an impact in regulating helper T cell 
differentiation during LIP, we performed single cell analysis of cytokine 
secretion in T cells harvested after the same transfers as above by flow 
cytometry, after in vitro stimulation of the harvested T cells with 
PMA/Ionomycin followed by standard intracellular stainings. This analysis 
revealed a similarly high frequency of Th1 cells, little Th17 and undetectable 
Th2 cells, as measured by the frequency of cells secreting IFN, IL-17 and 
IL-4, respectively, in cells recovered from recipients of both WT and Sf 
origin. In the same line of the above findings, the frequency of IL2 producing 
cells was also similarly high in both expanded WT and Sf T cells (Fig. 4.3D-
H). These results indicate that Treg developed during LIP are not able to 
control the activation and helper cell differentiation of the expanding naïve T 
cell population. 
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Figure 4.3. in vivo derived iTreg do not control lymphopenia induced T cell 
activation. (A-G) Analysis of recipients of transfers performed according to the 
protocol depicted in Fig. 4.2A. CD4
+
CD3
+
 cells were analyzed for activation by CD44 
and CD62L expression (A-C). (A) Representative FACS plots for CD62L vs. CD44 
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profiles of CD4
+
CD3
+
 cells from naïve WT mice (left) or from TCR KO mice 
recipients of WT (middle) or Sf (right) naïve T cells 4 weeks after transfer. 
Percentage of activated T cells represented as upregulation of CD44 (B) and 
downregulation of CD62L (C) inside CD4
+
CD3
+
 cells from all mice analyzed is 
shown. (D-H) CD4
+
CD3
+
 cells from the same recipients were also analyzed for IL-
17, IFN, IL-4 and IL-2 secretion after in vitro stimulation with PMA and ionomycin. 
Shown are the representative FACS plots of IL-17 vs. IFN profiles (D) and IL-2 vs. 
IL-4 profiles (E) with the corresponding percentage of IFN
+
 (F), IL-17
+
 (G) and IL-2
+
 
(H) cells within CD4
+
CD3
+
 cells recovered from the mice analyzed. IL-4 secreting T 
cells were not detected. 
 
 
 
The differentiation of iTreg during lymphopenia induced proliferation upon 
adoptive transfer to T cell deficient recipients limits the expansion of the T 
cells transferred 
As introduced above, it is known that Foxp3- T cells upregulate Foxp3 
expression upon transfer to lymphopenic recipients (27). With our protocol 
we found that 1 to 40% of the recovered T cells (15.8±10.5; 6.1±3.3; 4.9±2.9; 
Mean±SD for %Foxp3+ inside CD4+CD3+ cells recovered from biaLN, mLN 
and SPL, respectively) expressed Foxp3 (Fig. 4.4A). At the same time we 
confirmed that the majority of recipients of Sf cells were devoid of Foxp3+ 
cells, with a small number of exceptions where a minor contamination of 
Thy1.1 cells from the sorting were probably co-transferred, without any 
measurable effect in the parameters measured. Together with the sorting 
strategy used this result allowed us to ascribe the observed differences to 
the presence of iTreg. The seminal paper by Sakaguchi et al that identified 
CD25+ cells as the CD4 T cell subset largely enriched in the long sought 
after Treg, showed that the co-transfer of CD25+ cells could control the 
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expansion of naïve T cells upon transfer to T cell deficient recipients (1). The 
capacity of Treg to control the proliferation of Foxp3- T cells later became a 
prototypical property of Treg. Therefore, we followed the number of T cells 
recovered from recipients of WT and Sf naïve T cells to test if the 
differentiated iTreg were actively controlling the proliferation of the 
transferred T cell population. Despite WT naïve T cells displaying a robust 
expansion, as expected, Sf cells originated approximately 4 to 6 fold, 
between minimums and maximums, respectively, and about 6 fold, between 
averages, higher cell numbers (Fig. 4.4B - WT and Sf samples). This result 
is an indication that Foxp3 expression by naïve T cells during LIP contributes 
to control the extent of expansion of the transferred T cell population. 
However, and despite our careful design of the naïve T cell preparation 
protocol, we could not fully exclude that some unforeseen difference 
between WT and Sf naïve T cell populations was the source of the increased 
cell number obtained from Sf cells. To test if the presence of iTreg was 
indeed sufficient to limit the expansion of naïve T cells under LIP we made 
use of the dominant mode of regulation known to be a property of Treg, and 
designed co-transfer strategies where naïve Sf cells would expand in the 
presence of iTreg originating from a WT naïve T cell subset. First we 
transferred the same number of T cells again to TCR deficient recipients, 
with WT and Sf naïve T cells each composing half of the population. 
Analysis 4 weeks after transfer revealed that the number of T cells 
recovered was similar to the transfer of the WT cells alone and decreased 
when compared to the transfer of Sf cells (Fig. 4.4B - mix). This result 
strongly suggests that iTreg indeed control the expansion of the global naïve 
T cell pool transferred, irrespective of half not being able to upregulate 
Foxp3. On the other hand, this system was not designed to retrospectively 
identify WT and Sf donors which made it impossible to determine if both 
cells expanded similarly. However, another experiment was performed using 
WT Thy1.1 cells harvested from a Thy1.2 recipient of Thy1.1 BM, using the 
same strategy illustrated in Figure 4.1A but with the allotypic markers 
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Figure 4.4. Lymphopenia derived iTreg limit the number of T cells recovered 
after naïve T cell transfer to lymphopenic recipients. (A,G) 10
6
 Naïve T cells 
were transferred to TCR KO recipients according to the protocol depicted in Fig. 
4.2A, with adaptations for some cases (B,E). (A) Frequency of Foxp3
+
 in CD4
+
CD3
+
 
cells. (B) CD4
+
CD3
+
 Cell numbers for the transfers performed as illustrated in Fig. 
4.2A (WT and Sf samples), for experiments with a mix of 50% WT and 50% Sf naïve 
T cells (mix sample) and for co-transfers of WT and Sf cells at 1:1 ratio but analyzed 
in separate (WT (w/Sf) and Sf (w/WT), for the calculation of WT cells recovered from 
transfers in the presence of Sf cells, and for the calculation of Sf cells recovered in 
the presence of WT cells respectively). (C-E) Number of IL-2
+
 (C), IFN
+
 (D) and IL-
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17
+
 (E) CD4
+
CD3
+
 cells. (F) Weight change of mice subjected to the protocol 
depicted in Fig. 4.2A was followed up to 8 weeks after transfer. (G) Seric total IgG 
detected 4 weeks post transfer. * P<0.05; **P<0.01; ***P<0.001; Mann-Whitney U 
test. 
 
 
switched for the case of WT BM donor and recipient. In this case each T cell 
donor contributed with the same number has in the transfer of single 
populations, making the number of cells transferred double in total. In this 
setup, the number of cells harvested from WT donors was similar to the 
single transfer, while the donors of Sf cells gave rise to reduced number of 
cells (Fig. 4.4B - WT (w/Sf) and Sf (w/WT)) possibly indicating an 
unexpected impact of Sf cells in the function of iTreg, and/or vice-versa. This 
collection of data shows that the differentiation of iTreg during LIP 
contributes to limit the extent of naïve T cell expansion. 
In spite of the undetectable effect in T cell activation reported in Figure 4.3, it 
is plausible that the higher number of T cells due to the absence of iTreg 
leads to some effect at a functional level, such as increased pathology. First, 
the higher number of T cells recovered from recipients of naïve T cells of Sf 
origin resulted in the total number of IL-2, IFN and IL-17 producing T cells 
developing from Sf naïve T cells to be increased in comparison with the 
number of cells recovered from recipients WT cells (Fig. 4.4C, D and E). On 
the other hand, while most experiments were analyzed 4 weeks after 
transfer, before any disease manifestation was observable, recipients of 
scurfy cells did show an accelerated weight loss 5-6 weeks after T cell 
transfer (Fig. 4.4F) without showing an increase in the seric total IgG levels 4 
weeks post transfer (Fig. 4.4G), both in comparison to recipients of WT cells. 
This effect indicates that the control of T cell number but not of activation 
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leads to a different kinetic in disease manifestation without changing other 
properties. 
To further test the capacity of iTreg to control the lymphopenia induced 
expansion of naïve T cells we performed a sequential transfer of naïve T 
cells in which a group of TCR KO mice first received cells of Sf or WT origin 
and a second population of WT Foxp3-GFP- Tconv cells being transferred to 
all recipients 14 days after (Fig. 4.5A). In this setup it was predicted that 
iTreg differentiated in the recipients of WT cells would contribute to limit the 
number of cells recovered from the second transfer. However, while there 
was a small trend to recover less cells from the second transfer from the 
recipients that had received WT cells in the first transfer in comparison to 
recipients of Sf cells, the effect was small and not statistically significant (Fig. 
4.5B).  
Figure 4.5. iTreg differentiated while the expansion of naïve T cells is ongoing 
are able to control the final number of T cells. (A) Illustration of the protocol of 
sequential naïve T cells transfer. Briefly naïve T cells of WT or Sf origin prepared as 
indicated in Fig. 4.1A were transferred to TCR KO recipients. 14 days later all 
recipients received a second transfer of Foxp3-GFP
-
 CD4 cells and were analyzed 4 
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weeks after the first transfer. (B) Number of CD4
+
 cells of Foxp3-GFP
-
 origin 
(second transfer) recovered in recipients of WT or Sf cells in the first transfer. (C) 
Number of CD4
+
 cells of naïve origin (first transfer) recovered in recipients of WT or 
Sf cells in the first transfer. (D) Percentage of Foxp3
+
 in total CD4
+
 cells and total 
number of CD4
+
Foxp3
+
 cells (E). 
 
 
In the same direction, the number of T cells recovered from the first transfer 
was also similar irrespective of their WT or Sf origin (Fig. 4.5C). However, 
when the frequency and number of Foxp3+ cells in both groups of recipients 
was analyzed there was not a significant reduction of Treg in recipients of Sf 
cells (Fig. 4.5D). Surprisingly, this experiment revealed that even if iTreg are 
only allowed to differentiate past 2 weeks post transfer they can have a 
strong effect in the proliferation of the expanding T cell population. On the 
other hand, from the data in Figure 4.4B there were already indications that 
having only half of the population of naïve T cells able to differentiate to Treg 
was sufficient to limit the lymphopenia induced T cell expansion. 
Alternatively, if the second transfer would be performed with Sf cells, which 
was not possible due to the lack of a Thy1.1 congenic Foxp3 deficient strain, 
one would expect the recipients of WT naïve T cells in the first transfer to 
limit the expansion of T cells from both first and second transfer, in contrast 
to the recipients of Sf cells in both transfers. Nevertheless, this collection of 
data reinforces that iTreg developed during LIP have a regulatory role in the 
expansion of naïve T cells. 
 
iTreg differentiated during lymphopenia induced proliferation display stable 
Foxp3 expression but fail to be maintained by naïve T cells 
One of the most active discussions in the Treg field is to what extent iTreg 
are different to nTreg. The recent literature has however focused the 
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attention in rare differences identified rather than in the more common 
similarities. In fact some recent papers (10, 11, 30) have found that the 
majority of the transcriptional signature found in Treg isolated from the 
periphery of naïve mice, or subjected to the same protocols as iTreg, is 
shared. The work by Feurer et al where iTreg generated by different 
methods were compared to both thymic nTreg and peripheral Treg is rather 
striking in showing that the transcriptional profiles of Treg vary according to 
the conditions the cells are exposed to (30). While not biologically surprising, 
it illustrate how shallow most approaches to identify iTreg specific markers 
may have been so far. At the same time this work clearly illustrates the 
plasticity of Treg to adopt a transcriptional program that matches its 
microenvironment and opens the possibility that iTreg and nTreg are 
equivalent but have the potential to present diverse phenotypes, what may 
be expected is that Treg differentiated in the periphery display a set of 
phenotypes more frequently than Treg generated in the thymus that 
differentiate in the presence of a rather constant set of cues. To further 
address the properties of iTreg differentiated during lymphopenia we first 
assessed the expression of classical Treg associated markers to ascertain 
that iTreg presented a classical Treg phenotype beyond Foxp3 expression. 
Flow cytometry analysis revealed the expression of high levels of Foxp3 and 
the Treg classical markers CD25, GITR and CD103 (Fig. 4.6A and B), which 
were accompanied by an increase in the representation of cells positive for 
the same markers (Fig. 4.6C), all in comparison to peripheral Treg isolated 
from naïve mice. In vitro proliferation assay revealed that iTreg were equally 
able to suppress the proliferation of Foxp3- T cells and were equally anergic 
as Treg isolated from the periphery of naïve mice (Fig. 4.6D). Having 
confirmed that iTreg differentiated in our protocol resembled peripheral Treg, 
probably in an activated state, we decided to test if the iTreg cells we 
obtained displayed stable Foxp3 expression. The ability of Treg to maintain 
Foxp3 expression is another property that has been explored and met 
significant advances in recent works. On one hand, it has been shown that  
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Figure 4.6. iTreg display characteristic Treg 
phenotype. (A) Representative histograms of 
Foxp3 (far left), CD25 (middle left), GITR 
(middle right) and CD103 (far right) expression 
in steady state fresh Treg or iTreg developed 
during naïve T cell expansion in TCR KO 
recipients according to the protocol illustrated in 
Fig. 4.2A. (B) Mean fluorescence intensity (MFI) 
detected in cells isolated from several lymphoid 
organs, in the analysis shown in A. (C) Relative composition of positive cells for 
each marker inside CD4
+
Foxp3
+
. (D) Proliferation and suppression assays. Foxp3-
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GFP
-
 T cells were incubated in vitro in the presence of T cell depleted and irradiated 
splenocytes and stimulated with soluble CD3 and CD28 for 3 days, either alone 
(Tresp) or in the presence of half the amount Treg isolated from the periphery of 
naïve mice (+nTreg) or from the LNs of TCR KO recipients of Foxp3-GFP
-
 T cells 4 
weeks earlier (+iTreg). Both Treg populations were also incubated in the same 
conditions in the absence of responder T cells (nTreg and iTreg). Shown are the c. 
p. m. resulting from the incorporation of tritiated thymidine during the last 6 hours of 
culture 
 
 
peripheral Treg have the potential to lose Foxp3 expression and gain a 
helper cell phenotype, a process that may undermine Treg based 
therapeutic approaches (31, 32). On the other hand, one of the initially 
identified differences between Treg induced from peripheral cells and Treg 
isolated from the periphery of naïve mice, was the capacity of the later to 
sustain Foxp3 expression in contrast to the rapid loss presented by the 
former (14). However, the later interpretation may be misleading given that 
the iTreg tested in that work was prepared using the in vitro protocol alone, 
which may not represent in vivo derived iTreg. To test the stability of iTreg 
differentiated during LIP we sorted Thy1.1 or Thy1.2 cells, either iTreg from 
transfers of Foxp3-GFP- Tconv cells to TCR KO recipients that had lasted 4 
weeks or Foxp3-GFP+ Treg from naïve mice. We also sorted Thy1.2 or 
Thy1.1 Foxp3-GFP- Tconv cells from the Foxp3-GFP reporter mouse to be 
the respective Thy1.1 or Th1.2 Treg pairs. Thy1.1 + Thy1.2 pairs of iTreg + 
Tconv and nTreg + Tconv were then co-transferred to TCR KO recipients 
and analyzed 4 weeks after. Since this experiment also had the potential to 
test the regulatory capacity of iTreg in re-transfer system we monitored the 
number of Tconv cells originated in recipients of each Tconv pairing with the 
different Treg. Surprisingly, iTreg displayed no control of Tconv expansion 
illustrated by similar numbers of Tconv recovered from Tconv transferred 
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alone or with iTreg, while co-transfers with nTreg resulted in the expected 
reduction of Tconv cells recovered (Fig. 4.7A). Given the data presented in 
Fig. 4.3B it was expected that iTreg would be able to control the expansion 
of Tconv cells, at least to some extent. However, when we assessed the 
number of cells from Treg origin recovered we found that very little cells from 
iTreg origin were present (Fig. 4.7B). The absence of iTreg cells at the end 
of the experiment provides a simple explanation to the absence of 
suppression of T cell proliferation. Still, regarding the main aim of the 
experiment, the few cells recovered still expressed Foxp3 (Fig. 4.7C) 
indicating that iTreg differentiated during LIP are able to maintain Foxp3 
expression. Another pertinent question that this experiment allowed us to 
address is if the presence of iTreg or nTreg has an impact in the 
differentiation of iTreg from the Tconv population. This was achieved by 
simply measuring the Foxp3 frequency inside the cells originally Foxp3 -, 
which was found to be similar irrespective of Tconv cells being transferred 
alone (Fig. 4.7D), in the presence of iTreg or nTreg, showing that Treg 
presence has little impact in the differentiation of iTreg during LIP.   
The fact that little cells of iTreg origin were recovered after a secondary 
transfer raised the question of iTreg persistence. One hypothesis could be 
that iTreg are generated and are not kept for long, however, using the same 
protocol illustrated in Fig. 4.2A, but performing the analysis 8 weeks post 
transfer, we still found Foxp3+ cells (Fig. 4.7E) with a slight increase in 
frequency as what was found in the analysis at 4 weeks (Fig. 4.7E vs Fig 
4.4A), showing that iTreg cells can be maintained for the entire 8 week 
period that the experiment with the secondary transfer adds up to for the 
iTreg cells. An alternative explanation is that iTreg cells once differentiated 
and maintained in the inflammatory milieu that takes place during LIP are, or 
become, dependent on some of those inflammatory cues. This is not a 
completely 
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Figure 4.7.      iTreg 
developed from naïve T 
cells upon transfer to 
lymphopenic recipients 
display stable Foxp3 
expression but fail to 
control the expansion of 
fresh Foxp3
-
 cells. 
Foxp3-GFP
+
 cells were 
isolated from the LNs of 
TCR KO mice that had 
received Foxp3-GFP
- 
CD4 
T cells 4 weeks before 
(iTreg) and were 
compared to fresh Foxp3-
GFP
+
 cells isolated from 
naïve WT mice (nTreg) in several assays. (A-E) Foxp3-GFP
-
 CD4 T cells (Tconv) 
were transferred to TCR KO recipients either alone or in the presence of iTreg or 
nTreg at a ratio of 1:3. (A) Shown is the number of CD4
+
 cells originating from the 
Tconv subset recovered from the indicated lymphoid organs of the several 
recipients. (B) Number of CD4
+
 originating from the Foxp3-GFP
+
 subset. (C) 
Percentage of Foxp3-GFP
+
 cells within cells originally Foxp3-GFP
+
. (D) Percentage 
of Foxp3 in cells originally Foxp3-GFP
-
. (E) Percentage of Foxp3-GFP
+
 cells in 
CD4
+
CD3
+
 cells isolated from recipients of naïve T cells following the protocol 
illustrated in Fig. 4.2A but with the analysis being performed 8 weeks post transfer 
instead of 4 weeks as for the data in Fig. 4.3B. (F) IL-6 (left), IL-4 (middle) and IFN 
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(right) receptor surface levels represented by mean fluorescence intensity (MFI) in 
fresh Foxp3-GFP
+
 and Foxp3-GFP
-
 CD4 cells (steady state) or isolated from TCR 
KO recipients of Foxp3-GFP
-
 CD4 T cells 4 weeks before. MFI of CD4
-
TCR
-
 cells 
are shown for comparison. 
 
 
new mechanistic interpretation of Treg stability and function, since the 
maintenance of Foxp3 expression by nTreg as been ascribed to IL-2 
produced by Tconv cells, the number of nTreg has been shown to be 
dependent on the IL-2 produced by Tconv cells and Treg seem to adopt a 
genetic program that matches the T cell response that takes place (19). A 
small flow cytometry assessment of the surface levels of cytokine receptors 
know to be involved in different T cell polarizing conditions, IFN, IL-4 and IL-
6, revealed that iTreg express higher levels of IFN receptor than peripheral 
steady state Treg, while they maintain IL-4 and down modulate IL-6 
receptors (Fig. 4.7F). The upregulation of IFN matches the Th1 polarization 
reported in Fig. 4.2 (Fig. 4.3D-H). This last piece of data shows that iTreg, 
while being a stable lineage, seem to be fragile and possibly depend on the 
inflammatory environment to be kept. 
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Discussion 
The differentiation and function of regulatory T cells developed outside the 
thymus has recently been a focus of attention in the Treg field. After the 
initial demonstration that peripheral cells could be induced to express Foxp3, 
and gain regulatory properties, there have been many reports of methods to 
differentiate iTreg and to characterize the differences between peripheral 
steady state Treg and iTreg. However, the lack of markers that irrefutably 
discriminate Treg differentiated in the thymus from the ones differentiated in 
the periphery has been a major hurdle in the study of iTreg developed in WT 
mice. As a consequence TCR Tg T cells and in vitro protocols have been the 
major source of iTreg to be studied. 
In the first part of this work we made use of the classical experimental 
system of adoptive T cell transfer to T cell deficient recipients and applied a 
loss of function approach to track in vivo derived iTreg function. The use of a 
loss of function approach for iTreg requires the use of Foxp3 deficient naïve 
T cells. This, however, poses the challenge of obtaining such T cells in a 
naïve state since Foxp3 deficient mice develop a multi organ systemic 
disease where T cells present unrestricted activation. To circumvent this 
effect we developed a protocol involving the transfer of bone marrow from 
Foxp3-deficient donors to WT recipients, where WT Treg, some 
radioresistant from the recipients and an extra source provided by the 
transfer of total splenocytes, are enough to keep Foxp3 deficient T cells 
under control  and similarly functional to their WT counterpart (Fig. 4.1).  
Naïve T cells from BM chimeras were sorted according to high expression of 
CD45RB and no expression of CD25 (Fig. 4.2A and B), which allowed us to 
isolate equivalent T cells of WT and Sf origin from independent BM 
chimeras. By transferring these cells to TCR KO recipients and analyzing 
the T cell number and phenotype, serum IgG and weight change we found 
that the ability of naïve T cells to upregulate Foxp3 contributed to limit the 
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cell number recovered 4 weeks after transfer. This ability did not, however, 
have an impact in T cell activation, helper cell polarization and any functional 
output (Fig. 4.3 and Fig. 4.4). The fact that the differentiation of iTreg had no 
impact on the activation of transferred T cells was not particularly surprising, 
since the transfer of naïve T cells to lymphopenic recipients has for long 
been a protocol to induce colitis, and an original model to show the 
regulatory activity of CD25+ T cells (29). In summary this experimental 
setting represents a context in which naïve T cells are known to expand and 
get activated even when able to upregulate Foxp3 expression (1, 27). What 
was more surprising was the ability to limit the number of T cells recovered 
by iTreg differentiated during the T cell expansion. While this was one of the 
predicted outcomes for an iTreg functional readout the fact that the system 
ultimately leads to multi-organ disease with unrestricted T cell activation 
poses a challenge for iTreg differentiation and function due to the 
inflammatory milieu that installs. While the most straight-forward explanation 
is the induction of Foxp3 expression by WT naïve T cells and the lack of by 
Sf T cells, several alternative hypotheses could be put forward and 
confounder effects be in place. First the report by Gavin et al (28), in which a 
GFP mediated truncation of the Foxp3 allele was used as a reporter system 
to study Foxp3 deficient T cells, assures that the sorting strategy used 
excludes T cells of Sf origin that had received signals to express Foxp3. This 
guarantees that the differences observed are not due to differences in the 
initial T cell pool. On the other hand, the results from the co-transfer of WT 
with Sf naïve T cells, where we found again a reduction of the number of T 
cells recovered when compared to the transfers of Sf cells alone, proves that 
there is no cell autonomous property in the Sf cells that make them expand 
more, but it is rather the differentiation of iTreg in the WT cells pool that 
exerts a dominant regulation on the expanding T cell population. Despite this 
data irrefutably showing that iTreg limit the T cell expansion in lymphopenia 
it does not allow to pin point the effect of would be iTreg in the transfer of Sf 
cells. This is because the strategy of transferring Foxp3 deficient naïve T 
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cells while resulting in the loss of iTreg function it does not eliminate the cells 
that receive the signals to upregulate Foxp3 but do not become iTreg due to 
the lack of a functional Foxp3 protein. In this regard the results observed are 
linked to naïve T cells not being able to develop a full Treg transcriptional 
program and not to the elimination of iTreg cells. As a result cells that would 
turn on Foxp3 expression in the WT scenario but cannot in the Sf 
background can still contribute to any output observed by adopting a 
different phenotype in the later case. 
Given the results discussed above, the outcome of the experiment reported 
in Figure 4.5 was unexpected. In this case, we found that the same number 
of cells was recovered in recipients of WT and Sf cells that received a 
second transfer of Foxp3-GFP- conventional T cells 2 weeks after, and were 
analyzed at 4 weeks after the beginning of the experiment. What was 
expected was that the recipients of WT cells in the first experiment due to 
the presence of iTreg from both transfers would present a lower cell number 
of cells. First the number of cells from the second transfer was supposed to 
suffer some regulation from the iTreg that had already developed from the 
first transfer in the recipients of WT but not in recipients of Sf cells. 
Secondly, the number of cells recovered from the first transfer could also 
have been higher for cells of Sf than of WT origin. Both predictions were not 
verified. While it is possible that these results indicate lack of iTreg capacity 
to regulate the expansion of a second wave of conventional T cells it is also 
possible that the iTreg developed from the secondary transfer were able to 
provide enough regulation to control both its own expansion as to limit the 
final output of the Sf cells resulting in a similar number of Sf and WT naïve T 
cells. In fact the total number of Foxp3+ cells in both recipients of WT and Sf 
T cells in the first experiment, while reduced in the recipients of Sf cells, was 
not statistically different. It is also possible that the microenvironment at 2 
weeks after transfer of Sf and WT cells is somehow different in the recipients 
of Sf cells. This could lead to a higher activity of iTreg differentiated from the 
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second transfer in the recipients of Sf cells than in the recipients of WT cells 
resulting in a similar number of cells from the first transfer in both groups. 
This is however a speculative interpretation and further work has to 
undertaken to clarify the full potential of iTreg differentiated during 
lymphopenia as well as to possibly achieve some quantitative information. 
Meanwhile, others have published several works starting the elucidation of 
iTreg roles and its relevance. Curotto de Lafaille et al first shown that Foxp3 
induction in TCR Tg T cells is important to control the chronic phase of 
Asthma in an experimental setting (9).  In a more recent study, Josefowicz et 
al showed that iTreg, for which Foxp3 expression is dependent on a given 
enhancer in the Foxp3 locus, have a determinant role in preventing mucosal 
associated T cell pathology (12). And Haribhai et al have shown that iTreg 
enrichment synergize with nTreg contributing to a more efficient recovery 
from an IBD experimental model, caused itself by a conventional T cell 
transfer, and multiorgan autoimmune pathology caused by Foxp3 deficiency 
(10, 11). While the later two reports the first was performed with in vitro 
derived Treg, the second study demonstrated the functionality of in vivo 
differentiated iTreg, which was ultimately ascribed to a complementation of 
the steady state regulatory T cell repertoire by iTreg. Albeit, this study fails to 
acknowledge that steady state Treg may, and most likely do, contain iTreg. 
This leads to the proposition that in regulation demanding conditions the 
differentiation of iTreg complements the steady state regulatory T cell 
repertoire. This notion does not exclude a baseline contribution in the 
absence of external challenge but states that upon challenge the 
differentiation of iTreg can increase the efficiency of T cell based regulation, 
irrespective of any iTreg that may develop naturally in a naïve mouse. The 
steady state differentiation of iTreg is, in theory, expected to take place as a 
product of intrathymic Ag level/density and presence probabilities together 
with the fact that T cells have a grace period to become Treg just after 
leaving the thymus, as our data in the previous work shows (Chapter 2).  
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In the last part of this work and using the same experimental model of T cell 
adoptive transfer to lymphopenic recipients but with Foxp3-GFP reporter 
mice as donors we sought to track iTreg stability. After finding that iTreg 
differentiated in our system resemble Treg isolated from the periphery of 
naïve mice (Fig. 4.6) we performed secondary transfers of iTreg, which had 
developed during LIP for 4 weeks in T cell deficient recipients, to similar 
recipients together with Foxp3-GFP- conventional T cells. This experimental 
setup allowed us to determine that iTreg differentiated during LIP give rise to 
low number of cells after the re-transfer, while maintaining Foxp3 expression 
and showing little impact on the expansion of the Tconv cells (Fig. 4.7A, B 
and C). The lack of control of Tconv expansion was initially surprising since 
we report in the previous sections that the differentiation of iTreg is important 
to control the expansion of Foxp3- T cells. However, the low number of iTreg 
cells recovered is probably the explanation for the absence of regulatory 
activity. The clarification of why so little iTreg cells are recovered after re-
transfer needs further investigation. The simpler hypotheses being that the 
cells display low survivability or low proliferative potential. On the other hand, 
as for the sequential transfer results (Fig. 4.5), it is also possible that the 
presence of iTreg differentiating later during the expansion provide enough 
regulation to mask the impact of the initial Treg. While it is clear that the 
regulation exerted by iTreg on the secondary transfer was much lower, since 
it was undetectable, than the one provided by fresh peripheral Treg, only a 
co-transfer with naïve Scurfy cells will undoubtedly eliminate the possibility 
of iTreg to be exerting some regulation in this system. In any case, the later 
proposition depends on the iTerg now being maintained in such a setup. In 
this regard, we did find an upregulation of the IFN receptor (Fig. 4.7F) which 
indicates that iTreg isolated after 4 weeks of Tconv expansion in 
lymphopenic recipients seem to have adapted a phenotype sensitive to the 
Th1 polarization displayed by the expanding population, as shown in Figure 
4.3. It seems therefore plausible to propose that iTreg may require the milieu 
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from which they were isolated to survive, proliferate or exert regulatory 
activity. 
In fact the phenotypic adaptation of Treg to helper T cell polarization goes 
towards a concept that has recently been gaining shape within the T cell 
physiology field, which is the notion of phenotypic plasticity. This has been 
fueled by both Th17 and Treg studies. For Th17 several studies indicate that 
there are states of differentiation that, while fitting in a terminal differentiation 
phenotype by normal parameters, when analyzed more carefully cells are 
found that may still be re-diverted to another lineage previously thought to be 
mutually exclusive with the first, mainly Th1 (33). The recently described Th9 
seems to be another of such cases, with Th2 driving signals not being a final 
commitment to Th2 but leaving the possibility for the cells to be pushed to an 
IL-9 producing fate if other factors are added (34, 35). For the Treg field 
there are several studies describing the loss of Foxp3 expression by 
peripheral Treg cells as there are studies describing Treg genetic programs 
that mirror the program of Th response to be regulated. Mainly, Treg 
regulation has been shown to be dependent on several master transcription 
factors ascribed to a given Th polarization phenotype (19). In summary, the 
fact that we find a regulatory activity while iTreg differentiate together with 
the polarization of the helper T cells, fail to find one when the differentiation 
is temporally decoupled by having the iTreg from the beginning of the T cell 
activation, and not simultaneously, and the fact that we detect the 
upregulation of the receptor for the hallmark cytokine of the helper cell 
polarization that takes place, opens the possibility that it is not only the 
maintenance of Foxp3 expression that maybe dependent on helper T cell 
cues, but also Treg functional competence. If this proves to be correct the 
design of therapeutic strategies relying on the adoptive transfer of Treg 
differentiated from peripheral cell clones may require that the cells to be 
transferred to be differentiated in conditions that are contingent on the 
immune system activity to be regulated. 
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By showing a potential regulatory capacity in iTreg but also some possible 
frailties in the cells themselves, we hope this study is stimulates the further 
understanding of Treg physiology regarding their plasticity and adaptability 
to the immune system activity and raises questions that may one day guide 
the rational design of adoptive Treg based therapies. 
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Material and Methods 
Mice 
C57BL/6J (WT – Thy1.2), C57BL/6J Thy1.1 congenic (Thy1.1) C57BL6/JSf/y 
(Scurfy – Sf), C57BL6/J TCR-/- (TCR KO), C57BL6/J Foxp3GFP/Y (Foxp3-
GFP), were all bred and kept in our animal facility in SPOF conditions. Mice 
were used between 8-12 weeks of age at the beginning of each experiment. 
 
Preparing Foxp3 deficient naive T cells 
BM cells were extracted from femurs and tibias of C57BL/6J WT or Scurfy 
mice in HBSS by flushing with a 20G syringe. Cells were then spun down at 
300G for 10 min and incubated for 30 min at 37ºC with CD4 and CD8 
antibodies at 1 g/ml and complement that was pre-treated by a 30 min 
incubation with splenocytes on ice and passed through a .5 m filter. T cell 
depletion was stopped by adding FCS to achieve a 20% final concentration. 
Cells were then washed twice, re-suspended in PBS, counted and a 
minimum of 5x106 transferred i.v. by retro-orbital injection into C57BL/6J 
Thy1.1 congenic recipients which had been subjected to 900 rad of total 
body irradiation the day before. 7 days later 107 total splenocytes isolated 
from C57BL/6J Thy1.1 congenic mice were transferred to each recipient. 
Mice were kept under standard conditions for 8 weeks before being used as 
donors of WT or Sf naïve T cells. For the experiment where WT cells and Sf 
cells were co-transferred, and analyzed separately at the end of the 
experiment, WT (Thy1.2) mice were used as recipients of WT Thy1.1 bone 
marrow, and the Thy1.2 and Thy1.1 markers used to discriminate Sf and WT 
cell origin. 
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Sorting and Cell Transfer 
iTreg differentiation was performed by transferring 106 naïve 
(CD45RBhiCD25-) or conventional (Foxp3-GFP-) CD4+ T cells i.v. to TCR 
KO mice. For the case of Thy1.1 donors that had been reconstituted with 
WT bone marrow, Thy1.2 inclusion and Thy1.1 exclusion gating was 
applied. iTreg loss of function assays were performed by using naïve T cells 
from Thy1.1 mice reconstituted with Sf BM as described above. Sf naïve 
cells were sorted using the same strategy as for WT cells and were both 
transferred in parallel to TCR-/- recipients. For sorting, cells were harvested 
from mesenteric, inguinal, brachial, axillary, popliteal, cervical, and para-
aortic lymph nodes of donor mice and turned into single cells suspension in 
sorting buffer (2% FCS in PBS). After washing, cells were re-suspended in 
sorting buffer and stained with the according antibodies for 30 min on ice. 
Last, cells were again washed, passed through a 100 m mesh and sorted 
in a MoFlo or FACSaria cytometers. After sorting, cells were washed twice 
and ressuspended in PBS at a concentration of 107 per ml and 100 l were 
injected per recipient. Recipient mice brachial, inguinal and axillary pooled 
LNs (biaLN), mesenteric LN (mLN) and spleen (SPL) were analyzed at 4 
weeks after transfer except if otherwise stated. For some experiments 
recipient mice were weighed at the day of transfer and once a week 
thereafter until the day of cellular analysis. Each mouse weight change was 
calculated as a percentage of day 0 weight. Total IgG was determined by 
standard sandwich ELISA technique. 
 
Cellular analysis 
Cellular phenotypes were analyzed by flow cytometry using a FACScalibur 
or Cyan ADP flow cytometers. For ex-vivo analysis brachial, inguinal and 
axillary pooled LNs (biaLN), mesenteric LN (mLN) and spleen (SPL) were 
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analyzed. Cellular preparation for FACS analysis was performed as for 
sorting. For cytokine expression analysis cells were plated for 4 hours with 
PMA/ionomicyn stimulation, with brefeldin A being added in the last two 
hours of culture. Cells were then stained for surface CD4 and CD3, fixed for 
30 min with 1% paraformaldehyde, permeabilized for 30 min with Saponin 
and intracellular cytokine staining was then performed.  Recipients of 
transfers were analyzed 4 weeks after transfer, except if otherwise stated. 
Ex-vivo analysis of Thy1.1 recipients of bone marrow was performed 
between 8 and 12 weeks post transfer. iTreg samples were obtained from 
LNs harvested from TCR KO recipients that had received an adoptive 
transfer of naïve T cells (for ex-vivo analysis) or conventional T cells (for 
sorting and re-transfer) 4 weeks before. 
 
In vitro proliferation and suppression assays 
For in vitro proliferation of naïve T cells flat bottom 96 well plates were 
coated with CD3 by incubating plates for 3 hours at 37ºC with a solution of 
2 g/ml antibody in PBS. Plates were then washed with PBS and 2.5x104 
naïve T cells cultured in the presence of IL-2 (20 U/ml) TGF (5 g/ml) and 
soluble CD28 (1 g/ml) in complete RPMI. For iTreg proliferation and 
suppression assays cells were plated in round bottom plates in the presence 
of 105 splenocytes (after red blood cell lysis and T cell depletion, in a similar 
protocol as for the bone marrow depletion omitting complement pre-
treatment) and 1g/ml CD3 for 3 days at 37ºC. For Treg proliferation 5x103 
iTreg or nTreg were plated alone. For suppression assays 2.5x104 Tconv 
responder cells were plated either alone or together with 5x103 iTreg or 
nTreg. For detection of proliferation 1 Ci tritiated thymidine was added to 
each well in the last 6 hours of culture. Plates were frozen and thawed at the 
end of the culture and cell extracts harvested into a paper filter, covered with 
meltilex and scintillations read in a microbeta counter.  
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This Chapter aims at discussing the general concepts involved in the 
findings presented in this Thesis offering a personal evaluation of the ideas 
they bring about. At the same time it intends to leave a final note on the state 
of the art of the Treg field both in academic terms and in respect to potential 
clinical applications. The comparative analysis of the results in respect with 
the currently available literature is not the main aim of this chapter given that 
the general introduction together with each chapter’s introduction and 
discussion should already fit that purpose. 
 
5.1 Brief Historical Contextualization 
Since the original propositions on factors determining the establishment of 
immune tolerance, Immunology has advanced greatly in the characterization 
and understanding of the immune system. Astonishingly, the initial theories 
captured essential features of immunological tolerance, namely a 
developmental dependent factor for its establishment in physiological 
conditions. From Medawar and Burnet (1, 2) to Lederberg (3) and later 
Modigliani (4), with respective co-workers and contemporary scientists, and 
now to the work presented here in Chapter 3 as well as work by others (5), it 
is now clear that the organism age as well as the cell age are essential 
factors in the susceptibility of T cells to give rise to tolerance. By showing 
that RTE are more susceptible to differentiate to Treg in the experimental 
setting tested, our work is the latest confirmation of the cell age model for T 
cells and confirms that Treg differentiation is to be included in it. 
Other notion that is now known to be essential for robust immune tolerance 
and healthy homeostatic conditions is the system nature of 
immunoregulatory networks. The immune system being kept under control 
so that responses harmful to the host do not take place, or are minimized, 
with invading pathogens still being efficiently eliminated, is dependent in the 
correct functionality of a wide variety of cell types, different pathways in each 
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cell type and a proper interaction between all these factors. Two 
components that have gained increased attention recently are B cells with 
regulatory properties (6) and the necessity for an intact dendritic cell 
compartment (7). Treg have nevertheless maintained prime attention due to 
their capacity to regulate a wide variety of responses, affect the function of 
many cell types and being essential for the survival of mice and Humans. 
Naturally, all these factors turned Treg one of the main hopes for future 
therapies aiming at manipulating the immune system activity. 
Since Treg act by downmodulating or preventing immune responses, two 
possible angles are usually envisaged. In one hand, the aim can be to 
enhance Treg function and abolish an unwanted immune reaction, such as 
in autoimmune conditions, and on the other it is possible to prevent their 
action or cause their removal to allow the immune system to act, as it would 
be desired to attain more efficient anti tumor immune surveillance. The 
general lack of efficient treatment for several cases fitting in both types of 
situations makes Treg manipulation a very attractive candidate for clinical 
interventions. However, it is this same potential of Treg to either allowing 
immune responses to take place, if absent, or inhibit them, if present, that 
make a comprehensive knowledge about Treg physiology a requirement to 
guide the development of Treg based therapeutic applications. Mainly, due 
to the fact that erroneously generating tolerance to a pathogen may 
compromise the host by allowing infection to establish and inhibiting 
tolerance has the inherent risk of allowing autoimmune reactions to be 
initiated. It is therefore of paramount relevance that we understand both the 
requirements and constraints of Treg differentiation, maintenance and 
function. This knowledge shall help in evaluating safety and efficiency of 
potential protocols for therapies aiming at controlling particular immune 
system activities through Treg manipulation. Moreover, this knowledge 
should also make clear which conditions are required for Treg to provide 
long lasting tolerance when generated by external manipulation. The fulfilling 
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of this task has the potential of leading to the cure of several 
immunopathologies untreatable to date. 
 
5.2 Antigens in the Thymus and T cell selection 
Tolerance is commonly divided in central and peripheral mechanisms (8). 
Central tolerance is one that is established in primary lymphoid organs, the 
thymus and bone marrow, while the cells are developing, while peripheral 
tolerance is established in the periphery, that is, outside primary lymphoid 
organs, like the spleen or lymph nodes when the cells are already mature. 
Since it is during the initial cellular development that the repertoire is built 
and an initial assortment of clones to a regulatory or effector devoted 
phenotype takes place, central tolerance has to be taken into account when 
addressing T and B cell based tolerance. During their maturation in the 
thymus, T cells undergo several quality control steps, among which, proper 
TCR selection.  Both positive and negative selection are essential to 
generate a T cell compartment that is efficient in mounting responses 
against invading microorganisms while sparing the host from its damaging 
potential. 
While peptides involved as antigens in positive selection are essential to 
guarantee the generation of a repertoire that interacts correctly with the 
host’s MHC and may even be have an impact in the peripheral maintenance 
of T cells (9), deletion and Treg induction are considered the essential steps 
in assuring a self tolerant repertoire (8). These two outcomes are intrinsically 
constrained by the antigens that are presented by the cells that mediate the 
selection steps. In fact, the T cell repertoire that arises in the thymus is a 
product of the interaction between the TCRs generated and the antigens that 
are present in the time window for which the cells are susceptible to receive 
deletion and Treg induction signals, not excluding other contributing factors. 
Regarding the contribution of the antigen, it is mainly determined by its 
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diversity, quantity and distribution. All this factors are in their turn dependent 
on the process that makes antigens available in the thymus. The three main 
mechanisms contributing for intrathymic antigen diversity are simple 
diffusion of small molecules transported in the blood stream (10), ectopic 
expression of antigens that are specific of peripheral tissues mediated by the 
transcription factor Autoimmune Regulator (AIRE) (11), and transport by 
antigen presenting cells migrating from the periphery to the thymus (12). 
AIRE is expressed in medullary thymic epithelial cells (mTECs) which are 
found in the same thymic niche as thymocytes that are in the differentiation 
stage where deletion and Treg induction occur (11, 13). AIRE promotes 
random expression of antigens in a way that each cell expresses its own set. 
Its function is essential for robust tolerance since mice that cannot express a 
functional version of this transcription factor display autoimmune 
pathologies, albeit of mild severity and late in adulthood. A recent report has 
identified the main contribution of AIRE driven intrathymic antigen diversity 
to very early age (14). These data and the nature of mechanism by which 
AIRE induces peripheral antigen expression indicate it is important to set a 
baseline tolerance to self-antigens that may be present in the periphery. On 
the other end, blood borne and dendritic cell based mechanisms provide a 
source of antigen diversity and/or quantity adjustment that are directly 
contingent on the actual diversity of antigens present in the periphery at the 
respective moment. The work presented in Chapter 2 adds some new 
information about this process, particularly regarding Treg differentiation 
against peripheral antigens made available in the presence of inflammatory 
signals. In contrast, with the main research focus taken by the Treg field, 
which has been on Treg induced to novel antigens from peripheral naïve T 
cells, we have revealed an intrathymic source of Treg recognizing peripheral 
antigen. The main difference lays in the potential of thymocytes to 
differentiate to Treg under inflammatory settings while peripheral cells are 
inhibited by such immunogenic signals. As a consequence, even if an 
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antigen is provided in an together with inflammatory signals, it can access 
the thymus and shape the phenotype of exported T cells. As expected, 
providing antigen that thymocytes recognize can lead to both deletion and 
Treg differentiation depending on the antigen dose and TCR affinity/avidity, 
which shows that this process also has the potential to shape the repertoire 
of T cells being exported from the thymus. Importantly, in the lower end of 
Ag dose, Treg differentiate and deletion is minimal, while at higher Ag doses 
deletion may be close to complete and no cells that recognize the antigen 
with high affinity/avidity are exported. 
 
5.3 Intrathymic Treg differentiation – Tolerance vs. Immunity 
However, the potential to generate Treg in the thymus against antigens that 
are being targeted in an immune response in the periphery creates an 
apparent conundrum, as it creates the possibility of generating tolerance to 
antigens arising from a source that has also triggered receptors that lead to  
a ridding immune response. Moreover, Treg activity being so powerful, leads 
to the question of how is the response efficient if Treg are generated against 
the same antigens that are being targeted. Our work also showed that the 
differentiated Treg are functional, since they were essential to prevent the 
development of spontaneous autoimmune disease that occurs in the mouse 
model that was used. The solution for this potential conflict is not known, but 
it may involve a timing issue and/or an antigen property effect. Timing wise, 
it is possible that Treg only meet the antigen in the periphery once the 
response is ongoing, not preventing it from taking place but possibly 
contributing to limit its intensity. If true, this mechanism may represent a 
tradeoff between ensuring the control of immune responses to limit harm to 
the host by the immune response itself, at the cost of potentially allowing the 
persistence of infectious agents when they are not readily eliminated. The 
later scenario should only take place, however, when the initial response did 
Chapter 5 
207 
 
not produce efficient cellular or humoral effector mechanisms in the time 
window before Treg come into play. On the other hand, the persistence of 
the antigen may also play an important role. Once Treg against peripheral 
antigens are exported from the thymus the maintenance of the regulatory 
phenotype likely depends on interacting with the antigen in the periphery. In 
that way, if an invading pathogen is being eliminated the antigen will become 
unavailable and the cells selected against its antigens will lose Foxp3 
expression incorporate the conventional T cell pool and possibly 
participating in a re-challenge, or may even die if the antigen is providing 
essential survival signals. In any scenario they will no longer contribute with 
regulation that would inhibit a secondary response. In contrast, if the antigen 
reaching the thymus is self derived it will remain present in the periphery and 
the adaptive Treg will maintain their regulatory properties incorporating the 
Treg pool. The later is closer to the case represented by the main mouse 
model system used in our work, where the monoclonal T cells recognize a 
self antigen and generated Treg could prevent auto-immune disease that 
develops in untreated mice. As such, the protocol employed and its outcome 
can be taken as an anti-autoimmune vaccine which efficiency depends on 
the thymus function. 
Irrespective of the apparent contradiction of generating regulatory T cells 
against antigens being targeted in an ongoing immune response, the fact 
that the thymic output of Treg is able to adapt to the peripheral antigenic 
landscape is an important concept to understand the development of the 
Treg repertoire. This notion however needs to be incorporated in the 
constraints that exist upon Treg differentiation. For instance, the confirmation 
of the existence of a limited niche for intrathymic Treg differentiation, that 
most likely includes antigen availability as a constraint, has recently received 
experimental support. By generating new genetically modified mice carrying 
a TCR Tg recovered from Treg and investigating the intrathymic Treg 
differentiation in these mouse lines, it was found that the efficiency of Treg 
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differentiation of a given clone is dependent on its clonal size (15, 16). In 
short, high frequency of Treg in such clones is only observed when the 
clonal size is small, while, when the clonal size increases the frequency of 
cells maturing as non regulatory also increases. This new finding has 
introduced a new angle in the constraints ruling Treg induction, which is the 
fact that the clonal size has an impact in the chance cells have to be diverted 
to this phenotype. A possible interpretation of these results is that it is rather 
a confirmation of the antigen as a limiting factor. In this line of thought, the 
lower frequency of Treg, when clones are represented in a big clonal size, is 
a result of the physical limit placed by how many antigen presenting cells a 
thymocyte can interact with before being exported. In cases of self reactive 
clones of big clonal sizes, only the fraction of thymocytes that interact with 
the cells presenting the cognate antigen undergo deletion, or are induced to 
become Treg, with the remaining being exported as naïve. Noticeably, when 
the authors of such studies diluted the TCR Tg cells the frequencies of Treg 
observed tended to a 100% figure. This result indicates that, at lower clonal 
sizes, all cells of a given clone have the chance to interact with the cognate 
antigen. It is true that this did not take place for all TCR Tg lines, which could 
be a result of how much of the antigen is available. Alternatively, the lines in 
which a high frequency was reached could be the result of a compounded 
effect from having higher multireactivity, which should translate in a more 
diverse set of antigens with which the clones can interact with, directly 
increasing the antigen niche. Still, for the cases where the frequencies went 
up to close to 100%, it could also be a result of diluting the clone to the 
extent of the antigen being in excess in relation to the clones being 
generated, in a way that all thymocytes could meet the antigen. 
Nevertheless, this scenario implies that there would be more antigen 
available that was not being presented to a thymocyte bearing the Tg TCR, 
indicating that full Treg differentiation of a clone recognizing an antigen 
present in the thymus may require the antigen to be in excess. If the antigen 
availability limit is proven to be the main determinant in allowing self reactive 
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clones to escape Treg induction, this finding could be extrapolated to 
deletion and indirectly provide an experimental proof of a limited capacity for 
all clones to be correctly deleted, except for the antigens that are in excess 
in relation to the clones that recognize it with high affinity/avidity being 
generated. 
Nevertheless, the Treg niche is likely determined not only by the availability 
of antigen, but also by Treg inducing factors, such as gamma chain 
cytokines and TGF. The fact that these components are limiting, allows 
cells that recognize self to escape the central mechanisms of tolerance and 
be exported to the periphery. One of the main questions that arise from 
these limitations on repertoire assortment regards the way the Treg 
repertoire is built so that it is able to control the self reactive cells escaping 
deletion. Do Treg need to recognize all peripheral antigens or is there an 
effect such as immune dominant regulatory epitopes or antigens. This may 
allow Treg to regulate reactivities against other antigens of the same organ 
by some sort of cross regulation. On the other hand, it is possible that for a 
given reactivity to be regulated it is sufficient that a fraction of the cells of a 
clone recognizing self with high affinity/avidity are diverted to the regulatory 
pool. Our understanding of how the thymic repertoire is selected in respect 
to the peripheral image of self and environment derived innocuous antigens 
is still not complete and this is an important piece of information that may 
help in tracing defects in autoimmune or allergic reactions as well as provide 
insights into therapeutic opportunities to manipulate the activity of the 
immune system. Another possible route to complement incomplete thymic 
deletion and Treg differentiation of self reactive T cells is the differentiation 
of Treg in the periphery. 
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5.4 Thymic Contribution to Peripheral Treg Induction 
The observations laid above and the fact that transferring Treg depleted T 
cell preparations from healthy donors to lymphopenic recipients lead to 
autoimmune manifestations clearly indicate that self reactive T cells are 
exported from the thymus as non regulatory and the adjustment of the T cell 
compartment in the periphery to achieve full regulation may be a 
requirement. Following the concept prompted by the results presented in 
Chapter 2, showing the differential sensitivity of thymocytes and peripheral 
cells to inflammatory cues in respect to the upregulation of Foxp3, and early 
theories indicating that immature cells are more prone to be diverted to 
regulatory phenotypes (5), we decided to test if recently made T cells 
already found in the periphery shared those properties. 
The results from this part are presented in Chapter 3 where we did find that 
immature T cells are more prone to differentiate to Treg, at least in adoptive 
transfer of Foxp3 negative T cells to lymphopenic recipients. Recent thymic 
emigrants (RTE) display an intermediate sensitivity to IL-6 and IL-4 which 
translates in a higher susceptibility to upregulate Foxp3 in the presence of 
these inflammatory factors when compared to the same process in mature 
peripheral cells, in which Foxp3 expression is strongly inhibited by such 
factors. At the same time, we showed that immature cells, both thymocytes 
and RTE, require less TGF available to upregulate Foxp3 again when 
compared to mature peripheral cells. The fact that immature cells are more 
prone to differentiate to Treg seems to rely in a combination of differential 
sensitivity to signals inhibiting and inducing Treg differentiation. However, 
the fact that immature T cells require less exogenous TGF than more 
mature cells, indicates that the contribution of immature T cells to Treg 
differentiation is likely to be relevant in settings where TGF is a limiting 
factor, and not only in lymphopenia.  
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Having a more specific characterization of the RTE maturation stage will be 
important to reveal potential new opportunities for interventions aiming at 
inducing tolerance. In summary, the main contribution of this part of the work 
was to show another contribution of the thymus for tolerance, this time by 
providing cells to the periphery that are more amenable to be polarized to a 
tolerizing phenotype. On the other hand understanding the maturation 
process of T cells after thymic export is also required to fully understand how 
the T cell repertoire is built and the T cell pool formed. Going back to the 
initial proposition by Burnet and Medawar, that tolerance is a property of 
neonatal life, our finding with RTE during Lymphopenia fits it perfectly. The 
newborn peripheral immune compartment is a lymphopenic system which is 
being filled in by thymic output, that is, it is mainly composed of RTE. 
Without excluding the effect of other factors, such as the innate immune 
system activation, our finding of RTE being particularly efficient in 
differentiation to Treg during Lymphopenia induced proliferation, guarantees 
an initial buffering to thymic selection regarding the establishment of 
tolerance early in life to self and environment derived innocuous antigens. At 
the same time, the enrichment in RTE puts Treg differentiation from 
peripheral cells as a likely participant in the original observations of neonatal 
tolerance. 
 
5.5 Treg precursors and the Two Step Model 
The differentiation of Treg has long been marked by a discussion of which 
cells can indeed upregulate Foxp3. When intrathymic differentiation of Treg 
was the only origin proven, the discussion focused on the models already 
mentioned in the introduction of elective or instructive mechanisms. After the 
experimental proof of Treg differentiation from peripheral cells some groups 
have addressed the existence of preferential precursors of Treg. The most 
successful data reported so far showed that CD25 expressing Foxp3 
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negative CD4SP thymocytes, as well as peripheral CD4 cells, do display an 
increased efficiency in giving rise to Treg when compared to the CD25 
negative counterpart (17-19). The upregulation of Foxp3 by this 
subpopulation of T cells is dependent only on cytokine signaling, namely IL-
2, and the CD25 expression is, in its turn, dependent on TCR stimulation. 
This interpretation led to a model of a two step mechanism for the 
upregulation of Foxp3 expression, in which cells first receive TCR 
stimulation in a favorable microenvironment, which leads to the upregulation 
of CD25, and later receive cytokine signal that then leads in the expression 
of Foxp3 and the establishment of a regulatory T cell phenotype. While we 
did not detect an impact on excluding such CD25 expressing Foxp3 negative 
cells of our preparations, the authors had already put forward that in the 
lymphopenia system CD25 negative cells can upregulate CD25 and then 
receive the cytokine stimulation to become Treg. At the same time the 
possibility that both signals are received simultaneously was not addressed. 
As such our study is not incompatible with this notion, but if this intermediate 
step is mandatory for Foxp3 expression immature cells should more 
frequently upregulate CD25 than mature cells when transferred to 
lymphopenic recipients. This proposition is so far untested but certainly 
deserves some further investigation. What is not clear is what the 
mechanism behind a potential increase in the frequency of cells that 
upregulate CD25 would be. What we have excluded in our work is that it 
would arise from a different repertoire between mature and immature cells, 
given that monoclonal TCR Tg cells displayed the same maturation 
dependent Treg susceptibility variation. Alternatively, it could lay in a 
differential integration of TCR signaling by T cells at different maturation 
stage. Regarding this possibility we did find a differential response to antigen 
titration with monoclonal T cells stimulated with the cognate antigen but not 
with -CD3. This piece of data confirms the potential differences in TCR 
signal integration and highlights that different qualities of TCR signaling have 
the potential to alter the efficiency of Treg differentiation. In summary, while 
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we did identify several factors that are known to influence Treg differentiation 
having a different impact in immature and mature cells, we did not find a 
fundamental molecular basis for the different sensitivity, that is what is 
behind a thymocyte lower expression of IL6 and IL4 receptors. Nevertheless, 
one of the most active researchers studying RTE has herself proposed that 
the rules behind the phenotype of RTE and their transition to mature cells 
are likely to depend in a collection of factors and modifications, and this 
multiparameter nature of immature vs mature T cells transition has made it 
difficult to understand RTE phenotype and mechanisms (20). 
 
5.6 Peripherally Differentiated Treg – Phenotype and Function 
Induced Treg studies have been mainly performed using TCR transgenic T 
cells. While being an invaluable tool to clarify antigen specific responses this 
tool is not always complemented with experiments with polyclonal WT T cell 
samples, leaving questions about the physiological relevance of iTreg 
unanswered for a long time. This scenario suffered a positive step forward 
with some recent reports using genetically modified mice where the genetic 
region controlling Foxp3 expression in peripheral cells is deleted (21). While 
the original report of this mouse line did not show any pathology the 
backcrossing of the mutation to a C57BL/6 background revealed a T cell 
based immunopathology. A further evaluation of the condition showed that 
the absence of iTreg differentiated through the activity of this genetic 
element led to a Th2 based uncontrolled immune response at mucosal 
interfaces. While the regulatory potential of Treg differentiated from 
peripheral cells had been demonstrated this was the first system showing a 
role for iTreg in an immune system that develops from the beginning without 
the capacity to generate iTreg.  
Both Chapter 2 and Chapter 3 give a strong indication that preventive 
therapies against auto-immune disorders may profit from being administered 
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at the youngest age possible. The fact that thymic activity decreases with 
age (22) leads to a lower chance of harnessing intrathymic Treg 
differentiation and the lower amount of RTE produced reduces the pool of 
cells in the periphery that are more prone to differentiate to Treg. An 
alternative to deal with this physiological constraint is to couple strategies 
that boost thymic activity with interventions relying on young peripheral cells 
and thymocytes as the source of cells differentiating to Treg. While such 
strategies are not yet available in the clinic there is active research ongoing 
with that goal in mind (23). Once both are established, the potential of the 
feature of young T cells being efficient in generating tolerance may help 
design applications to be performed in adults. 
It is nowadays widely accepted that Treg differentiate in vivo in different 
anatomical locations and at different maturation stages, namely from 
recently formed thymocytes in the thymus and from T cells already exported 
to the periphery. Moreover, Treg can also be generated through a quite 
diverse set of experimental manipulations (24).  
What has also been shown is that the phenotype obtained in the different 
conditions is not always the same. It seems important to have a full 
understanding of the factors influencing the different phenotypes Treg may 
adopt and address how each phenotype translates into functional properties. 
While studies that explore potential differences between Treg found at 
steady state of naïve mice and Treg differentiated from peripheral non 
regulatory T cells tend to interpret any discrepancies as arising from the 
differences in the Treg origin, precautions against confounder factors have 
not always been taken into consideration.  In most of the studies published 
so far Treg from different sources are not subjected to the same treatment. 
As such, there is the possibility that the conditions to which Treg are 
subjected are an important determinant to obtain the observed phenotypes 
and not the cells that gave rise to them. However, it is possible that Treg 
originating from conventional T cells in the periphery will have a particular 
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phenotype simply due to being exposed to a particular environment that 
Treg made in the thymus are not frequently in contact with. This would be a 
scenario of an extrinsic influence on Treg characteristics by which iTreg 
would differ from nTreg simply due to being exposed to particular cues and 
not related to differences in the phenotype related to the maturation stage at 
which the cells were first induced to express Foxp3. Such influences could 
explain why many studies report higher or lower level of expression of 
potential markers instead of a positive negative discrimination. The 
proposition of Helios as a marker of nTreg is an example of how comparing 
a narrow sample of iTreg may generate a wrong interpretation. While the 
original report compared only in vitro derived iTreg with steady state Treg, 
albeit both subjected to the same treatments. Nevertheless, works 
performed later, clarified that Treg induced from peripheral cells in vivo 
rather than in vitro can express Helios. Our own analysis which is presented 
in Chapter 3 shows that iTreg differentiated in the lymphopenia induced 
proliferation system also express Helios (25-27). On the other hand, two 
reports published back to back while this thesis was being finished, showed 
that Neuropilin-1 is preferentially expressed in thymic derived Treg. 
However, iTreg in a given environment also upregulate Nrp-1 expression 
which provides an example supporting that the main determinant for the 
different Treg phenotypes that can be observed  is the environment in which 
Treg are in contact with (28, 29). 
This is a similar concept to what has been observed in the plasticity of Treg, 
particularly in regards to the loss of Foxp3 expression. The main studies 
published so far have shown that Treg depend on IL-2 and TGF to keep 
Foxp3 and the regulatory phenotype. More recently, a notion of Treg 
adaptability in the form of sub-phenotypes with particular functions has also 
started to take form (30).  In these studies it was established that Treg 
require a functional transcriptional program that is orchestrated by 
transcription factors that are also determining the phenotype of helper cell 
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polarization of Tconv cells. Once Treg are made deficient in these pathways, 
by Foxp3 driven genetic manipulation, T cell mediated responses of the 
corresponding polarization are found deregulated. The work we present in 
Chapter 4 hints at a behavior of adaptability and dependence on the 
microenvironment the Treg are exposed to, to adopt a particular phenotype. 
In the lymphopenia system we used, where naïve or conventional T cells are 
transferred to lymphopenic recipients, a Th1 response takes place 
concomitantly with the differentiation of iTreg. While this iTreg seem to have 
little impact in controlling the activation of the global population of transferred 
T cells they do have an impact in the number of T cells recovered. However, 
the fact that little cells are recovered in a secondary transfer indicates they 
are either dependent in the microenvironment they differentiated in or are 
short lived. While we do not have data to provide a final answer to explain 
this phenomenon, we did find indications that the first possibility may be 
involved. iTreg differentiated in this system upregulate the IFN-R with no 
relevant changes in other cytokine receptors tested. Since IFN is the main 
cytokine secreted by Th1 polarized cells, it is likely that iTreg adopted a 
response to the IFN rich environment originating from the Tconv cells. It 
seems worth to explore this finding further and understand what the effect of 
INF in iTreg differentiated in this setting may be. 
Irrespective of the potential to generate Treg from peripheral cells, one must 
not forget that immune responses do take place. When exogenous antigens 
are presented together within an inflammatory context T cells get activated 
and a response is mounted despite the presence of Treg recognizing self 
antigens that are likely presented simultaneously. This implies that Treg 
activity can to some extent be circumvented by Tconv provided there are the 
right signals leading to an immune response and there are no Treg 
recognizing such antigens. The fact that Treg administration in experimental 
models usually works preemptively, as a prophylactic measure, rather than 
as a treatment against an ongoing response is likely to be a result of such 
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mechanism. However, immune responses can indeed be terminated and 
there maybe ways of making Treg efficient in dealing with ongoing immune 
system activity. One possible proposition is that the activity of Treg having a 
particular sub-phenotype may be more efficient at terminating a particular 
ongoing response than a blind mix of Treg isolated from steady state or 
differentiated in “neutral” conditions. Again, the studies with mouse models 
where Treg are deficient for transcription factors known to orchestrate a 
particular phenotype in helper T cells fit this hypothesis. While not many 
Treg are found expressing these transcription factors at steady state, they 
do develop together with the helper T cell polarization and keep the helper T 
cell activation under non pathological limits. In fact, this new concept on the 
potential of Treg to adapt to the immune system activity is another model 
that fits well with the adaptive nature of T cells. Together with the potential to 
adapt to the antigens present in the correct microenvironment at the correct 
time, Treg may also be able to adapt to the ongoing T cell responses to 
guarantee the maintenance of self-tolerance and minimize harmful side 
effects from exacerbated immune responses. This can be looked at as the 
Treg mirror image of the adaptability of the effector immune responses to 
any conceivable antigen and the adaptability of the type of response to be 
mounted according to the different challenges posed by different threats. 
A clarification of which immune system activities do Treg differentiated in 
different conditions influence and to what extent can it be influenced will 
provide invaluable information to set up efficient Treg boosting protocols. For 
instance, such differences may translate in how many cells need to be 
present to achieve the desired regulation. If a small population of Treg 
generated in one condition is more efficient than Treg generated in another 
in controlling a given activity, the implementation of a therapeutic 
intervention may be facilitated. At the same time, if a given Treg phenotype 
is particularly adapted to regulate a given response, it may be desirable to 
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only promote this sub-type of Treg so that unwanted over regulation of 
activities unrelated to the one to be targeted are prevented.  
 
5.7 A Potential System to Allow the Discrimination of Treg Differentiated in 
the Thymus and in the Periphery  
Irrespective of the lack of markers that distinguish Treg differentiated in the 
thymus and in the periphery, characterizing the contribution of both origins is 
important to understand how the Treg repertoire is shaped. The inability to 
define a distinctive phenotype of induced and natural Treg make this task 
more difficult but there should be ways to achieve it. We have indeed 
designed a system based on genetic manipulation to map the origin of Treg 
that should label Treg made in the thymus differently from Treg differentiated 
in the periphery. While the technical state of the art turn the project a high 
risk one, the concept should be valid for when the tools become available.  
The system basically requires a method to label cells under the exclusive 
condition of being expressing two genes simultaneously. Such a system 
would be integrated to label cells expressing Foxp3 at the same time as they 
are expressing a thymocyte stage specific gene, for which we found the 
proximal Lck promoter a valid candidate. While genetic labeling systems 
dependent on the activity of two genes are not fully developed we did find a 
few reports targeting this issue by expressing the Cre recombinase in two 
different halves, inactive when alone and only active when co-expressed 
through heterodimerization (31-33). In theory, If one half of Cre is driven by 
Foxp3 and the other by the proximal Lck promoter only cells upregulating 
Foxp3 in the thymocyte stage would have the potential to recombine a 
genetic label, permanently and exclusively tagging Treg made in the thymus. 
Then by coupling a reporter construct encoding GFP and RFP with a floxed 
stop codon separating them, also driven by Foxp3 together with one of the 
halves of the Cre, should reveal recombination events by Foxp3 driven 
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expression of both GFP and RFP. As such, Treg cells that first upregulated 
Foxp3 at the thymocyte stage would be GFP and RFP positive while cells 
upregulating Foxp3 after the proximal Lck promoter activity had been shut 
down would be GFP alone. However, the fidelity and efficiency of the system 
do not seem up to par for the task of efficiently labeling such a small 
population of cells to the extent of attributing a particular origin to a small 
percentage within them. 
The capacity to efficiently track Treg depending exclusively on the 
maturation stage at which Treg upregulate Foxp3 will provide invaluable 
information about the potential of generating Treg in a WT scenario. An 
advance in understanding iTreg differentiation will be essential to evaluate 
the potential of generating tolerance outside the thymus and help clarify the 
best manipulations to harness its full power.  
 
5.8 Concluding Remarks 
While the work presented in this thesis was designed from an academic 
interest with a particular focus in elucidating rules governing Treg 
differentiation, it is impossible to disregard the potential interest of future 
clinical applications when studying Treg. This was pursued by analyzing the 
findings here reported not only as clarifications of biological phenomena but 
also in the light of their potential in enhancing or maintaining tolerance, 
which has by itself a direct correlation to clinical settings. In Chapter 2 the 
potential access to the thymus by peripheral antigens offers information 
about how the Treg repertoire may be selected against antigens that are 
exclusively peripheral but at the same time gives an example of a proof of 
concept for an anti autoimmune disease vaccine. Chapter 3 is focused on 
the impact of cell age in the differentiation of Treg in the periphery. While 
extending the findings presented in the previous chapter, Chapter 3 is fully 
focused in Treg differentiation outside the thymus and provides an example 
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of an age dependent property that may be taken advantage of in the 
application of therapies aiming at generating tolerance. Then, Chapter 4 
presents a brief study of Treg differentiated in the periphery, their function 
and stability in lymphopenia, where we obtained indications that Treg 
differentiated in the periphery can act on the naïve T cell population from 
which they arise, but that they may also be fragile and/or dependent on 
particular conditions to survive and exert their function. In toto, the work 
presented here provides new findings regarding the origin and physiology of 
Treg in respect to their adaptation to the peripheral immune compartment. 
In conclusion, the body of work elucidating Treg physiology indicates Treg 
are a heterogeneous population, however this heterogeneity may not 
translate in a constitutive phenotype identifiable by surface markers 
particularly reflecting the maturation stage of the cells that were the 
precursors. In turn, Treg seem to display a great degree of plasticity that 
represents the milieu in which they are inserted in a transitory manner. As 
such, Treg may lose Foxp3 and gain effector functions, adopt transcriptional 
profiles that match the immune responses to be regulated and can be 
differentiated from T cells at different stages. These features fit perfectly the 
notion of adaptive immunity which is based on the ability of the immune 
system to recognize and respond concordantly to previously uncharted 
challenges. This emerging picture of Treg dynamics represents anticipatory 
capacity to tolerance as the generation of a random repertoire of antigen 
receptors does for immunity. 
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